Page last updated: 2024-10-30

mechlorethamine and Granuloma, Hodgkin

mechlorethamine has been researched along with Granuloma, Hodgkin in 1224 studies

nitrogen mustard : Compounds having two beta-haloalkyl groups bound to a nitrogen atom, as in (X-CH2-CH2)2NR.

Research Excerpts

ExcerptRelevanceReference
"This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome."9.09Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000)
"In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine."9.08Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997)
"In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease."9.07Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993)
"Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose."7.85Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017)
"Fifty-six patients with newly diagnosed Stage II-IV Hodgkin disease, ages 18-77 years, were randomized to receive GM-CSF (5 microg/kg subcutaneously) or placebo from Day 7 to Day 4 before each chemotherapy administration (6 cycles of a hybrid of mechlorethamine, vincristine, procarbazine, and prednisone with doxorubicin, bleomycin, vinblastine, and dacarbazine)."5.09Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease. ( Aglietta, M; Amadori, S; Botto, B; Cantonetti, M; Castoldi, GL; Dammacco, F; Fagioli, F; Ferrara, R; Levis, A; Montemurro, F; Racanelli, V; Teofili, L; Volta, C, 2000)
"This study was undertaken to systematically evaluate the agreement rates among single photon emission computed tomography using gallium-67 (Ga-67 SPECT), lymphangiography (LAG), and computed axial tomography (CT) scan findings for Hodgkin disease and to correlate radiologic findings with clinical outcome."5.09Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome. ( Allen, PK; Choe, JG; Cox, JD; Edmund, E; Ha, CS; Kong, JS; Oh, YK, 2000)
"In the last two decades, it has become evident that secondary leukemias after Hodgkin's disease (HD) are mainly caused by the treatment with alkylating agents, especially mechlorethamine."5.08Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group. ( Creutzig, U; Gadner, H; Harbott, J; Mann, G; Riepenhausen, M; Ritter, J; Schellong, G, 1997)
"9 years, range, 1-15 years) received the AIEOP-MH 1983 Hodgkin disease protocol of low-dose radiation therapy (20-25 Gy), with three cycles of adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) for children with early-stage and favorable disease, and with alternating cycles of an eight non-cross-resistant drug combination regimen (nitrogen mustard, vincristine, procarbazine, and prednisone [MOPP]/ABVD) for 6 months for those with bulky and unfavorable disease."5.07Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. ( Bontempi, N; Burnelli, R; Carli, M; Comelli, A; Di Tullio, MT; Pileri, S; Rosati, D; Sotti, G; Testi, AM; Vecchi, V, 1993)
"In a pilot study, Cancer and Leukemia Group B (CALGB) incorporated etoposide into primary combination therapy for advanced Hodgkin disease."5.07Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study. ( Anderson, JR; Barcos, M; Burns, LJ; Cooper, MR; Gottlieb, AJ; Kirshner, JJ; Parker, B; Peterson, BA, 1993)
"Survivors of advanced Hodgkin disease, who were assigned randomly to treatment by mechlorethamine, vincristine, procarbazine, and prednisone (MOPP); doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD); or MOPP alternating with ABVD in a clinical trial of the Cancer and Leukemia Group B (protocol 8251), were compared in terms of their psychosocial adaptation and psychosexual function an average of 2."5.07Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD. ( Anderson, J; Canellos, GP; Cella, DF; Cherin, E; Cooper, MR; Henderson, ES; Kornblith, AB; Kosty, MP; Tross, S; Zuckerman, E, 1992)
" Patients were randomized in the Southwest Oncology Group (later the Pediatric Oncology Group [POG] to involved-field (IF) radiotherapy alone or IF radiotherapy followed by six courses of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP) chemotherapy; patients in the Children's Cancer Study Group (CCSG) and Cancer and Leukemia Group B (CALGB) were randomized to receive extended-field (EF) radiotherapy or IF radiotherapy followed by six courses of MOPP."5.06The intergroup Hodgkin's disease in children. A study of stages I and II. ( Fryer, C; Fuller, LM; Gehan, EA; Gilchrist, GS; Hanson, W; Hays, DM; Heller, R; Johnston, J; Kennedy, P; Sullivan, MP, 1990)
" The authors describe a patient with Hodgkin's disease who developed an atypical aortic dissection while receiving MOPP/ABV chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone, doxorubicin, bleomycin, and vinblastine)."4.79Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report. ( Bavaria, JE; Crooks, GW; Golden, MA; Holland, GA; Vaughn, DJ, 1997)
" After a median follow-up of more than 6 years following MOPP (mechlorethamine/vincristine/procarbazine/prednisone) chemotherapy with or without radiotherapy, 5% of patients with Hodgkin's disease developed second primaries, 60% of which were leukemias."4.78Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects. ( Petru, E; Schmähl, D, 1991)
" The risk of treatment-induced acute leukemias as well as sterility can be avoided or greatly decreased with drug combinations not including procarbazine HCI and alkylating agents."4.77Chemotherapy of malignant lymphomas. ( Bonadonna, G, 1985)
"Colorectal cancer surveillance should be considered for HL survivors who received Infradiaphragmatic radiotherapy and a high cumulative procarbazine dose."3.85Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. ( Aleman, BM; de Boer, JP; De Bruin, ML; Janus, CP; Kremer, LC; Krol, AD; Louwman, MW; Schaapveld, M; van der Maazen, RW; van Eggermond, AM; van Leerdam, ME; van Leeuwen, FE; Visser, O; Zijlstra, JM, 2017)
"The proportion of intravenous drug abusers (IVDA) in HIV-HD (38%) is higher than in French HIV-infected population as a whole (20."3.78Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors. ( Andrieu, JM; Brice, P; Colonna, P; Gastaut, JA; Lévy, R; Raphaël, M; Taillan, B; Tourani, JM, 1995)
" We describe a 5-year-old boy with stage IV HD, successfully treated with MOPP (mechlorethamine, vincristine, procarbazine, and prednisone)/ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy followed by 35 Gy mantle radiotherapy who developed primary hyperparathyroidism because of benign PTA at the age of 20 years, and died of CS in thoracic vertebrae at the age of 22 years."3.76Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease. ( Albayrak, M; Coskun, U; Gursel, T; Kaya, Z; Keskin, EY; Kocak, U; Uluoglu, O, 2010)
"To determine the long-term outcome of patients presenting with synchronous lymphoma and severe liver dysfunction and to describe the outcome of patients treated with initial mechlorethamine-based therapy used as a bridge to more conventional chemotherapy."3.72Therapeutic options in patients with lymphoma and severe liver dysfunction. ( Ansell, SM; Colgan, JP; Fonseca, R; Ghobrial, IM; Habermann, TM; Inwards, DJ; Markovic, SN; Micallef, IN; Pereira, DL; Porrata, LF; White, WL; Witzig, TE; Wolf, RC, 2004)
"In addition to mechlorethamine, lomustine and teniposide combinations were also linked to an elevated risk of developing leukemia."3.69Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage. ( Chorus, AM; Hagenbeek, A; Noyon, R; Pinedo, HM; Somers, R; van den Belt-Dusebout, AW; van Kerkhoff, EH; van Leeuwen, FE, 1994)
"From January 1980 to September 1986, 50 patients with Hodgkin disease, clinical stages (CS) IIIB (26 cases) and IVB (24 cases) were treated by three cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy, followed by high-dose (40 Gy) (sub)total lymphoid irradiation, including the spleen."3.67Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation. ( Afiane, M; Andrieu, JM; Belhadj-Merzoug, K; Colonna, P; Ghouadni, R; Krisch, C; Kubisz, P; Laugier, A; Tourani, JM; Zouaoui-Benhadji, Z, 1989)
"Eighteen children with Hodgkin disease (16 previously untreated; two relapsed) were treated with MOPP chemotherapy (nitrogen mustard, vincristine, prednisone, procarbazine) only."3.66Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality. ( Ekert, H; Waters, KD, 1983)
"A case of human fetal renal maldevelopment following the administration of nitrogen mustard, vincristine, procarbazine, and prednisone in early pregnancy for therapy of Hodgkin's disease is reported."3.65Fetal renal malformation following treatment of Hodgkin's disease during pregnancy. ( Mellman, WJ; Mennuti, MT; Shepard, TH, 1975)
" Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their initial treatment with MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) or CVP (cyclophosphamide, vincristine, and prednisone) chemotherapy, respectively."3.65Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma. ( Canellos, GP; DeVita, VT; Ihde, DC; Young, RC, 1976)
"Chemotherapy for classic Hodgkin lymphoma (cHL) patients on hemodialysis (HD) is an extremely challenging situation because pharmacokinetic and pharmacodynamic studies of most chemotherapeutics are lacking for the HD patient, and the small amount of evidence available comes mostly from case reports and small case series."2.82Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations. ( Ando, J; Ando, M; Komatsu, N; Yasuda, H, 2022)
"After MOPP-Bleo induction for advanced Hodgkin lymphoma, ABVD provides better consolidation than local RT."2.74Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up. ( Bennett, JM; Glick, JH; Hong, F; Wiernik, PH, 2009)
"Treatment of early-stage Hodgkin's disease is usually tailored in line with prognostic factors that allow for reductions in the amount of chemotherapy and extent of radiotherapy required for a possible cure."2.73Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease. ( Baars, JW; Berger, F; Blanc, M; Bosq, J; Brice, P; Carde, P; Carrie, C; Creemers, GJ; Diviné, M; Eghbali, H; Fermé, C; Gabarre, J; Girinsky, T; Gyan, E; Hagenbeek, A; Henry-Amar, M; Jaubert, J; Kluin-Nelemans, JC; Lederlin, P; Lugtenburg, PJ; Meerwaldt, JH; Monconduit, M; Noordijk, EM; Poortmans, P; Raemaekers, JM; Reman, O; Rieux, C; Salles, G; Thomas, J; Tirelli, U; Van den Neste, E; van't Veer, MB; Vié, B; Viseu, F; Walewski, JA, 2007)
"The causes of death were Hodgkin's lymphoma in 36 patients, second neoplasms in 12, cardiorespiratory diseases in 4, pulmonary diseases in 2, and unknown in 6."2.72MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. ( Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F, 2006)
"In early-stage Hodgkin's lymphoma (HL), subtotal nodal irradiation (STNI) and combined chemotherapy/radiotherapy produce high disease control rates but also considerable late toxicity."2.72Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials. ( Aleman, BM; Bosq, J; Carde, P; Dupouy, N; Eghbali, H; Girinsky, T; Hagenbeek, A; Henry-Amar, M; Kluin-Nelemans, JC; Krol, AD; Monconduit, M; Noordijk, EM; Pény, AM; Raemaekers, JM; Thomas, J; Tirelli, U; Verschueren, TA; Vovk, M, 2006)
"Adult patients (N = 856) with advanced Hodgkin's disease were randomly assigned to treatment with ABVD or MOPP/ABV."2.71Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. ( Canellos, GP; Connors, JM; Duggan, DB; Fisher, RI; Glick, JH; Johnson, JL; Peterson, BA; Petroni, GR, 2003)
"One hundred patients with Hodgkin's disease (97 with stage I-II disease at presentation) who relapsed after radiation therapy alone were salvaged with either MOPP or ABVD."2.71Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease. ( Fisher, DC; Li, S; Mauch, PM; Neuberg, D; Ng, AK; Silver, B; Stevenson, MA, 2004)
"Management of advanced-stage Hodgkin's disease with a MOPP/ABV hybrid regimen (mechlorethamine, vincristine, procarbazine, prednisone, Adriamycin, bleomycin and vinblastine) has yielded a high complete response rate (75-85%)."2.69Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy. ( Bélanger, D; Bergeron, M; Cantin, G; Couture, F; Desjardins, L; Dufresne, J; Gyger, M; Hewitt, LA; L'Espérance, B; Lacroix, L; Ouellet, PA; Pirc, L; Yelle, L, 1999)
"The treatment of advanced Hodgkin's disease (HD) with chemotherapy (CTx) alone or combined modality treatments has been controversial."2.69Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial. ( Berger, F; Bordessoule, D; Brice, P; Caillot, D; Diviné, M; Fermé, C; Ferrant, A; Gabarre, J; Hennequin, C; Lederlin, P; Lepage, E; Moullet, I; Sebban, C, 2000)
"Patients with Hodgkin's disease (HD) who fail to enter a complete remission after an initial course of combination chemotherapy are usually considered to have an induction failure (IF); this subset of patients has an extremely poor outcome with further conventional therapy."2.68High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy. ( Barnett, MJ; Fairey, RN; Hogge, DE; Klasa, RJ; Klingemann, HG; Nantel, SH; Reece, DE; Shepherd, JD; Sutherland, HJ; Voss, NJ, 1995)
"Fourteen had Hodgkin's and four non-Hodgkin's lymphoma."2.68Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. ( Avivi, I; Ben-Shahar, M; Blumenfeld, Z; Epelbaum, R; Haim, N; Linn, S, 1996)
"Two cases developed a second malignancy."2.68Treatment of childhood Hodgkin's disease without radiotherapy. ( Behrendt, H; van den Berg, H; Zsiros, J, 1997)
"Eighty patients presented with Hodgkin's disease and a mediastinal mass greater than one third the greatest chest diameter on chest radiograph."2.68Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease. ( Bastian, AW; DeVita, VT; Duffey, PL; Glatstein, E; Hubbard, SM; Ihde, DC; Jaffe, ES; Longo, DL; Wilson, WH; Wittes, RE; Young, RC, 1997)
"(mean 43 yr."2.68[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes]. ( Ziółko, E, 1997)
"A retrospective review of patients with Hodgkin's disease treated at Stanford University Medical Center was undertaken to determine if, within the pediatric population, children < or = 10 years of age have a unique prognosis and response to treatment."2.67Hodgkin's disease in the very young. ( Cleary, SF; Donaldson, SS; Link, MP, 1994)
"Of our 19 patients with Hodgkin's disease (age range, 6 to 20 years) treated with this regimen, 2 had clinical stage I disease, 10 had stage II, 6 had stage III, and 1 had stage IV."2.67Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence. ( Arndt, CA; Chen, MG; Gilchrist, GS; Khan, SP; Matsumoto, JM; O'Fallon, WM; Schomberg, PJ; Smithson, WA, 1994)
"Twenty-four patients with Hodgkin's disease refractory or resistant to at least two chemotherapy regimens were enrolled in this study."2.67Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease. ( Balzarini, L; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Valagussa, P; Viviani, S, 1994)
"Patients with PSIII 1A Hodgkin's disease treated with RT have a significantly higher risk of relapse and potentially a poorer survival compared with patients treated with CMT."2.67Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy. ( Canellos, GP; Coleman, CN; Kalish, LA; Marcus, KC; Mauch, PM; Rosenthal, DS; Shulman, LN, 1994)
"Relapses were most frequent in previously involved unirradiated areas."2.67Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience. ( Breed, WP; Burgers, JM; Carde, P; de Pauw, BE; Hagenbeek, A; Henry-Amar, M; Monconduit, M; Somers, R; Tarayre, M; Thomas, J, 1991)
"In patients with stage IV Hodgkin's disease mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) was randomly tested against MOPP alternated monthly with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD)."2.66Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results. ( Bonadonna, G; Santoro, A; Valagussa, P, 1986)
"In 1982 a French cooperative study for Hodgkin's disease was designed to minimize adverse side effects of therapy in childhood."2.66[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation]. ( Lemerle, J; Leverger, G; Oberlin, O; Schaison, G, 1987)
"Fifty-three children with Hodgkin's disease were clinically staged and treated with chemotherapy alone."2.66Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease. ( Ekert, H; Mauger, D; Smith, PJ; Toogood, I; Waters, KD, 1988)
" Buserelin (d-Ser-[TBU]6 LHRH ethylamide) was prescribed in two different dosage schedules to twenty men, and in a single dosage schedule to eight women."2.66Failure to preserve fertility in patients with Hodgkin's disease. ( Ahmed, R; Besser, GM; Crowther, D; Gregory, W; Malpas, JS; Rees, LH; Shalet, S; Smith, D; Waxman, JH; Wrigley, PF, 1987)
"The H5 study of supradiaphragmatic Hodgkin's disease in clinical stages I-II consisted of two controlled trials adapted to patients considered to have either favorable or unfavorable characteristics, based on prognostic factors identified in two former studies by the European Organization for Research and Treatment of Cancer."2.66Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr ( Burgers, JM; Carde, P; Cosset, JM; Hagenbeek, A; Hayat, M; Meerwaldt, JH; Monconduit, M; Sizoo, W; Somers, R; van der Schueren, E, 1988)
"Of the 188 patients with Hodgkin's disease, 157 achieved a complete response (CR) (84%), and 66% of them (101 patients) have remained disease-free more than 10 years from the end of treatment."2.66Twenty years of MOPP therapy for Hodgkin's disease. ( DeVita, VT; Duffey, PL; Hubbard, SM; Jaffe, ES; Longo, DL; Wesley, M; Young, RC, 1986)
"299 patients with stage III or IV Hodgkin's disease were randomised to receive cyclical chemotherapy with MOPP (mustine, Oncovin, procarbazine, prednisone) or LOPP (Leukeran substituted for mustine)."2.66Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation. ( Hancock, BW, 1986)
"Three patients with remission of Hodgkin's disease after involved-field (two) and extended-field (one) radiotherapy died from cardiovascular disease that could only be attributed to the prior radiotherapy."2.66Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities. ( Caravelli, J; Cirrincione, C; Cunningham, I; Koziner, B; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Redman, J; Straus, DJ, 1986)
"From 1976 to 1981, 335 patients with untreated Hodgkin's disease, clinical stages I, II, and IIIA, have been treated by MOPP (nitrogen mustard, vincristine, procarbazine, prednisone) chemotherapy, three to six cycles according to the prognostic factors, combined with radiotherapy."2.66Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease. ( Audebert, A; Bernadou, A; Diebold, J; Eghbali, H; Hoerni, B; Krulik, M; Merle-Béral, H; Parlier, Y; Rojouan, J; Zittoun, R, 1985)
" From 1976 to 1979 patients with Stage IV disease were treated wither with MOPP or with MOPP plus bleomycin at low dosage (B-MOPP); the incidence of complete remission was not significantly different in the two groups of patients (52 vs."2.65Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). ( Goldman, JM, 1981)
"Eighteen patients with advanced Hodgkin's disease, refractory to combination chemotherapy with nitrogen mustard, vincristine, prednisone, and procarbazine (MOPP), were treated with vinblastine, doxorubicin (Adriamycin), bleomycin, CCNU, and dacarbazine (DTIC) (VABCD)."2.65Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine. ( Bond, WH; Chenoweth, L; Einhorn, LH; Stevens, EE; Williams, SD, 1983)
"Seven patients with active Hodgkin's lymphoma who had relapsed 4-39 months following six or more cycles of MOPP were treated with a combination of vinblastine-bleomycin-cis-platin (VBP)."2.65Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma. ( Clamon, GH; Corder, MP; Wiesenfeld, M, 1984)
"Forty-seven patients with advanced Hodgkin's disease were entered in a prospective, randomized trial comparing MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) with a regimen containing lomustine (CCNU), vinblastine, and prednisone (CCNU-VP)."2.65Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone. ( Bateman, JR; Hum, GJ; Liebman, HA; Ryden, VM; Sheehan, WW, 1983)
"Of 209 Hodgkin's disease patients treated at least 6 months with a five-drug combination of induction chemotherapy and having a complete remission, four patients developed acute myelogenous leukemia (AML) as a second malignant neoplasm."2.65Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease. ( Bartolucci, AA; Durant, JR; Gams, RA; Liu, C, 1983)
"Advanced Hodgkin's disease appears to be curable by chemotherapy."2.65Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute. ( Berard, CW; Canellos, GP; Carbone, PP; DeVita, VT; Frei, E; Hubbard, SM; Moxley, JH; Simon, RM; Young, RC, 1980)
"Thirty seven Hodgkin's lymphoma patients with recurrence after first remission induced by radiation therapy and/or chemotherapy with mustine, oncovin, procarbazine and prednisolone (MOPP) were randomised to treat with a new combination chemotherapy comprising of doxorubicin, oncovin, procarbazine and prednisolone (DOPP)."2.65A new combination chemotherapy for recurrent Hodgkin's lymphoma. ( Ahmed, Q; Rahim, MA; Sarma, SK, 1982)
"Twenty-one patients with advanced Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, prednisone) were treated with ABVD (adriamycin, bleomycin, vinblastine, dacarbazine)."2.65Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD). ( Bonadonna, G; Santoro, A, 1979)
"No deaths from Hodgkin's disease have occurred in patients who received combined modality therapy, whereas 24 per cent of the patients who received radiotherapy alone have died with active disease."2.65Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later. ( Diggs, C; Gustafson, J; Schimpff, SC; Wiernik, PH, 1979)
"117 patients with stage IIIA Hodgkin's disease were randomly allocated for treatment in a multicentre trial comparing the results of total nodal irradiation (T."2.64Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation. ( , 1976)
"Thirty-seven patients with advanced Hodgkin's disease have been treated for greater than or equal to 3 months with a protocol consisting of alternate monthly courses of MOPP (mechlorethamine, Oncovin [vincristine], procarbazine, and prednisone) and ABDV (adriamycin, bleomycin, DTIC, and vinblastine) with local radiotherapy (RT) to areas of originally bulky disease."2.64Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease. ( Case, DC; Clarkson, BD; Lee, BJ; Nisce, L; Young, CW, 1976)
"Thirty-four children with Hodgkin's disease were treated during the years 1969--75."2.64MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children. ( Armata, J; Borkowski, W; Depowska, T; Depowski, M; Kaczor, Z; Stopyrowa, J; Strzeszynski, J, 1978)
"Prednisone seems to be an important component of the MOPP combination in the management of stage IV Hodgkin's disease."2.64Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. ( , 1975)
"204 patients with Hodgkin's disease not previously treated were given vincristine, chlormethine, procarbazine and prednisone (protocol H2-65) for six months, followed by monthly vinblastine injections."2.64[Polychemotherapy of Hodgkin's disease (author's transl)]. ( Auclerc, G; Bernard, J; Boiron, M; Chastang, CL; Chelloul, N; Delbrück, H; Jacquillat, CL; Weil, M, 1975)
"Hodgkin lymphoma is a rare lymphoid malignancy affecting ∼9,200 new patients in the United States annually."2.53Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond. ( Ansell, SM, 2016)
"We discuss the characteristics of breast cancer that occurs after Hodgkin's lymphoma and also treatment options that could be implemented."2.44Breast cancer after treatment of Hodgkin's lymphoma: general review. ( Alm El-Din, MA; El-Badawy, SA; Taghian, AG, 2008)
"Primary treatment of advanced Hodgkin's disease."2.43[Primary treatment of advanced Hodgkin's disease]. ( Illés, A; Molnár, Z; Udvardy, M, 2005)
"We describe a 59-years-old woman with limbic encephalitis, not explained by other causes, preceding diagnosis of Hodgkin's disease."2.42[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis]. ( Bernard, P; Flocard, F; Kadouri, A; Talarmin, F; Vinzio, S, 2003)
"There are two major goals in advanced Hodgkin's disease: (1) to improve the cure rate and (2) to reduce acute and long-term toxicities."2.41Treatment of advanced stage Hodgkin's disease. ( Diehl, V; Sieber, M; Tesch, H, 2001)
"The patients with advanced-stage Hodgkin's disease who did not achieve a complete remission from their initial treatment with combination chemotherapy have a dismal prognosis."2.40[The management of Hodgkin's disease with chemotherapy or combined modality treatment]. ( Shimoyama, M; Tsushita, K; Utsumi, M, 1998)
"80% or more of patients suffering from Hodgkin's lymphoma (HD) of limited stage are cured with modern treatment."2.39[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults]. ( Glanzmann, C; Stahel, R, 1995)
"Death still occurs in Hodgkin's disease (HD) patients with advanced stages, but also in early stages."2.39[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?]. ( Carde, P, 1995)
"Malignant lymphoma is classified into the following five major categories: aggressive lymphoma, indolent B-lymphoma, Hodgkin's disease, T-lymphoblastic lymphoma and adult T-cell leukemia-lymphoma (ATL)."2.39[Recent progress in the chemotherapy of malignant lymphoma]. ( Tobinai, K, 1995)
"In most patients with newly diagnosed Hodgkin's disease, initial therapy is curative."2.39Hodgkin's disease: management of first relapse. ( Horning, SJ; Yuen, AR, 1996)
"The association between Hodgkin's disease and pregnancy is rare."2.38[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature]. ( Abboud, J; Chahine, G; Nasnas, R; Nasrallah, T, 1993)
"Thymic hyperplasia was noted after treatment was initiated or completed in all but two patients; and all did well, with one exception: a 17 year-old boy who was inadvertently treated for relapsed Hodgkin disease and who died of fibrinous pneumonitis and nocardia, with pathologic CR noted at autopsy."2.38Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission. ( Erner, SM; Keller, SM; Langer, CJ, 1992)
"The cases of 63 children treated for Hodgkin's disease were retrospectively evaluated according to clinical and laboratory characteristics at initial appearance, clinical and pathologic staging, and treatment for their effects on survival and disease-free survival."2.38Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota. ( Aeppli, D; Day, DL; Heise, R; Lee, CK; McClain, KL; Woods, WG, 1990)
"Treatment of disseminated Hodgkin's disease still fails in about 50 percent of the cases."2.38[Treatment of relapses and failures in disseminated Hodgkin's disease]. ( Bastion, Y; Coiffier, B; Tigaud, JD, 1991)
"A case of Hodgkin's disease associated from the start with visceral leishmaniasis in the absence of antitumoral treatment shows that leishmaniasis is a severe opportunistic infection in endemic areas and can be masked by the tumoral syndrome of an underlying pathology."2.38[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties]. ( Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N, 1991)
"Cutaneous manifestations of Hodgkin's disease are relatively uncommon."2.38Hodgkin's disease presenting in the skin: case report and review of the literature. ( Hayes, TG; Rabin, VR; Rosen, T; Zubler, MA, 1990)
"Ten patients developed SANLL between the 34th and 123rd month of CR."2.38Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease. ( Andrieu, JM; Coscas, Y; Fermanian, J; Flandrin, G; Ifrah, N; Payen, C, 1990)
"Pulmonary toxicity is a well recognised side effect of anticancer agents particularly bleomycin, cyclophosphamide, methotrexate, and busulphan."2.38Pulmonary toxicity following MOPP chemotherapy. ( Byrne, MJ; Cohney, SJ; Millward, MJ; Ryan, GF, 1990)
"Chemotherapy of malignant lymphomas has accomplished a significant progress during the two decades."2.38[Current status of chemotherapy in the treatment of malignant lymphomas]. ( Hayashi, K; Kimura, I; Mizuta, J; Murashima, M; Ohnoshi, T; Tada, A; Tagawa, S; Ueno, K, 1989)
"The outlook for patients with Hodgkin's disease has improved dramatically over the past 20 years."2.37Hodgkin's disease. ( Portlock, CS, 1984)
"Patients with advanced Hodgkin's disease not achieving a complete remission with initial MOPP therapy are significantly less responsive to adriamycin and nitrosourea-containing regimens than patients with relapsing disease following a complete remission with MOPP."2.37Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment. ( Coleman, M; Friedlander, RJ, 1988)
"Most patients with early-stage Hodgkin's disease can now be cured by one of several therapeutic approaches."2.37Early-stage Hodgkin's disease: current approaches to treatment. ( MacKenzie, R; Rusthoven, JJ, 1985)
"The prognosis of patients with Hodgkin's disease has dramatically improved over the past few decades."2.37Current management of Hodgkin's disease. ( Behrens, BC; DeVita, VT; Young, RC, 1985)
"Classical Hodgkin lymphomas (cHLs) include small numbers of malignant Reed-Sternberg cells within an extensive but ineffective inflammatory/immune cell infiltrate."1.43PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome. ( Advani, RH; Armand, P; Chapuy, B; Connelly, CF; Daadi, SE; de Jong, D; Freeman, GJ; Homer, H; Hoppe, RT; Ligon, AH; Natkunam, Y; Neuberg, DS; Redd, RA; Rodig, SJ; Roemer, MG; Shipp, MA; Sun, HH, 2016)
"To quantify the incidence of thyroid cancer after Hodgkin lymphoma (HL) and determine disease characteristics, risk factors, and treatment outcomes."1.40Thyroid malignancies in survivors of Hodgkin lymphoma. ( Chen, YH; Marcus, KJ; Michaelson, EM; Ng, AK; Silver, B; Stevenson, MA; Tishler, RB, 2014)
"Azathioprine was withdrawn."1.40Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy. ( Khuroo, MS, 2014)
"Seventy-five Hodgkin lymphoma and non-Hodgkin lymphoma patients and a control group of 257 fertile men."1.40Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network. ( Auger, J; Berthaut, I; Brugnon, F; Bujan, L; Daudin, M; Hennebicq, S; Moinard, N; Rives, N; Saias, J; Szerman, E; Walschaerts, M, 2014)
"To assess therapy-related acute myeloid leukemia/myelodysplastic syndrome (t-AML/MDS) risk in patients treated for Hodgkin lymphoma (HL) on successive generations of Stanford clinical trials."1.39Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials. ( Advani, RH; Balise, R; Greenberg, PL; Hoppe, RT; Horning, SJ; Koontz, MZ; Rosenberg, SA, 2013)
"Ductal invasive carcinoma and ductal carcinoma in situ represented, respectively, 51 cases (71%) and 14 cases (19%)."1.38Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option. ( Belin, L; Bollet, MA; Campana, F; Decaudin, D; Fourquet, A; Haberer, S; Kirova, YM; Le Scodan, R; Moisson, P; Pierga, JY; Reyal, F; Savignoni, A; Stevens, D, 2012)
"Twelve women (12%) experienced 13 miscarriages after a median of 50 months (range, 13-120) from the end of therapy."1.38Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma. ( Alfò, M; Annechini, G; Cavalieri, E; De Sanctis, V; Enrici, RM; Filippone, FR; Minniti, G; Muni, R; Osti, MF; Pulsoni, A; Valeriani, M, 2012)
" Prospective pharmacokinetic studies to devise a rational dosing strategy for vinblastine in patients receiving ritonavir/lopinavir are warranted."1.38Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma. ( Boro, J; Cheung, MC; Ezzat, HM; Harris, M; Hicks, LK; Leitch, HA; Lima, VD; Montaner, JS, 2012)
"The majority of patients with Hodgkin's disease can be cured by combination of polychemotherapy and radiotherapy (RT) that can produce late toxic pulmonary and cardiac effects which often remain at a subclinical level."1.36Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S, 2010)
"The behavior of Hodgkin's lymphoma (HL) is different in developing countries, perhaps due to differences in epidemiology and population access to health care."1.35Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study. ( Alves, AC; Baiocchi, OC; Oliveira, JS; Souza, EM; Zanichelli, MA, 2009)
" Since survival rates for patients receiving risk-adapted programs (DAL-Hd, SPBLKH-05) were higher than in control (MOPP), relevant protocols using lower drug dosage should be recommended in groups of favorable and intermediate risk."1.35[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents]. ( Kuleva, SA, 2008)
"Therefore, 126 patients suffering from Hodgkin's disease were investigated after a follow-up of at least 5 years from the completion of the combined treatment."1.35Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease. ( Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S, 2009)
"Relative risks (RRs) of stomach cancer and the radiation-related excess relative risk (ERR) per gray were calculated by conditional logistic regression analysis."1.35Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. ( Aleman, BM; Besseling, G; de Bruin, ML; de Wit, R; Gietema, JA; Hauptmann, M; Kerst, JM; Noordijk, EM; Ribot, JG; van 't Veer, MB; van den Belt-Dusebout, AW; van Leeuwen, FE, 2009)
" It is suggested that total focal dosage used after chemotherapy be reviewed since total dosage for the entire lymph collector in excess of 30 Gy might contribute to hazards of cardiopathology."1.35[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma]. ( Bozhenko, VK; Datsenko, PV; Ivashin, AV; Mel'nik, IuD; Pan'shin, GA; Podol'skiĭ, PN; Sotnikov, VM, 2009)
"The treatment results of our Hodgkin's disease patients improved, additionally we showed that patients with early stage favourable disease the treatment toxicity should be reduced, while patients with advanced, unfavourable prognosis (10% of all patients) aggressive primary treatment should be used even with more severe side effects and complications."1.34[Our experiences in treating patients with Hodgkin disease in the last decade]. ( Gergely, L; Illés, A; Keresztes, K; Miltényi, Z; Ress, Z; Simon, Z; Vadász, G; Váróczy, L, 2007)
"Hodgkin lymphoma is considered a common type of non-AIDS defining tumor among patients infected with HIV, commonly presenting as a widespread disease and with different pathologic features compared with Hodgkin lymphoma in the general population."1.34Hodgkin lymphoma among patients infected with HIV in post-HAART era. ( Buccheri, V; Calore, EE; Chamone, DA; Pessoa, VP; Pracchia, LF; Tanaka, PY, 2007)
"The treatment strategies of Hodgkin's lymphoma (HL) are different according to clinical stage and risk factors, yet the optimal treatment strategy remains unclear."1.34[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases]. ( Hu, DS; Hu, S; Song, QB; Tan, WY; Wei, L; Zeng, FY; Zhou, LQ, 2007)
"Of the 13 cases, 5 were Hodgkin's disease (HD), and 8 were non-Hodgkin's lymphoma (NHL)."1.33[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma]. ( Ling, JY; Sun, XF; Wang, ZH; Xia, Y; Zhen, ZJ, 2006)
"Actuarial risk of second malignancy for adolescents and adults was not different (P = ."1.33Hodgkin's lymphoma in adolescents. ( Connors, JM; Foltz, LM; Song, KW, 2006)
"Of 6 patients who developed recurrence, 3 (7."1.33[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease]. ( Han, JZ; Jin, J; Li, YX; Liu, XF; Liu, YP; Song, YW; Wang, SL; Wang, WH; Yu, ZH; Zhou, LQ, 2006)
"Currently, 60% patients with advanced Hodgkin's lymphoma could be cured by receiving standard treatments."1.33[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. ( Fu, XH; Huang, HQ; Huang, Y; Lin, TY; Sun, XF; Wang, B; Wang, SS; Xu, RH; Zhang, L, 2006)
"In patients with advanced Hodgkin's disease, consolidation RT improved survival."1.32Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy. ( Dyduch, M; Korzeniowski, S; Skolyszewski, J; Sokolowski, A, 2003)
"To collect second cancers in patients treated for Hodgkin disease (HD) during adolescence and young adulthood at Salah Azaïz Institute of Tunis."1.32[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz]. ( Belhaj Ali, Z; Benna, F; Besbes, M; Bouaouina, N; Boussen, H; Gammoudi, A; Ghilen, L; Kochbati, L; Maalej, M; Rahal, K, 2003)
"Children treated for Hodgkin disease are at risk for gonadal damage."1.32Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease. ( Behrendt, H; Furstner, F; van den Berg, H; van den Bos, C, 2004)
"One Stage IV patient has died with Hodgkin's disease 28 months after treatment with combination therapy."1.32Pediatric Hodgkin's disease. ( Bertolone, S; Koerner, P; Oliapuram Jose, B; Paris, KJ; Patel, CC; Silverman, CL; Spanos, WJ; Yashar, CM, 2004)
"We followed-up 33 patients with non-Hodgkin's lymphoma or with Hodgkin's disease during the years 1987-1997 who were referred for semen cryopreservation."1.31Follow-up of sperm concentration and motility in patients with lymphoma. ( Botchan, A; Hauser, R; Paz, G; Tal, R; Yavetz, H; Yogev, L, 2000)
"We transplanted 42 patients with Hodgkin's disease between 1990-1998."1.31[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer]. ( Avigdor, A; Ben-Bassat, I; Grotto, I; Hardan, I; Raanani, P; Shpilberg, O, 2000)
"Risk of lung cancer was borderline significantly greater in patients treated with mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) chemotherapy than those who did not receive this treatment (relative risk [RR] = 1."1.31Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment. ( Allerton, R; Barber, JA; Cunningham, D; Horwich, A; Linch, DC; Lister, TA; Rohatiner, AZ; Schoemaker, MJ; Swerdlow, AJ; Vaughan Hudson, G; Williams, MV, 2001)
"Today, 80% of patients with advanced Hodgkin's disease may be cured, with low rate of long-term toxicity."1.31[The chemotherapeutic treatment of advanced Hodgkin's disease]. ( Ben-Arie, Y; Ben-Shahar, M; Cohen, Y; Epelbaum, R; Faraggi, D; Haim, N; Sharabi-Nov, A; Valtuch, I, 2001)
"There were no deaths from Hodgkin's disease."1.31Subdiaphragmatic Hodgkin's disease: the University of Florida experience. ( Colgan, ME; Hull, MC; Mendenhall, NP, 2002)
"A total of 128 patients with advanced Hodgkin's disease was included in this study."1.31[Treatment of advanced Hodgkin's disease: an analysis of 128 cases]. ( Feng, F; Wang, Q; Zhou, L, 2000)
"Procarbazine is a chemotherapy methylating agent that has been used in combination with other drugs, perhaps most successfully in the treatment of Hodgkin's disease."1.31Pulmonary toxicity secondary to procarbazine. ( Mahmood, T; Mudad, R, 2002)
"Concerning ANLL, the MOPP regimen was significantly associated with a higher risk: 3."1.31Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation. ( Andrieu, JM; Colonna, P; Delwail, V; Jais, JP, 2002)
"The relative risk of second cancers overall was 27."1.30Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital. ( Barber, JA; Cunningham, D; Horwich, A; Milan, S; Omar, RZ; Swerdlow, AJ, 1997)
"Patients treated for Hodgkin's disease and non-Hodgkin lymphomas were followed for 5 years after start of therapy."1.30Five-year follow-up of saliva in patients treated for lymphomas. ( Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L, 1997)
"Sixteen patients with Hodgkin's disease were treated with MOPP/ABVD and filgrastim support between January 1992 and March 1994."1.30G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease. ( Gustavsson, A, 1997)
"In this series, risk factors for second cancer were age >/=40 years (RR = 3."1.30Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease. ( André, M; Attal, M; Bastion, Y; Blaise, D; Cahn, JY; Colombat, P; Fermé, C; Fleury, J; Gisselbrecht, C; Henry-Amar, M; Kuentz, M; Milpied, N; Nedellec, G; Pico, JL, 1998)
"Patients treated with radiotherapy for Hodgkin's disease have a considerable risk for a second cancer in long-term follow-up."1.30Second cancer among long-term survivors from Hodgkin's disease. ( Joensuu, H; Muhonen, T; Nyandoto, P, 1998)
"Risk of leukemia was 0."1.30The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con ( Anselmo, AP; Baroni, CD; Bernasconi, C; Brusamolino, E; Klersy, C; Lazzarino, M; Lunghi, F; Mandelli, F; Maurizi-Enrici, R; Orlandi, E; Pagnucco, G; Santoro, M, 1998)
"Hodgkin's disease was diagnosed in a 12-year old boy and a 2-year old his sister whose mother had been treated with repeated cycles of nitrogen mustard for optic neuritis."1.30[Hodgkin's disease in two children of mother treated with nitrogranulogen]. ( Armata, J; Balwierz, W; Eliasińska, A; Moryl-Bujakowska, A; Tacik, J, 1998)
"The nephrotic syndrome is a rare complication of Hodgkin's disease."1.30[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome]. ( Baron, F; Beguin, Y; Fassotte, MF; Fillet, G; Hermanne, JP, 1998)
"Hodgkin's disease is curable in the majority of patients, although a proportion of patients are resistant to or relapse after initial therapy."1.30High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. ( Devereux, S; Goldstone, AH; Gregory, W; Hancock, B; Harrison, CN; Hoskin, P; Hudson, GV; Linch, DC; MacMillan, AK; Milligan, D; Newland, AC; Winfield, D, 1999)
"Optimal treatment for Hodgkin's disease during childhood is unknown."1.30Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy. ( Farah, RA; Geara, F; Hajjar, T; Khogali, M; Muwakkit, S; Nabbout, B; Shabb, NS, 1999)
"28 patients suffering from advanced Hodgkin's disease were treated according to protocol containing 7 cytostatic drugs including methotrexate and corticosteroids, but not cyclophosphamide, chlormethine or procarbazine."1.29[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate]. ( Gabryś, K; Kotlarek-Haus, S; Potoczek, S, 1995)
"Management of Hodgkin's disease (HD) and large mediastinal adenopathy (LMA) usually includes intensive chemotherapy (CT) with or without radiation therapy (XT) regardless of stage."1.29Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches. ( Allen, PK; Besa, P; Cabanillas, F; Cox, JD; Hagemeister, FB; McLaughlin, P; Preti, A; Rodriguez, A; Swan, F, 1994)
"In patients with advanced Hodgkin's disease (HD), the alternation of MOPP with ABVD or hybrid MOPP/ABVD are associated with a high CR rate and a high probability of 5-year survival."1.29Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease. ( Aversa, S; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Mazzarotto, R; Pappagallo, GL; Salvagno, L; Scarzello, G; Sorarù, M; Sotti, G, 1995)
"We report a 54-year-old patient with Hodgkin's disease who achieved a complete remission after combined modality treatment."1.29Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease. ( Bendandi, M; Cantagalli, F; Macchi, S; Mancino, A; Simoncelli, F; Stefanati, V; Tura, S; Visani, G; Zaccaria, A; Zinzani, PL, 1995)
"Treatment of Hodgkin's disease resulted in complete remission and complete disappearance of the pontine abnormality."1.29Hodgkin's disease associated with central pontine myelinolysis. ( Carrol, CL; Chintagumpala, MM; Dreyer, ZE; Fishman, MA; Mahoney, DH; McClain, K; Steuber, CP, 1993)
"Between 1980 and 1988, 48 patients with Hodgkin's disease who had large mediastinal masses were treated at Stanford University."1.29Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy. ( Behar, RA; Hoppe, RT; Horning, SJ, 1993)
"The occurrence of HIV associated non-Hodgkin's lymphoma (NHL) is a well recognized event."1.29Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient. ( Brody, J; Goh, JC; Kaplan, MH; Koduru, P; Lichtman, SM; Susin, M, 1993)
"60 cases of Hodgkin's lymphoma were treated with combined chemotherapy and radiotherapy."1.29[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma]. ( Wang, H; Yong, WB; Zhu, XM, 1993)
"Patients with Hodgkin's disease whose initial complete remissions (CR) after primary chemotherapy were longer than 1 year are thought to have better prognoses than patients whose initial remissions were shorter than 1 year."1.29Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy. ( Aversa, SM; Bianco, A; Chiarion Sileni, V; Fiorentino, MV; Pappagallo, GL; Salvagno, L; Sorarù, M, 1993)
"A past history of treated Hodgkin disease is a factor of risk for breast cancer and suggests the need for annual mammography screening 10 years after the end of treatment."1.29[Breast cancer after treatment of Hodgkin's disease]. ( Blanchot, J; Dugast, J; Grall, JY; Le Prise, E; Levêque, J; Meunier, B; Poulain, P, 1995)
"A case of Hodgkin's disease with isolated cerebral relapse is reported here."1.29Meningioma-like cerebral relapse of Hodgkin's disease. ( Catarini, M; Discepoli, G; Leoni, P; Montillo, M; Rychlicki, F; Scarpelli, M, 1994)
"Thirteen patients have died of their second malignancy, including two of a third malignancy, while four have been followed for less than one year."1.29Second malignant neoplasms in patients with Hodgkin's disease. ( Atkinson, CH; Colls, BM; Fitzharris, BM; Robinson, BA, 1994)
"The risk of second cancer was analyzed (1) relative to the general population and (2) between risk subgroups using the Cox proportional hazards model."1.29Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen? ( Bodis, S; Bosq, J; Cosset, JM; Dietrich, PY; Hayat, M; Henry-Amar, M, 1994)
" Comparison of the dose-response relationships for humans and rats indicates that, under conditions of no depletion of O6-alkylguanine-DNA alkyltransferase (AGT), O6-meG accumulates in blood leukocyte DNA of humans at a rate which is only approximately 2-fold lower than in rats, implying that, to the extent to which O6-meG contributes to the genotoxic activity of procarbazine, human susceptibility to it is likely to be comparable to that of the rat."1.29Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine. ( Boussiotis, VA; Kyrtopoulos, SA; Pangalis, GA; Souliotis, VL; Valavanis, C, 1994)
"Two cases of malignant schwannoma are reported 13 and 15 years following combined modality treatment for Hodgkin's disease."1.29Malignant schwannoma following treatment for Hodgkin's disease. ( Bridges, LR; Cartwright, SC; Dodwell, DJ; Fisher, PM; Stone, J, 1994)
"The association of Hodgkin's disease and minimal-change nephrotic syndrome is well established."1.29The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease. ( Delmez, JA; Kissane, JM; Safdar, SH, 1994)
"Cardiotoxicity is a well recognized side effect of anthracyclines (doxorubicin and epirubicin) or antracenadiones (mitoxantrone) at cumulative or high doses."1.29Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults. ( Arévila, N; Avilés, A; Díaz Maqueo, JC; García, R; Gómez, T; Nambo, MJ, 1993)
"Two patients developed breast cancer 14 and 8 years after treatment of Hodgkin's disease."1.29Breast cancer developing after therapy for Hodgkin's disease. ( Cascinu, S; Catalano, G; Fedeli, A, 1993)
"Following irradiation alone, secondary acute nonlymphocytic leukemia (ANLL) is uncommon; following chemotherapy alone, the risk is increased, but not as much as when combined modality treatments are used."1.29Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease. ( Brusamolino, E; Fiacchini, M; Gobbi, PG; Tura, S; Zinzani, PL, 1993)
"More than 50% of patients with non Hodgkin's lymphomas (NHL) are long-term survivors."1.29[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993]. ( Auger, J; Bendahmane, B; Decaudin, D; Koscielny, S; Munck, JN; Naccache, P, 1996)
"Cholestasis was observed in all cases; in most patients a moderate increase in the transaminase activity was also seen."1.29Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients. ( Briones, J; Bruguera, M; Cervantes, F; Font, C; Grau, JM; Montserrat, E; Rozman, C, 1996)
"Results of recent trials in Hodgkin's disease suggest that the cure rates which increased considerably between 1960 and 1980 have reached a plateau."1.28The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials. ( Diehl, V; Hasenclever, D; Lathan, B; Löffler, M; Pfreundschuh, M; Rüffer, U, 1992)
"Four patients with fresh Hodgkin's disease were treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride (NH2-O)."1.28[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride]. ( Kodo, H; Kozai, Y; Ohyama, T; Tomori, G, 1992)
"We report about two cases of cancer of the testis occurring 2 and 7 years after Hodgkin's disease treated with combined chemotherapy and radiation therapy."1.28[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases]. ( Averous, M; Chevallier, P; Grasset, D; Guiter, J; Iborra, F; Lavabre-Bertrand, T; Rebillard, X; Robert, M, 1992)
"2) Non-Hodgkin's lymphoma has not appeared in any of the patients in this series."1.28[Second neoplasms as a late complication of the treatment of Hodgkin's disease]. ( Alvarez, A; Colomé, JA; del Potro, E; Díaz Mediavilla, J; González, FA; Martínez, R; Morales, MD; Villegas, A, 1992)
"Systemic symptoms of Hodgkin's disease were present for 6 months, and rapidly developing patchy hair loss of the scalp was present for 2 weeks prior to presentation."1.28Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy. ( Berk, MA; Chan, PD; Kucuk, O; Singh, S, 1992)
"20 untreated Hodgkin's disease patients and 1 patient relapsing after radiotherapy (17 stage IIB-IV and 4 stage I-IIA) were given doxorubicin, bleomycin, etoposide and prednisone on a 21-day cycle."1.28ABEP as primary chemotherapy for Hodgkin's disease. ( Alberto, P; Mermillod, B; Zulian, GB, 1992)
"2846 patients first treated for Hodgkin's disease during 1970-87, for whom follow up was complete in 99."1.28Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation. ( Bennett, MH; Douglas, AJ; Hudson, BV; Hudson, GV; MacLennan, KA; Swerdlow, AJ, 1992)
"Group two included Hodgkin's disease patients who were treated 12-24 years previously and have been continuously free of disease."1.28The frequency of translocations after treatment for Hodgkin's disease. ( Brown, JM; Evans, JW; Mori, M; Smith, LM, 1992)
"In three patients with advanced Hodgkin's disease treated with combination chemotherapy (MOPP) incorporating vincristine, and receiving at the same time a fixed daily dose of 8000 U of rHu-EPO subcutaneously for 10 to 15 days because of myelosuppressive anemia, myeloaspirates were performed one week before and 24 hours after the administration of vincristine."1.28Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia. ( Marmont, AM, 1992)
" All other disease stages will require a different strategy that should consist of radiotherapy combined with short-term effective regimens, such as ABVD (doxorubicin, bleomycin, vinblastine and decarbazine) or VBM (vinblastine, bleomycin and methotrexate) to reduce the incidence of MOPP-associated gonadal dysfunction and leukaemogenesis."1.28Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP. ( Banfi, A; Bonadonna, G; Bonfante, V; Devizzi, L; Santoro, A; Tesoro Tess, JD; Valagussa, P; Viviani, S; Zanini, M; Zucali, R, 1992)
"The frequency of chromosome aberrations in the peripheral blood of patients successfully treated for Hodgkin's disease (HD) and non-Hodgkin's lymphoma is compared with that seen in age-matched haematologically normal subjects."1.28Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma. ( Clark, RE; Jacobs, A; Jones, BM; White, AD, 1992)
" In a multivariate analysis where both disease-related and treatment-related factors were taken into account drug dosage remained a significant prognostic factor."1.28Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome. ( Bezwoda, MA; Bezwoda, WR; Dansey, R, 1990)
"Three patients with Stage III or IVB Hodgkin's disease were cured with MOPP (regimen of nitrogen mustard, Oncovin, prednisone, and procarbazine) and/or B-DOPA (regimen of bleomycin, dacarbazine, Oncovin, prednisone, and Adriamycin)."1.28Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group. ( Lokich, JJ, 1990)
"Forty-nine patients with Hodgkin's disease who relapsed after a first complete remission of more than 12 months following primary chemotherapy were treated with salvage therapy regimens."1.28Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission. ( Bonadonna, G; Bonfante, V; Negretti, E; Santoro, A; Valagussa, P; Viviani, S, 1990)
"Reports on salvage treatments for Hodgkin's disease in first relapse after primary chemotherapy should include data on the proportion of patients having stage IV disease at diagnosis, B symptoms at relapse, and a time from primary treatment to relapse of less than 1 year."1.28Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988. ( Barnett, M; Connors, JM; Fairey, RN; Lohri, A; O'Reilly, SE; Phillips, GL; Reece, D; Voss, N, 1991)
"Sixty-three cases of Hodgkin's disease in intravenous drug users (IVDUs) have been collected by the Italian Cooperative Group on AIDS-Related Tumors (GICAT)."1.28Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT). ( Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E, 1991)
"Twenty four patients diagnosed with Hodgkin's disease were introduced to our studies."1.28Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy. ( Dabrowska, M; Kemona, H; Kiluk, S; Kretowska, J; Prokopowicz, J, 1991)
"While current medical therapies for Hodgkin's disease are usually quite effective, it has become increasingly clear that some of the therapies utilized carry an inherent risk for the induction of secondary malignancies."1.28In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients. ( Caggana, M; Coleman, CN; Kelsey, KT; Liber, HL; Mauch, PM, 1991)
"Sixty-two patients with advanced-stage Hodgkin's disease and a median age of 12 years (range, 3 to 22 years) were treated with four cycles of mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) alternating with four cycles of doxorubicin, vinblastine, bleomycin, and dacarbazine (ABVD) followed by low-dose radiotherapy (RT)."1.28Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. ( Behm, FG; Brecher, M; Cantor, A; Chauvenet, A; Leventhal, BG; Marcus, R; Ternberg, J; Weiner, MA; Wharam, M, 1991)
"We report preliminary results of treatment of Hodgkin disease according to the National Protocol on Antineoplastic Drugs."1.28[Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report]. ( Cao, C; García, H; Gutiérrez, J; Osorio, G; Vacarezza, R, 1991)
"The peak incidence of Hodgkin's disease occurs during the reproductive age, and its association with pregnancy is at a rate of between 1:1,000-1:6,000."1.28Maternal and foetal outcome following Hodgkin's disease in pregnancy. ( Degendorfer, P; Koren, G; Lishner, M; Panzarella, T; Sutcliffe, SB; Zemlickis, D, 1992)
"The patient remains free of Hodgkin's disease 34 months after completion of chemotherapy."1.28Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy. ( Connaghan, DG; Johnston, PG; Longo, DL; Ruscetti, FW; Sullivan, FJ, 1991)
"Radiation pneumonitis was seen in 3% of patients receiving radiation therapy alone."1.28Thoracic irradiation in Hodgkin's disease: disease control and long-term complications. ( Mauch, P; Tarbell, NJ; Thompson, L, 1990)
"The progeny of patients treated for Hodgkin's disease appear normal and no excess fetal wastage has been noted."1.28Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience. ( Donaldson, SS; Ortin, TT; Shostak, CA, 1990)
"A patient with advanced Hodgkin's disease being treated with MOPP chemotherapy presented with delayed life-threatening pulmonary toxicity secondary to procarbazine."1.28Delayed life-threatening pneumonitis secondary to procarbazine. ( Alvarez, S; Ancalmo, N; Brooks, BJ; Grinton, SF; Hendler, NB, 1990)
" There were three fatal toxic events, two due to viral infection and one to a second malignant tumor (NHL)."1.28Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity. ( Berry, M; Blanchette, V; Chan, H; Doherty, M; Doyle, J; Freedman, M; Greenberg, M; Jenkin, D; Panzarella, T; Saunders, F, 1990)
"Since pediatric Hodgkin's disease is a curable malignancy, it is essential to limit treatment sequelae."1.28Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy. ( Donaldson, SS; Link, MP; Mefferd, JM, 1989)
"Eight patients with refractory Hodgkin's disease received intensive combination chemotherapy conditioning with cyclophosphamide, carmustine (BCNU), and etoposide (VP 16-213), and allogeneic marrow transplants."1.28Allogeneic marrow transplantation for refractory Hodgkin's disease. ( Barnett, MJ; Connors, JM; Fay, JW; Herzig, GP; Herzig, RH; Klingemann, HG; Phillips, GL; Reece, DE; Shepherd, JD; Wolff, SN, 1989)
"Seventeen patients with advanced stage Hodgkin's disease who relapsed or failed to respond to multiple regimens of combination chemotherapy (mostly Mechlorethamine, Vincristine, Procarbarzine, Prednisone and Adriamycin, Bleomycin, Vinblastine, Dacarbazine) were treated with accelerated hyperfractionated total lymphoid irradiation (TLI) and high-dose chemotherapy followed by autologous bone marrow transplantation (AuBMT)."1.28Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease. ( Clarkson, B; Fuks, Z; Gulati, S; Shank, B; Yahalom, J, 1989)
"Neoadjuvant chemotherapy in Hodgkin's disease has improved survival time and tolerance to irradiation, allowing a lowering of the total doses used and the volumes irradiated."1.28[Radiotherapy with neoadjuvant chemotherapy]. ( Alapetite, C; Baillet, F; Dessard-Diana, B; Housset, M; Jacquillat, C; Michel-Langlet, P, 1989)
"A 58-year-old man with Hodgkin's disease exhibited erythrodermia due to allergic reaction to vincristine sulfate (VCR) and vindesine sulfate (VDS)."1.28[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids]. ( Kosaka, M; Matsumoto, N; Okagawa, K; Saito, S; Yoshimoto, K, 1989)
"Hence a diagnosis of Hodgkin's disease (HD) stage IVB was made."1.28[Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow]. ( Abe, T; Hasegawa, Y; Mori, N; Nakazawa, M; Noguchi, Y; Yoda, Y, 1989)
" The predictive value of mechlorethamine dosage with regard to OS was retained in an analysis restricted to the patients receiving greater than or equal to six cycles of chemotherapy."1.28Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease. ( de Meijer, AJ; Dekker, AW; Haanen, C; van Rijswijk, RE; Verbeek, J, 1989)
"At Kanazawa University 28 patients with Hodgkin's disease were treated between 1975 and 1988."1.28[Hodgkin's disease]. ( Nakamura, S; Ohtake, S, 1989)
"Fifty-three patients with advanced Hodgkin's disease, most of them previously treated, received 8 to 16 courses of modified MOPP regimens (nitrogen mustard replaced by trichlormethine in arm A, with addition of vinblastine to the 4-drug regimen in arm B, and alternation of three drugs--trichlormethine, vincristine, and prednisone--with probably non-cross resistant two drugs--vinblastine and procarbazine in arm C)."1.28Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation. ( Bohunický, L; Cerný, V; Gyárfás, J; Koza, I; Mardiak, J; Svancárová, L, 1989)
"Between 1979 and 1987, 28 children with Hodgkin's disease were treated with MOPP (nitrogen mustard, Oncovin, prednisone, procarbazine) combination chemotherapy without radiotherapy."1.28MOPP therapy in children with Hodgkin's disease. ( Madanat, FF, 1989)
"A patient with hypogonadotropic hypogonadism owing to endogenous gonadotropin releasing hormone deficiency, who developed Hodgkin's disease is described."1.28Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases? ( Nikolaou, N; Orfanos, S; Pavlidis, N; Tolis, C; Tolis, G, 1989)
"Hodgkin's disease is one of the most curable cancers thanks to progress in radiotherapy and multi-drug chemotherapy regimens such as mechloretamine-vincristine-procarbazine-prednisone, best known as MOPP."1.28Ten-year nodular sclerosis Hodgkin's disease and second malignancies. ( Mirimanoff, RO; Zulian, GB, 1989)
"Four patients with Hodgkin's disease and bone marrow fibrosis are presented in whom the clinical presentation was dominated by cytopenias; this was associated with a delayed diagnosis for an average of 20 months."1.28Hodgkin's disease presenting as myelofibrosis. ( Crawford, J; Kaufman, RE; Laszlo, J; Meadows, LM; Moore, JO; Rosse, WR, 1989)
"Skin involvement with Hodgkin's disease is rare."1.28Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection. ( Jacobs, SR; Shaw, MT, 1989)
"The Hodgkin's disease was insensitive to conventional MOPP chemotherapy in two of two, and was sensitive to combined MOPP-Bleomycin in one patient."1.27Hodgkin's disease in renal transplant recipients. ( Doyle, TJ; Maeda, K; Saeed, SM; Tilchen, EJ; Venkatachalam, KK, 1983)
"Fourteen patients with Hodgkin's disease resistant to ABVD were treated with MOPP chemotherapy (nitrogen mustard, vincristine, procarbazine, prednisone)."1.27MOPP treatment of resistant Hodgkin's disease following ABVD failure. ( Anselmo, AP; Cimino, G; Mandelli, F; Marzullo, A; Maurizi Enrici, R; Mauro, F; Papa, G, 1983)
"Bone and soft tissue sarcomas have rarely been observed after treatment of Hodgkin's disease, and only a few cases are described in the literature."1.27Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease. ( Banfi, A; Zanini, M; Zucali, R, 1983)
"Although most patients with Hodgkin's disease refractory to MOPP treatment will respond to either ABVD or B-CAVe chemotherapy, subsequent long-term disease-free survival is unusual."1.27Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe. ( Harker, WG; Kushlan, P; Rosenberg, SA, 1984)
"Twenty-seven children with Hodgkin's disease were treated with MVOPP (mustine, Velban [vinblastine], Oncovin [vincristine], procarbazine, prednisone) combination chemotherapy."1.27Hodgkin's disease in children. A ten-year experience in South Africa. ( Hartley, P; Jacobs, P; Karabus, C; King, HS; Werner, D, 1984)
"The example of Hodgkin's lymphoma staging and treatment selection is used."1.27A decision-analysis methodology for consideration of morbidity factors in clinical decision-making. ( Corder, MP; Ellwein, LB, 1984)
"The patients would have symptomatic Hodgkin's lymphoma."1.27Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis. ( Corder, MP; Ellwein, LB, 1984)
"Thirty-four subsequent second malignant neoplasms were observed in 33 patients among those treated for Hodgkin's disease."1.27Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience. ( DeVita, VT; Glatstein, E; Kelley, PA; Kinsella, TJ; Makuch, RW; Tester, WJ; Waller, B, 1984)
"A patient suffering from Hodgkin's disease exhibiting acute allergic reaction to vincristine sulfate with mild to moderate dermatologic and cardiovascular signs is described."1.27Acute allergic reaction due to vincristine sulfate. A case report. ( Gassel, WD; Gropp, C; Havemann, K, 1984)
"This case of optic neuropathy is supposed to be a rare example of involvement of the 2nd cranial nerve due to vinca alkaloids."1.27Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case. ( Guidelli Guidi, S; Maccolini, E; Oddo Bravetti, G; Serra, L; Vecchi, V, 1984)
"Appropriate management of Hodgkin's disease is based on both the stage of disease and the specific anatomic sites of involvement within each stage."1.27Diagnosis and management of Hodgkin's disease in the adult. ( Fuller, LM; Hagemeister, FB, 1983)
"Hodgkin disease was confirmed histologically in three, and confirmed by electron microscopy in two."1.27Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two. ( Amorosi, EL; Hawkins, KA; Ramsey, D; Schinella, R; Schwartz, M; Silber, R; Weintraub, AH, 1983)
"In 164 patients with Hodgkin's disease staged between 1973 and 1979 the response to the 3 initial cycles of multiagent chemotherapy was evaluated as a prognosticator of survival."1.27Early response to chemotherapy as a prognostic factor in Hodgkin's disease. ( Bierling, P; Brun, B; Dreyfus, B; Farcet, JP; Imbert, M; Kuentz, M; Le Bezu, M; Lebourgeois, JP; Reyes, F; Rochant, H; Vernant, JP, 1983)
"Patients who had a relapse of Hodgkin's disease did not have an increased incidence of second malignancy."1.27Second malignancy complicating Hodgkin's disease. ( Mercier, JP; Tawil, E, 1983)
"Of 157 patients with Hodgkin's disease treated between 1970 and 1981 an assessment of the clinical course was possible in 134 cases."1.27[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)]. ( Denz, H; Huber, H; Lechleitner, M; Peer, L; Peschel, C, 1983)
"The rate of recurrence formation was found to be in a significant correlation with general symptoms, age, size of the largest cluster of involved lymph nodes, combination of drugs and type of consolidating therapy."1.27[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy]. ( Kharatishvili, ZV; Kolygin, BA, 1983)
"A patient with primary Hodgkin's disease of the lung is described."1.27Primary Hodgkin's disease of the lung. Case report and review of the literature. ( Czembirek, H; Homan, R; Lechner, K; Moritz, H; Neumann, E; Resch, F, 1983)
"There was no significant difference in recurrence rates between patients without mediastinal mass and patients with a small mass, and in these patients adjuvant chemotherapy MOPP after radiotherapy showed an evident benefit in reducing the relapse rate."1.27Prognostic significance of large mediastinal involvement in Hodgkin's disease. ( Baccarani, M; Cantore, M; Dominici, G; Emiliani, E; Faedi, M; Fiacchini, M; Frezza, G; Lauria, F; Mazza, P; Sciascia, R, 1983)
"A dose-response analysis of the results of MOPP chemotherapy in 132 patients with Hodgkin's disease was carried out."1.27A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy. ( Carde, P; MacKintosh, FR; Rosenberg, SA, 1983)
"Six patients with Hodgkin's disease who failed MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy, with recurrences confined to lymph node areas, are reported."1.27Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy. ( Baldwin, PE; Diehl, LF; Dorn, RV; Hurwitz, M; Kimball, DB; Perry, DJ; Terebelo, H, 1983)
"Seventy patients with advanced Hodgkin's disease, 54 with new disease, and 16 in first relapse after initial radiotherapy, have been treated with a seven-drug, 8-month program: MOPP (nitrogen mustard, vincristine, procarbazine, prednisone)/ABV (Adriamycin [Adria Laboratories of Canada, Mississauga, Ontario], bleomycin, vinblastine) hybrid."1.27MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease. ( Connors, JM; Klimo, P, 1985)
"Eight patients with disseminated Hodgkin's disease resistant to MOPP (mechlorethamine, vincristine, procarbazine, and prednisone) chemotherapy were treated with high-dose chemoradiotherapy and marrow transplantation from an HLA-identical sibling."1.27Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease. ( Appelbaum, FR; Buckner, CD; Clift, RA; Deeg, HJ; Neiman, PE; Sanders, JE; Stewart, P; Storb, R; Sullivan, KM; Thomas, ED, 1985)
"A strategy for treatment of malignant lymphoma requires fundamentally a field of multidisciplinary treatment including mainly radiotherapy and chemotherapy in a collaboration with surgical procedure and immunotherapeutic maneuver."1.27[Malignant lymphoma]. ( Kita, K; Shirakawa, S; Tanaka, I, 1985)
" It is noteworthy that in all subsets, ABVD (Adriamycin + bleomycin + vinblastine + dacarbazine), either combined with irradiation or alternated with MOPP (mechlorethamine + vincristine + procarbazine + prednisone), yielded superior results compared with MOPP with or without irradiation."1.27Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy. ( Bonadonna, G; Santoro, A; Valagussa, P, 1985)
"Sixty-eight patients with Hodgkin's disease stage III and IV were evaluated after three out of six MOPP cycles."1.27Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV. ( Barbot, A; Le Fur, R; Menard, JF; Monconduit, M; Piguet, H; Tilly, H, 1987)
"Five hundred and seven patients with Hodgkin's lymphoma (HL), forming the basis of our 18 years experience, are retrospectively analyzed."1.27Hodgkin's disease (HD): a historical perspective. ( Baccarani, M; Bandini, G; Emiliani, E; Fiacchini, M; Gobbi, M; Lauria, F; Mazza, P; Tura, S; Verlicchi, F; Zinzani, PL, 1986)
"Most of the children with Hodgkin's disease diagnosed before or during puberty can be cured with chemotherapy alone, and thus will not suffer from the damaging late effects of radiotherapy."1.27Treatment of Hodgkin's disease in children with or without radiotherapy. ( Behrendt, H; Van Bunningen, BN; Van Leeuwen, EF, 1987)
"Thirty eight patients with Hodgkin's disease, stage I to IIIA, previously untreated, received three courses of this regimen before radical radiotherapy."1.27[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials]. ( Audebert, A; Blanc, CM; David, B; Debray, J; Eghbali, H; Hoerni, B; Rojouan, J; Zittoun, R, 1987)
"The observed cure rates in childhood Hodgkin's disease (85 to 95%) and the knowledge of late complications of treatments, radiotherapy as well as chemotherapy, lead to studies aiming at decreasing the treatment burden without compromising these good results."1.27[Hodgkin's disease in children. Current therapeutic strategies]. ( Habrand, JL; Lemerle, J; Leverger, G; Oberlin, O; Olive, D; Schaison, G; Zucker, JM, 1988)
"In 82 children affected with Hodgkin's disease, in whom a complete remission was obtained, the first relapses occurred in 13 patients, their outcome was a follows: one child died of relapse and in 12 others second complete remissions were achieved."1.27Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients. ( Armata, J; Balwierz, W; Moryl-Bujakowska, A; Pekacki, A, 1987)
"Results of treatment of 25 Hodgkin's disease patients at Kyushu University Hospital from 1981 to 1985 were reviewed."1.27[Improved survival rates in Hodgkin's disease]. ( Hayabuchi, N; Hirata, H; Ishii, E; Jingu, K; Kikuchi, M; Komiyama, S; Masuda, K; Miyoshi, M; Nishimura, J; Shibuya, T, 1988)
"Fifty patients with recurrent Hodgkin's disease have been treated with high-dose therapy followed by autologous bone marrow transplantation."1.27High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report. ( Carella, AM; Cimino, G; Congiu, AM; Coser, P; Gaozza, E; Mangoni, L; Mazza, P; Meloni, G; Ricci, P; Visani, G, 1988)
"A patient is described who developed Hodgkin's disease 16 years after treatment of Wilms' tumor with radiation and actinomycin D."1.27Hodgkin's disease following Wilms' tumor: a case report. ( Bell, BA; Esseltine, DW; Freeman, CR, 1987)
"This case shows that relapse of Hodgkin's disease may occur after a 10 year interval and furthermore it may preceded by nephrotic syndrome."1.27Glomerulonephritis preceding late relapse of Hodgkin's disease. ( Lynn, WA; Marcus, RE, 1988)
"Two patients developed breast cancer after treatment of Hodgkin's disease."1.27Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. ( Anderson, T; Cox, JD; Gillin, M; Greenberg, M; Janjan, NA; Schewe, K; Wilson, JF, 1988)
"Two hundred ninety patients with Hodgkin's disease pathologic stage (PS) I or II were treated in the prospective randomized trial of the Danish National Hodgkin Study (see Appendix) with radiotherapy +/- adjuvant combination chemotherapy."1.27Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment. ( Clausen, NT; Cold, S; Nissen, NI; Nordentoft, AM; Specht, L, 1988)
"We have described a patient with Hodgkin's disease who had fever and pulmonary infiltrates after treatment with mantle x-ray therapy and two courses of MOPP."1.27Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP). ( Davenport, OL; Huskison, WT; Wells, JD, 1986)
"Nineteen patients with Hodgkin's disease who relapsed primarily in nodal sites after intensive combination chemotherapy were retreated with wide-field radiation therapy alone or with additional chemotherapy between January 1971 and December 1984."1.27Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy. ( Mauch, P; Rosenthal, D; Skarin, A; Tarbell, N; Weinstein, H, 1987)
"In 41 patients with Hodgkin's disease nitroblue tetrazolium (NBT) dye reduction with resting and stimulated granulocytes, before, in the course and after chemotherapy was examined."1.27Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy. ( Kemona, H; Kiluk, S; Prokopowicz, J; Wysocka, J, 1987)
"Of 244 patients with Hodgkin's disease, 126 (52%) had an abnormal mediastinum."1.27Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure. ( Chan, PY; Hintz, BL; Kagan, AR; McMahon, J; Nussbaum, H; Rao, AR; Ryoo, MC; Wollin, M, 1987)
"A case of recurrent Hodgkin's disease of the "sarcomatoid" or "syncytial variant" type was seen that occurred as an extension from the mediastinum to a previously uninvolved extranodal site (breast) and pericardium after treatment of classical nodular sclerosing Hodgkin's disease based in the lymph nodes."1.27Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis. ( Blaustein, JC; Lewkow, L, 1987)
"Seven patients with newly-diagnosed Hodgkin's disease, having standard mustine-vinblastine-prednisolone-procarbazine therapy, had a large and regular pattern of rise in SCE frequency in their peripheral lymphocytes, which apparently started to fall before the end of the course (32 wk)."1.27Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment. ( Brown, T; Bullock, I; Dawson, AA; King, DJ; Watt, JL, 1986)
"A patient seen at presentation for Hodgkin's disease (HD) at stage IV B was successfully treated with MOPP."1.27Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease. ( Eridani, S; Singh, AK, 1986)
"Hodgkin's disease is characterized by its peculiar histopathology and by the early and consistent existence of impaired cell-mediated immunity, although its oncogenetic mechanisms still remains unsolved."1.27[Clinical features and treatment of Hodgkin's disease]. ( Kita, K; Kobayashi, T; Ohno, T; Shirakawa, S, 1986)
"In addition, acute renal failure developed in both patients, and myolysis in one."1.27Purpura fulminans in pneumococcal sepsis. ( Berneman, ZN; Bieger, R; Bridts, C; Buyssens, N; Hautekeete, ML; Peetermans, ME; Stevens, WJ, 1986)
"Localized pneumonitis and fibrosis are well-known sequelae of this treatment."1.27Unusual thoracic radiographic findings in children treated for Hodgkin's disease. ( Jochelson, MS; Tarbell, NJ; Weinstein, HJ, 1986)
"We report here a case of Hodgkin's disease that progressed untreated for almost four years by virtue of a delayed diagnosis before constitutional symptoms developed."1.27A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease. ( Haines, IE; Schwarz, MA, 1986)
"94 patients with Hodgkin's disease PS I or II, treated during the period 1969-78 and followed until death, or from 33 to 136 months after initiation of therapy, were analysed."1.27Prognostic significance of tumour burden in Hodgkin's disease PS I and II. ( Nissen, NI; Specht, L, 1986)
"The results of treatment of I-II stage Hodgkin's disease in children aged 2-14 have been studied."1.27[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children]. ( Chikrizov, SI; Kanaev, SV; Kolygin, BA; Malinin, AP, 1986)
"Central nervous system involvement with Hodgkin's disease is extremely rare and is almost always a late complication in patients who have widely disseminated disease in the usual nodal sites."1.27Hodgkin's disease presenting with isolated craniospinal involvement. ( Bender, BL; Mayernik, DG, 1986)
"Thymic hyperplasia is a poorly understood, apparently benign process that may be confused with recurrent lymphoma."1.27Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature. ( Edington, H; Longo, DL; Pass, H; Roth, JA; Salwitz, J, 1986)
"A case of thymic Hodgkin's disease presenting with an anterior mediastinal mass is reported."1.27Cystic degeneration of thymic Hodgkin's disease following radiation therapy. ( Haas, A; Kim, HC; Lewis, R; Nosher, J; Sweeney, W, 1985)
"Thirty-four patients with Hodgkin's disease and non-Hodgkin's lymphoma underwent therapeutic splenectomies to improve hematologic tolerance for chemotherapy."1.27The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas. ( Cox, RS; Hoppe, RT; Jacobs, C; Rosenberg, SA; Schreiber, DP, 1985)
" Demonstration of systemic signs, bioptically confirmed bone-marrow infiltration and suboptimal cytostatic dosage correlated significantly with a lower full-remission rate."1.27[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen]. ( Becher, R; Höffken, K; Ippisch, A; Pfeiffer, R; Schmidt, CG; Seeber, S, 1985)
"Intracranial hodgkin's disease, an extremely uncommon finding, is reported in a 21-year-old man."1.27Hodgkin's disease, intracranial involvement. Report of a case and review of the literature. ( Enriquez, R; Papac, R; Vera, R, 1985)
"Br."1.27[Pregnancy and fetal development after therapy of Hodgkin's disease]. ( Slanina, J; Spratler, J; Wannenmacher, M, 1985)
"47 patients with advanced Hodgkin's disease (stage IIIB or IV) and mediastinal involvement, treated during the period 1969-78 and followed till death or from 36 to 126 months after initiation of therapy, were analysed."1.27Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease. ( Nissen, NI; Specht, L; Walbom-Jørgensen, S, 1985)
"Twenty-one percent of all Hodgkin's disease in India was seen in the pediatric age groups at the Tata Memorial Hospital (Bombay, India)."1.27Pediatric Hodgkin's disease in India. ( Advani, S; Desai, P; Dinshaw, K; Nair, C; Notani, P; Pande, S; Ramakrishnan, G; Rao, DN; Rao, R; Talvalkar, G, 1985)
"Three cases of primary gastric Hodgkin's disease confirmed by pathology are reported."1.27[Primary gastric Hodgkin's disease]. ( Bo, YK, 1985)
"Twenty-two patients with Hodgkin's disease were treated at Kanazawa University between 1975 and 1982."1.27[The role of radiotherapy in the treatment of Hodgkin's disease]. ( Chohtoh, S; Hirose, J; Kamimura, R; Kobayashi, A; Nakamura, S; Nishijima, H; Ohtake, S; Saito, Y; Takashima, T; Yoshida, T, 1985)
"Of 602 patients treated for non-Hodgkin's lymphomas, 9 developed overt acute nonlymphocytic leukemia or preleukemia with refractory cytopenia and cytogenetic abnormalities of the bone marrow."1.27Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents. ( Ersbøll, J; Keiding, N; Larsen, MS; Larsen, SO; Nissen, NI; Pedersen-Bjergaard, J; Philip, P; Schultz, H; Sørensen, HM, 1985)
"One patient with Hodgkin's disease involving the liver is alive at 36 months with further therapy."1.26Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease. ( Gamble, JF; Loh, KK; Rodgers, RW; Shullenberger, CC, 1980)
" Reduced drug dosage was associated with treatment failure in 19 out of 37 patients receiving suboptimal chemotherapy compared to only four of 27 patients in the relapse-free group (P less than 0."1.26Factors affecting relapse following chemotherapy for Hodgkin's disease. ( Hudson, GV; Jelliffe, AM; Yarnold, JR, 1982)
"The eight patients who reported pretreatment nausea had more extensive disease than the other patients and had received twice as much chemotherapy."1.26Pretreatment nausea in cancer chemotherapy: a conditioned response? ( Carli, T; Curtis, GC; Kleinman, PD; Nesse, RM, 1980)
" The planned dosage intensity had to be significantly reduced in over half of the patients because of marrow toxicity."1.26Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease. ( Dawson, AA; Fell, LF; Green, JA; Murray, S, 1980)
"50 patients with Hodgkin's disease were treated with MOPP chemotherapy."1.26[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)]. ( Neumann, E, 1981)
"Thirty-six patients with advanced Hodgkin's disease who were treated primarily with MOPP were evaluated to determine the reasons for MOPP failure."1.26Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule. ( Armitage, JO; Corder, MP, 1982)
"A case of Hodgkin's disease is reported in which acute promyelocytic leukaemia developed within 5 months of initiation of chemotherapy."1.26Hodgkin's disease and acute promyelocytic leukaemia. A case report. ( King, JB; Rosenstrauch, WJ; Steytler, JG; van der Merwe, AM; van Eeden, PJ, 1980)
"Long-term survivors of advanced diffuse histiocytic lymphoma treated with comparable chemotherapy, who served as a control population, had significantly higher percentages of E rosettes and no reduction in mitogen-induced lymphocyte proliferation."1.26Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease. ( Bostick, F; DeVita, VT; Fisher, RI; Howser, DM; Hubbard, SM; Vanhaelen, C; Young, RC, 1980)
"Persistent amenorrhea has occurred in 11 of 24 patients (46 percent) treated with MOPP alone or MOPP plus radiation excluding the pelvis."1.26Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. ( DeVita, VT; Hubbard, SM; Schilsky, RL; Sherins, RJ; Wesley, MN; Young, RC, 1981)
"Stage II Hodgkin's disease probably should be divided into two substages requiring different treatment."1.26[The current state of curability of Hodgkin's disease]. ( Streuli, RA; Ultmann, JE, 1981)
"We present a case of Hodgkin's disease and extensive skin infiltration with a favorable outcome."1.26Skin infiltration in Hodgkin's disease. ( Abt, AB; Gordon, RA; Lookingbill, DP, 1980)
"58 patients with early stages of Hodgkin's disease (I, II, III l) were treated by 3 courses of MOPP chemotherapy followed by extended field irradiation."1.26[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)]. ( Alaoui, Y; Baillet, F; Brun, B; Dreyfus, B; Kuentz, M; Maylin, C; Pierquin, B; Reyes, F; Rochant, H; Vernant, JP, 1980)
"Thirty South African children with Hodgkin's disease were studied over a 7-year period (1970 - 1977)."1.26Hodgkin's disease in South African children. ( Clinton, C; de Moor, NG; Jacobson, RJ; Klappenbach, RS; Wong, O, 1981)
"In 18 patients with advanced Hodgkin's disease, refractory to previous 'C-MOPP' treatment, a new therapeutic protocol of adriamycin, DTIC, CCNU and bleomycin was introduced."1.26[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. ( Bruntsch, U; Gallmeier, WM; Osieka, R; Schmidt, CG; Seeber, S, 1976)
"Twenty-four patients with advanced Hodgkin's disease, resistant to the MOPP regimen, were treated with a combination of Adriamycin, bleomycin, dacarbazine and vinblastine (ABDV)."1.26Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV). ( Case, DC; Lee, BJ; Young, CW, 1977)
"Our present knowledge of Hodgkin's disease is briefly reviewed and the prognostic importance of histologic subtype and stage is demonstrated."1.26[Hodgkin's disease: classification, staging, therapy]. ( Wewerka, JR, 1978)
"Of 14 splenectomized patients with Hodgkin's disease who were treated with total nodal irradiation and combination chemotherapy (MOPP), fulminant sepsis developed in three (21."1.26Fulminant sepsis after the successful treatment of Hodgkin's disease. ( Aisenberg, AC; Weitzman, S, 1977)
"The ideal management of stage IIB Hodgkin's disease is less certain; it is our plan to study the efficacy of combined modality treatment."1.26Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment. ( Goldstein, M; Goodman, R; Hellman, S; Mauch, P; Piro, A; Rosenthal, D; Tullis, J, 1977)
"Thirty-two patients with Hodgkin's disease who relapsed after a first complete remission induced by nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) were retreated with MOPP chemotherapy."1.26Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse. ( DeVita, VT; Fisher, RI; Hubbard, SP; Simon, R; Young, RC, 1979)
"Malignant myelosclerosis or acute myelofibrosis is a rare acute myeloproliferative disorder characterized by pancytopenia, myeloblastosis and marrow fibrosis."1.26Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy. ( Ali, NO; Janes, WO, 1979)
"Despite the dramatic response of Hodgkin's disease to intensive chemotherapy, the skin lesion was rapidly transformed into squamous cell carcinoma in 10 weeks."1.26Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease? ( Poleksic, S; Yeung, KY, 1978)
"After 12 cycles of MOPP therapy for Hodgkin's Disease, an adolescent black male developed hemorrhagic cystitis, which clinically and histologically was similar to that induced by cyclophosphamide."1.26Hemorrhagic cystitis with MOPP therapy. ( Royal, JE; Seeler, RA, 1978)
"Gynecomastia was not associated with an increase in either serum estradiol or prolactin concentrations."1.26Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. ( Olweny, CL; Sherins, RJ; Ziegler, JL, 1978)
"Between 1967 and 1977, 48 patients with Hodgkin's disease under 16-years-old were treated with MOPP chemotherapy alone at the Uganda Cancer Institute because radiotherapy facilities are not available."1.26Childhood Hodgkin's disease in Uganda: a ten year experience. ( Katongole-Mbidde, E; Kiire, C; Lwanga, SK; Magrath, I; Olweny, CL; Ziegler, JL, 1978)
"Sixty-three patients with Hodgkin's disease, in stages I or II, asymptomatic (A) or symptomatic (B), were diagnosed and followed at the Chaim Sheba Medical Center from 1969 to 1976."1.26Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment. ( Aghai, E; Ben-Bassat, I; Berkowicz, M; Brenner, H; Hulu, N; Many, A; Ramot, B; Rath, P, 1978)
"Procarbazine may have been the responsible agent."1.26Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone. ( Armstrong, JD; Farney, RJ; Hammer, S; Morris, AH, 1977)
"Study 81 cases of Hodgkin's disease at stages I, II or III led to the following conclusions from a therapeutic standpoint (in relation to the apparent results obtained): The addition of chemotherapy on the form of three courses of MOPP before irradiation improved the results of the latter on the one hand and, principally, by reducing the number of failures and, secondly, by reducing the complications."1.26[81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)]. ( Baillet, F; Brun, B; Dreyfus, B; Maylin, C; Mazeron, JJ; Pierquin, B, 1977)
"We studied 680 patients with Hodgkin's disease, treated at Stanford University Medical Center from July 1, 1968, through December 31, 1975, to determine the risk of development of hematologic neoplasia."1.26Hematologic neoplasia in patients treated for Hodgkin's disease. ( Coleman, CN; Flint, A; Glatstein, EJ; Kaplan, HS; Rosenberg, SA; Williams, CJ, 1977)
"Thirty-eight patients with advanced Hodgkin's disease were treated with a combination of cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP)."1.26Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. ( Bloomfield, CD; Fortuny, I; Kennedy, BJ; Vosika, G; Weiss, RB, 1976)
"A new treatment program for advanced Hodgkin's disease employing five-drug combination chemotherapy and low dose radiation to the sites of bulk disease (nodal or parenchymal) was designed in 1969."1.26Long term remissions with combined modality therapy for advanced Hodgkin's disease. ( Bertino, JR; Farber, LR; Fischer, DB; Fischer, JJ; Prosnitz, LR, 1976)
"Forty-five children with advanced Hodgkin's disease (stages III and IV) received combination chemotherapy in three schedules: MOPP (mustargen, Oncovin, procarbazine, prednisolone); COPP (cyclophosphamide was substituted for mustargen); and CVPP (cyclophosphamide, vinblastine, procarbazine, prednisone)."1.26Combination chemotherapy of Hodgkin's disease in children. ( Kolygin, BA, 1976)
"A case of nodular sclerosis Hodgkin's disease, stage IVB, with lung involvement and hypertrophic pulmonary osteoarthropathy (HPOA), was treated with quadruple cytotoxic chemotherapy."1.26Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy. ( Atkinson, MK; McElwain, TJ; Peckham, MJ; Thomas, PP, 1976)
"Twenty-five cases of hodgkin's Disease (15 males and 10 females) aged 5 to 17 years were studied from April 1970 to July 1976 (75 month period)."1.26Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children. ( Aral, I; Karayalcin, G; Lanzkowsky, P; Shende, A, 1976)
"A 27 year old man with Hodgkin's disease experienced three separate episodes of chest pain, each occurring on the sixth day of a cycle of mustargen, oncovin, procarbazine, prednisone (MOPP) combination chermotherapy."1.26Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease. ( Greenwald, ES; Grossman, J; Weinstein, P, 1976)
"It is found that the spinal cord compression caused by malignant lymphomas is generally a late manifestation of the illness, although primary or early involvements are occasionally seen."1.26Spinal cord compression in malignant lymphoma. Treatment and results. ( Friedman, M; Kim, TH; Panahon, AM, 1976)
"Treatment of advanced Hodgkin's disease by associating vincristine, adriblastine, prednisone and procarbazine is compared with other widely employed protocols."1.25[Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy]. ( Buttolo, Q; Colle, R; Maiolini, E; Marinone, G; Mauro, PL, 1975)
"Progress in the chemotherapy of Hodgkin's disease and experimental therapeutic, pharmacologic, and clinical studies of the antitumor antibiotic, adriamycin, are presented in this abstract."1.25Progress in the chemotherapy of hematologic diseases. ( Frei, E, 1975)
"The results of modern radiotherapy for Hodgkin's disease are correlated to the stage of the disease."1.25Combination chemotherapy in Hodgkin's disease: relation to radiotherapy. ( Rosenberg, SA, 1975)
" Methodology and dosage schemes are discussed."1.25Towards curative treatment of advanced Hodgkin's disease. ( Falkson, G; Falkson, HC, 1975)
"Fifty-two patients with generalized Hodgkin's disease were treated with a combination of mustine hydrochloride, vinblastine, procarbazine, and prednisolone."1.25Combination chemotherapy in generalized Hodgkin's disease. ( Beard, ME; Crowther, D; Fairley, GH; Malpas, JS; Nicholson, WM; Scott, RB; Stansfeld, AG; Vartan, CP, 1970)
"Urethane is the best treatment available for multiple myeloma."1.23New therapy for leukemia, polycythemia, and lymphoma. ( BARTLETT, GR; MARLOW, AA, 1953)

Research

Studies (1,224)

TimeframeStudies, this research(%)All Research%
pre-1990803 (65.60)18.7374
1990's265 (21.65)18.2507
2000's114 (9.31)29.6817
2010's38 (3.10)24.3611
2020's4 (0.33)2.80

Authors

AuthorsStudies
Yasuda, H1
Komatsu, N1
Ando, J1
Ando, M1
Purvis, KN1
Swanson, HD1
Niloy, KK1
Zhou, Y1
Panetta, JC1
Crews, KR1
Flerlage, JE1
Zawati, I1
Adouni, O1
Finetti, P1
Manai, M2
Gamoudi, A1
Birnbaum, D1
Bertucci, F1
Mezlini, A2
Mou, E1
Advani, RH6
von Eyben, R1
Rosenberg, SA29
Hoppe, RT25
van Eggermond, AM1
Schaapveld, M1
Janus, CP1
de Boer, JP1
Krol, AD2
Zijlstra, JM1
van der Maazen, RW4
Kremer, LC1
van Leerdam, ME1
Louwman, MW1
Visser, O1
De Bruin, ML3
Aleman, BM7
van Leeuwen, FE4
Filatova, LV3
Plotnikova, AA1
Gershanovich, ML5
Semiglazova, TIu1
Canellos, GP24
Friedberg, JW4
Lister, TA10
Devita, VT34
Michaelson, EM1
Chen, YH1
Silver, B4
Tishler, RB1
Marcus, KJ1
Stevenson, MA2
Ng, AK2
Khuroo, MS1
Bujan, L1
Walschaerts, M1
Brugnon, F1
Daudin, M1
Berthaut, I1
Auger, J2
Saias, J1
Szerman, E1
Moinard, N1
Rives, N1
Hennebicq, S1
Englund, A1
Hopstadius, C1
Enblad, G3
Gustafsson, G1
Ljungman, G1
Nagai, H1
Zietman, AL1
Hong, F6
Fisher, RI9
Bartlett, NL6
Robinson, KS1
Gascoyne, RD5
Wagner, H4
Stiff, PJ4
Cheson, BD5
Stewart, DA2
Gordon, LI5
Kahl, BS5
Blum, KA3
Habermann, TM4
Tuscano, JM3
Horning, SJ16
Cao, Z1
Wang, Z1
Sun, J1
Peng, C1
Feng, S1
Zhou, X1
Yang, Q1
Diefenbach, CS1
Li, H2
Crump, M3
Ansell, SM2
Almagro-Casado, E1
Sánchez, A1
Cantos, B1
Salas, C2
Pérez-Callejo, D1
Provencio, M1
Roemer, MG1
Ligon, AH1
Natkunam, Y1
Redd, RA1
Homer, H1
Connelly, CF1
Sun, HH1
Daadi, SE1
Freeman, GJ1
Armand, P1
Chapuy, B1
de Jong, D2
Neuberg, DS1
Rodig, SJ1
Shipp, MA1
Conway, JL1
Connors, JM12
Tyldesley, S1
Savage, KJ1
Campbell, BA1
Zheng, YY1
Hamm, J2
Pickles, T1
Celkan, T1
Yildiz, I1
Evens, AM2
Hutchings, M1
Diehl, V8
ANDERSEN, BJ1
BRØCHNER-MORTENSEN, K1
ZANES, RP1
DOAN, CA2
HOSTER, HA2
DE LANDSHEERE, B3
COTTE, P1
WINTROBE, MM4
HUGULEY, CM3
SHERRY, M1
SCHNEIDER, M1
POTH, EJ1
LEVIN, WC1
OTTO, P1
Souza, EM1
Baiocchi, OC1
Zanichelli, MA1
Alves, AC1
Oliveira, JS1
Alm El-Din, MA1
El-Badawy, SA1
Taghian, AG1
Abuzetun, JY1
Loberiza, F1
Vose, J3
Bierman, P1
Bociek, RG1
Enke, C1
Bast, M1
Weisenburger, D2
Armitage, JO2
Niu, Y1
Shi, YK2
He, XH2
Feng, FY1
Zhou, LQ4
Gu, DZ1
Pass, AK1
McLin, VA1
Rushton, JR1
Kearney, DL1
Hastings, CA1
Margolin, JF1
Régis, A1
Ben Salem, D1
Lambert, A1
Couaillier, JF1
Casasnovas, O2
Piard, F1
Krausé, D1
Kuleva, SA1
van Beek, RD3
van den Heuvel-Eibrink, MM3
Hakvoort-Cammel, FG4
van den Bos, C4
van der Pal, HJ1
Krenning, EP1
de Rijke, YB1
Pieters, R3
de Muinck Keizer-Schrama, SM3
Villani, F4
Busia, A2
Villani, M1
Laffranchi, A2
Viviani, S19
Bonfante, V20
Aversa, SM3
Trentin, C1
Sorarů, M4
Di Bona, E1
Marino, D1
Canova, F1
Salvagno, L4
Adami, F1
Wiernik, PH9
Glick, JH6
Bennett, JM2
García-Sanz, R1
González-López, TJ1
Vázquez, L1
Hermida, G1
Graciani, IF1
San Miguel, JF1
van den Belt-Dusebout, AW2
Besseling, G1
Hauptmann, M2
van 't Veer, MB2
de Wit, R1
Ribot, JG1
Noordijk, EM7
Kerst, JM1
Gietema, JA1
Podol'skiĭ, PN1
Datsenko, PV1
Pan'shin, GA2
Sotnikov, VM2
Mel'nik, IuD1
Ivashin, AV1
Bozhenko, VK1
Niedzwiecki, D1
Johnson, JL2
Kuruvilla, J1
Al-Tonbary, Y1
Sarhan, MM1
El-Ashry, RA1
Salama, E1
Sedki, M1
Fouda, A1
ApTHOMAS, MI1
CULLUMBINE, H1
HOFMEYR, HO1
Reddy, N1
Thompson-Arildsen, MA1
Keskin, EY1
Gursel, T1
Uluoglu, O1
Albayrak, M1
Kaya, Z1
Coskun, U1
Kocak, U1
GOODMAN, LS2
Haberer, S1
Belin, L1
Le Scodan, R1
Kirova, YM1
Savignoni, A1
Stevens, D1
Moisson, P1
Decaudin, D2
Pierga, JY1
Reyal, F1
Campana, F1
Fourquet, A1
Bollet, MA1
Chisesi, T6
Bellei, M2
Luminari, S3
Montanini, A1
Marcheselli, L1
Levis, A6
Gobbi, P1
Vitolo, U3
Stelitano, C2
Pavone, V3
Merli, F2
Liberati, M2
Baldini, L2
Bordonaro, R2
Pesce, EA1
Federico, M8
De Sanctis, V1
Filippone, FR1
Alfò, M1
Muni, R1
Cavalieri, E1
Pulsoni, A1
Annechini, G1
Valeriani, M1
Osti, MF1
Minniti, G1
Enrici, RM2
Niembro, A1
Lozano, V1
Gallardo, E1
Molina, B1
Sánchez, S1
Ramos, S1
Carnevale, A1
Pérez-Vera, P1
Rivera Luna, R1
Frias, S1
Ezzat, HM1
Cheung, MC1
Hicks, LK1
Boro, J1
Montaner, JS1
Lima, VD1
Harris, M2
Leitch, HA1
Dunleavy, K1
Grant, C1
Eberle, FC1
Pittaluga, S1
Jaffe, ES6
Wilson, WH2
Kochbati, L2
Fdhila, F1
Belaid, I1
Rifi, H1
Barsaoui, S1
Ben Romdhane, N1
Bel Hadj Ali, Z2
Oubich, F1
Maalej, M2
Baer, D1
Mason, J1
Warnke, R1
Allen, J1
Daadi, S1
Xing, PY1
Dong, M1
Yang, JL1
Liu, P1
Gospodarowicz, M2
Advani, R4
Schlienger, M1
Ferroir, JP1
Huguet, F1
Deluen, F1
Pène, F1
Marseguerra, R1
Touboul, E2
Metzger, ML1
Billett, A1
Link, MP6
Koontz, MZ1
Balise, R1
Greenberg, PL1
Miller, TP3
Kanakry, JA1
Gellert, LL1
Lemas, MV1
Hsieh, WS1
Tan, KL1
Stiff, P1
Ambinder, RF1
Spina, M3
Gabarre, J5
Rossi, G1
Fasan, M2
Schiantarelli, C1
Nigra, E1
Mena, M1
Antinori, A1
Ammassari, A1
Talamini, R1
Vaccher, E5
di Gennaro, G1
Tirelli, U9
Radman, I1
Basić, N1
Labar, B1
Kovacević, J1
Aurer, I1
Bogdanić, V1
Zupancić-Salek, S1
Nemet, D1
Jakić-Razumović, J1
Mrsić, M1
Santek, F1
Grgić-Markulin, L1
Boban, D1
Zanotti, R1
Trolese, A1
Ambrosetti, A1
Nadali, G1
Visco, C1
Ricetti, MM1
Benedetti, F1
Pizzolo, G2
Veronesi, G1
Spaggiari, L1
Solli, PG1
Leo, F1
Villa, G1
Pastorino, U1
Chronowski, GM2
Wilder, RB2
Tucker, SL1
Ha, CS3
Sarris, AH1
Hagemeister, FB17
Barista, I2
Hess, MA1
Cabanillas, F6
Cox, JD5
Duggan, DB2
Petroni, GR2
Peterson, BA6
Bernard, P1
Vinzio, S1
Talarmin, F1
Kadouri, A1
Flocard, F1
Dyduch, M1
Skolyszewski, J1
Korzeniowski, S1
Sokolowski, A1
Raemaekers, JM5
Bortolus, R3
Lybeert, ML3
Keuning, JJ1
Carde, P14
Girinsky, T5
Tomsic, R2
Vovk, M3
van Hoof, A2
Demeestere, G2
Lugtenburg, PJ2
Thomas, J9
Schroyens, W1
De Boeck, K1
Baars, JW2
Kluin-Nelemans, JC3
Carrie, C2
Aoudjhane, M1
Bron, D1
Eghbali, H7
Smit, WG2
Meerwaldt, JH7
Hagenbeek, A9
Pinna, A4
Henry-Amar, M12
Brice, P10
Brugiatelli, M1
Nagler, A2
Gisselbrecht, C7
Moretti, L1
Colombat, P3
Fabbiano, F1
Di Renzo, N3
Goldstone, A1
Carella, AM5
Longo, DL14
NARDI, FL1
WISNIEWSKI, B1
ROSE, LW1
TUCKER, HS2
RICHMAN, S1
WILLIAMS, JP1
MARLOW, AA1
BARTLETT, GR1
CROIZAT, P2
PAPILLON, J2
PINET, F2
HARRIS, MW1
JUSTIN-BESANCON, L1
LAMOTTE-BARRILLON, S1
DEBRAY, J2
KLIMA, R1
HORNISCHER, R1
HOLY, J1
SUCHAN, M1
DEUSCHLE, KW1
WIGGINS, WS1
SIEVERS, K1
HARWERTH, HG1
PIEMONTE, M1
VALDIVIESO CONDE, L1
MORANDEIRA VAAMONDE, L1
BERNARD, J15
GENIS GALVEZ, JM2
CASALLA CHACON, JM1
PETRONE, P1
MEYER, OO1
GASALLA CHACON, JM1
PERIERA, JR1
CHEVALLIER, P2
BILSKI-PASQUIER, G1
CHRISTOL, D1
BOIRON, M12
SEDAN, J2
INTROZZI, P2
MARINONE, G2
CORDIVIOLA, LA1
BOSQ, P2
ROSSELLI, S1
BEATTIE, JW1
HOWELLS, LH1
DESAIVE, P1
CLOSON, J1
LAVIGNE, J1
GOHR, H1
GORGES, T1
BOLDER, H1
VIDEBAEK, A3
KAAE, S2
HOCHMAN, A2
ICKOWICZ, M1
VIDEBAEK, AA1
SOROKIN, NM1
MOURIQUAND, C1
CAKMAKCI, A1
GIL, YG1
RAMIOUL, H1
JAMAR, B1
LARIONOV, LF2
RINGENBACH, MG1
BOURONCLE, BA1
WISEMAN, BK1
FRAJOLA, WJ1
SELLEI, C2
ECKHARDT, S1
HARTAI, F2
DUMBOVICH, B1
KUDRIASHOVA, OI2
MATHE, G4
WEIL, M10
MIROWSKA-STELMACHOWSKA, A1
TOPOLSKA, P1
HORLIN, W1
SCHMITT, W1
ROTTINO, A2
CHIARIONI, T1
FRACASSO, I1
NARDI, E1
SHAMINA, EV1
BROWN, FA1
KAPLAN, HS11
LIBANSKY, J2
CHUDOMEL, V2
SOCHMAN, J2
BRABEC, V2
PERNOT, C1
SCHOUMACHER, P1
PERNOT, M1
MASSE, P1
IVANOVA, EM1
DIESSNER, GR1
HECK, FJ1
VASILE, B2
MOSCHIDIS, C1
KIOSOGLOU, K1
MAOUNI, F1
ZULIK, R1
LOVISETTO, P2
CASTELLANO, M1
ZIV, MA1
CHILOV, K1
IVANOV, S1
KIRCHEV, P1
GERBRANDY, J1
HELLENDOORN, HB1
RUDCHENKO, NB1
CAPUTI, S1
Gupta, T1
Sanghavi, V1
Laskar, S1
ROUSSO, C1
CONRAD, ME1
CROSBY, WH1
COOK, JC1
KRABBENHOFT, KL1
LEUCUTIA, T1
SPEAR, PW1
PATNO, ME1
GYENES, G1
SAMPEY, JR4
SCOTT, JL1
MOLANDER, DW1
REWCASTLE, NB1
TAGLIORETTI, D1
TESTERO, S1
TISO, R1
ERIDANI, S2
HENNESSY, JP1
KARNOFSKY, DA3
MILLER, DG1
PHILLIPS, RF1
BRINDLEY, CO1
SALVIN, LG1
POTEE, KG1
LIPOWSKA, B1
SHNIDER, BI1
REGELSON, W1
COLSKY, J1
MAUER, AM1
KRILL, CE1
HEINEMAN, HS1
JENSEN, WN1
COOPER, WM1
BRAUDE, AI1
DOGLIOTTI, GC1
CREPALDI, G1
PARPAJOLA, A1
KURZ, GH1
VIGI, F1
MURPHY, WT2
BILGE, N2
LANE, M1
BERLIN, NI1
MENGEL, CE1
ROKICKA-MILEWSKA, R2
KOEROES, Z1
MATE WOJCINSKA, U1
TANIDA, T1
STEEL, SJ1
WATILLON, M1
PRIJOT, E1
FARRA, M1
TEILUM, G2
PAPAC, RJ2
WOOD, DA2
SHINGLETON, WW1
PARKER, RT1
IRIARTE, P1
JAGASIA, H1
THURMAN, WG1
HUNEYCUTT, HC1
ANDERSON, WR1
HENDRY, WS1
FRIEDMAN, BI1
SAENGER, EL1
KREINDLER, MS1
HUTCHISON, JL1
CHEEVER, AW1
VALSAMIS, MP1
RABSON, AS1
TODD, ID3
BERNHARDT, G1
LUDEWIG, H1
KEIDAN, SE1
MAINWARING, D1
HALNAN, KE1
SMITH, JC1
BOLANDE, RP1
MORROW, LB1
ANDERSON, RE1
MATTOSO, LF1
STONE, DL1
FERRARA, A1
BRAUN, H2
EICKE, WJ1
VESIN, S1
KEIBL, E1
HANRATTY, WJ1
POSLAVSKII, EV1
LEKSIKOV, IM1
RABENKO, J2
CORREA URQUIZA, LM1
SANDOR, L1
CERNY, V2
UJHAZY, V1
WINKLER, A1
RAEVSKII, IG1
Stevanato, F1
Pancotto, P1
Reimers, P1
Salvano, L1
Cella, G1
Boussen, H1
Benna, F1
Belhaj Ali, Z1
Gammoudi, A1
Bouaouina, N1
Besbes, M1
Ghilen, L1
Rahal, K1
Ogawa, M3
Hodgson, DC2
Tsang, RW1
Pintilie, M1
Sun, A1
Wells, W1
Gospodarowicz, MK1
van den Berg, H5
Furstner, F1
Behrendt, H6
Li, S1
Neuberg, D1
Fisher, DC1
Mauch, PM7
LENZI, F1
WEICKER, H1
MOESER, H1
LINDEMANN, M1
GUMMEL, H1
MASOUREDIS, SP1
LOW-BEER, BV1
BIERMAN, HR3
CHERNEY, LS1
SHIMKIN, MB3
GARDIKAS, C1
WILKINSON, JF1
GIL y GIL, C2
LEQUESNE, M1
di PIETRO, S1
GIACOMELLI, V1
NINNI, M1
LEVI, M1
MENE, G1
FERRI, A1
de LORENZO, J1
JANNINI, P1
KELLY, KH1
LOWENHAUPT, E1
FURST, A1
BARENGHI, G1
ABOU SINNA, I1
BOLAND, J1
INNES, J1
GELLHORN, A2
COLLINS, VP1
KIELER, J1
INGRASSIA, G1
STORTI, E2
BILLERBECK, K1
CALARESU, I1
ROSWIT, B1
PISETSKY, JE1
LEIBETSEDER, F1
RABL, I1
LENTINI, S1
POLIMENI, R2
MEDETTI, M1
Ghobrial, IM1
Wolf, RC1
Pereira, DL1
Fonseca, R1
White, WL1
Colgan, JP1
Inwards, DJ1
Markovic, SN1
Micallef, IN1
Porrata, LF1
Witzig, TE1
Oliapuram Jose, B1
Koerner, P1
Bertolone, S1
Patel, CC1
Spanos, WJ1
Paris, KJ1
Silverman, CL1
Yashar, CM1
Buitendijk, S1
van den Heuvel-Eibrink, M1
Hählen, K1
Vassilakopoulos, TP1
Angelopoulou, MK1
Siakantaris, MP1
Kontopidou, FN1
Dimopoulou, MN1
Kokoris, SI1
Kyrtsonis, MC1
Tsaftaridis, P1
Karkantaris, C1
Anargyrou, K1
Boutsis, DE1
Variamis, E1
Michalopoulos, T1
Boussiotis, VA2
Panayiotidis, P1
Papavassiliou, C1
Pangalis, GA2
Hohaus, S1
Di Febo, A1
Storti, S1
Teofili, L2
Voso, MT1
Leone, G1
Mazzarotto, R2
Boso, C1
Gaion, F1
Chiarion-Sileni, V1
De Franchis, G1
Favaretto, AG1
Crivellari, G1
Banna, GL1
Sotti, G3
Monfardini, S5
SARTORI, P1
AJELLI, C1
PITZURRA, M1
ROZABAL, F1
ORTIZ VAZQUEZ, J1
RUIZ FALCO, F1
PAVAN, S1
DE RITIS, F1
SCALFI, L1
MATTHEWS, WB1
NAVARRO, F1
PINKER, H1
SPURR, CL3
SMITH, TR1
BLOCK, M1
JACOBSON, LO1
ALBER, M1
BETHELL, FH1
ANDREWS, GA1
NELIGH, RB1
MEYERS, MC1
HETTIG, RA1
TEWES, H1
Balwierz, W7
Moryl-Bujakowska, A6
Depowska, T7
Klekawka, T1
Stanuch, H1
Matysiak, M3
Sopyło, B2
Kołakowska-Mrozowska, B2
Krenke, K1
Chybicka, A1
Raś, M1
Sońta-Jakimczyk, D3
Moszant, A1
Wachowiak, J1
Kaczmarek-Kanold, M2
Kowalczyk, J2
Odój, T1
Balcerska, A1
Drozyńska, E1
Wysocki, M1
Kołtan, A1
Krawczuk-Rybak, M1
Stolarska, M1
Wessels, G2
Bernard Hesseling, P1
Illés, A2
Udvardy, M1
Molnár, Z1
Kneller, A1
Cohen, N1
Berkowicz, M2
Reichart, M1
Rosner, E1
Sokolovski, M1
Rechavi, G1
Amariglio, N1
Trakhtenbrot, L1
Bonadonna, G31
Gianni, AM3
Valagussa, P21
DeLair, SM1
White, RW1
Kurzrock, EA1
Strijk, S1
Meijnders, P1
Olofsen-van Acht, MJ1
Lievens, Y2
Poortmans, PM1
Campbell, B1
Wirth, A2
Milner, A1
Di Iulio, J1
MacManus, M1
Ryan, G1
Marisavljević, D1
Ristić, B1
Hajder, J1
Gobbi, PG6
Broglia, C3
Cavanna, L4
Santini, G3
Deliliers, GL2
Angelucci, E1
Comella, P1
Abate, G1
Fiore, M1
Di Finizio, G1
Frezza, P1
Scoppa, G1
Anania, C1
Coucourde, F1
Zarrilli, D1
Morbidini-Gaffney, S1
Alpert, TE1
Hatoum, GF1
Sagerman, RH1
La Sala, A1
Valentino, F1
Sacchi, S1
Corbella, F2
Iannitto, E3
Molica, S2
Corazza, GR1
Fermé, C9
Mounier, N1
Divine, M4
Sonet, A1
Bouafia, F1
Bastard-Stamatoullas, A1
Bordessoule, D2
Voillat, L1
Reman, O2
Blanc, M3
Zhen, ZJ1
Sun, XF2
Xia, Y1
Wang, ZH1
Ling, JY1
Foltz, LM1
Song, KW1
Dupouy, N2
Monconduit, M8
Bosq, J3
Verschueren, TA1
Pény, AM1
Kung, FH1
Schwartz, CL1
Ferree, CR1
London, WB1
Ternberg, JL2
Behm, FG3
Wharam, MD2
Falletta, JM1
de Alarcon, P1
Chauvenet, AR2
Wang, WH1
Li, YX1
Song, YW1
Jin, J1
Liu, YP1
Wang, SL1
Liu, XF1
Yu, ZH1
Han, JZ1
Fu, XH1
Wang, SS1
Huang, Y1
Wang, B1
Huang, HQ1
Zhang, L1
Xu, RH1
Lin, TY1
Pivnik, AV1
Rastrigin, NA1
Moiseeva, TN1
Lutsenko, IN1
Dudarova, RG1
Shavlokhov, VS1
Efimov, IV1
Kozhurin, SV1
Shitareva, IV1
Gemdzhian, EG1
Tsyba, NN1
Kolosova, LIu1
Melikian, AL1
Skidan, NI1
Dotsenko, PV1
Nechistiuk, AV1
Majhail, NS1
Weisdorf, DJ1
Defor, TE1
Miller, JS1
McGlave, PB1
Slungaard, A1
Arora, M1
Ramsay, NK1
Orchard, PJ1
MacMillan, ML1
Burns, LJ3
Tomiŝiĉ, R1
Baaijens, MH1
Lugtenburg, P1
Chow, LM1
Nathan, PC1
Jenkin, D7
Weitzman, S2
Grant, RM1
Manson, D1
Bross, A1
Doyle, JJ1
Danjoux, C1
Greenberg, ML1
Mandal, S1
Mandal, AK1
Simon, Z1
Keresztes, K1
Miltényi, Z1
Ress, Z1
Váróczy, L1
Vadász, G1
Gergely, L1
Giuseppe, L1
Attilio, G1
Edoardo, DN1
Loredana, G1
Cristina, L1
Vincenzo, L1
Tanaka, PY1
Pessoa, VP1
Pracchia, LF1
Buccheri, V1
Chamone, DA1
Calore, EE1
Maeda, L1
Lavori, P1
Quon, A1
Hoppe, R1
Breslin, S1
Fuchs, M1
Laven, JS1
de Jong, FH2
Themmen, AP1
Huisbrink, J1
Kuenen, MA1
Ouwens, GM1
van't Veer, MB2
Diez, P1
Hoskin, PJ1
Aird, EG1
Smit, M1
Weber, RF1
Rieux, C1
Berger, F3
Walewski, JA1
Lederlin, P4
Van den Neste, E1
Gyan, E1
Salles, G2
Creemers, GJ1
Vié, B1
Viseu, F1
Poortmans, P1
Jaubert, J1
Tan, WY1
Hu, DS1
Zeng, FY1
Song, QB1
Hu, S1
Wei, L1
BEN-ASHER, S1
MEYER, AH1
OVERMILLER, WC1
CORNELL, VH1
BLAUW, AS1
DAMESHEK, W2
WEISFUSE, L1
STEIN, T1
ERF, LA1
BAUER, RD1
OTTE, P1
NABARRO, JD1
KAY, WR1
GROEN, J1
GODFRIED, EG1
Olweny, CL4
Ziegler, JL4
Joensuu, H2
Brauer, MJ1
McEvoy, BF1
Mitus, WJ1
Shohat, B1
Gitter, S1
Lavie, D1
Goguel, A1
Jacquillat, C12
Tanzer, J2
Santoro, A25
Lombardi, C1
Ragni, G2
Lira, P1
Grebe, G1
Bakemeier, RF2
Anderson, JR4
Costello, W2
Rosner, G1
Horton, J1
Hines, JD1
Berard, CW3
Straus, DJ11
Myers, J7
Passe, S1
Young, CW4
Nisce, LZ6
Lee, BJ8
Koziner, B7
Arlin, Z2
Kempin, S2
Gee, T2
Clarkson, BD6
Rodgers, RW2
Gamble, JF7
Loh, KK1
Shullenberger, CC8
Malpas, JS9
Sutcliffe, SB7
Economopoulos, T1
Wrigley, PF11
Stansfeld, AG6
Goldman, JM2
Armata, J12
Borkowski, W5
Kaczor, Z3
Grozea, PN2
De Persio, EJ1
Coltman, CA6
Fabian, CJ2
Morrison, FS1
Gehan, EA7
Jones, SE4
Fossati Bellani, F1
Franchi, F1
Banfi, A4
Mayer, RJ1
Prosnitz, LR9
Farber, LR6
Kapp, DS3
Bertino, JR4
Nordlund, M1
Lawrence, R2
DePersio, EJ1
Dixon, DO2
Gassmann, W3
Schmitz, N3
Löffler, H3
Klastersky, J1
Cech, P1
Testa, U1
Dubart, A1
Schneider, P1
Bachmann, F1
Guerrasio, A1
Beuzard, Y1
Schmidt, PM1
Clément, F1
Rosa, J1
Bartual, J1
Roquette, J1
Gil, M1
Magro, E1
Bascuas, JL1
Yarnold, JR1
Jelliffe, AM2
Hudson, GV3
Doyle, TJ1
Venkatachalam, KK1
Maeda, K2
Saeed, SM1
Tilchen, EJ1
Papa, G4
Mandelli, F4
Anselmo, AP6
De Luca, AM1
Maurizienrici, R1
Mauro, F2
Testi, AM2
Amadori, S2
Biagini, C2
Haut, A1
Weick, JK1
Wilson, HE2
Grozea, P1
McKelvey, E1
Byrne, GE1
Hartsock, R1
Einhorn, LH2
Williams, SD1
Stevens, EE1
Bond, WH1
Chenoweth, L1
Moser, K1
Pohl, A1
Hubbard, SM14
Moxley, JH2
Come, SE3
Skarin, AT1
Ricciardi, O2
Dal Fior, S2
Cappellari, F2
Pozza, F2
Battista, R1
Cortelazzo, S1
Capnist, G1
D'Emilio, A1
Rodeghiero, F1
Cimino, G7
Marzullo, A1
Maurizi Enrici, R3
Zanini, M6
Zucali, R9
Olver, IN2
Wolf, MM2
Bishop, JF1
Ding, JC2
Cooper, IA3
Matthews, J2
McCormick, B3
Mertelsmann, R2
Tannir, N1
Hagemeister, F1
Velasquez, W2
Corder, MP5
Clamon, GH2
Wiesenfeld, M1
Portlock, CS7
Harker, WG1
Kushlan, P1
Teillet, F11
D'Agay, MF4
Sagar, HJ1
Read, DJ1
Krikler, SH1
Bain, GO1
Gordon, PA1
Liebman, HA1
Hum, GJ1
Sheehan, WW1
Ryden, VM1
Bateman, JR2
Khayat, D1
Desprez-Curely, JP2
Brocheriou, C1
Auclerc, G6
Chamseddine, N1
Goodman, MJ1
Gilman, A1
McLennan, MT1
Anderson, H3
Deakin, DP5
Wagstaff, J3
Jones, JM1
Wilkinson, PM3
James, RD2
Steward, WP2
Blackledge, G3
Scarffe, JH2
Cooper, MR6
Pajak, TF4
Gottlieb, AJ4
Glicksman, AS1
Nissen, N2
Richards, F1
Bloomfield, C1
Holland, JF7
Crowther, D12
Deakin, D1
Todd, I2
Wilkinson, P1
Jones, M1
Dein, RA1
Mennuti, MT2
Kovach, P1
Gabbe, SG1
Marty, M3
Whitehead, E4
Shalet, SM8
Beardwell, CG2
Specht, L4
Hansen, MM1
Geisler, C1
Westberg, MW1
Burns, CP1
Klassen, LW1
Goeken, NE1
Ray, TL1
Macfarlane, DE1
Jacobs, P1
King, HS1
Karabus, C1
Hartley, P1
Werner, D1
Kovryzhkina, TA1
Ellwein, LB2
Semenov, II2
Artiushkin, AV1
Vorob'ev, AI2
Brilliant, MD2
Voltarelli, JC1
Falcão, RP1
Bottura, C1
Weitberg, AB1
Harmon, DC1
Bayle-Weisgerber, C4
Lemercier, N1
Asselain, B4
Gout, M1
Schweisguth, O2
da Cunha, MF1
Meistrich, ML2
Fuller, LM18
Cundiff, JH1
Velasquez, WS6
McLaughlin, P6
Riggs, SA1
Cabanillas, FF1
Salvador, PG1
Tester, WJ1
Kinsella, TJ1
Waller, B1
Makuch, RW1
Kelley, PA1
Glatstein, E7
Coyne, J1
Dervan, P1
Sampi, K2
Honda, T1
Hattori, M1
Schmitt, K1
Tulzer, W1
Yosida, T1
Nakanisi, J1
Kobayasi, S1
Ohtake, S4
Ito, K1
Nakamura, S3
Hattori, K1
Saito, Y2
Tanimoto, K1
Heinz, R1
Hanak, H1
Berényi, E1
Szegedi, G1
Dorreen, MS2
Laidlow, JM1
Plowman, PN1
Neudachin, L1
Tucker, AK1
Faux, MM1
Jones, AE4
Gassel, WD1
Gropp, C1
Havemann, K1
Cyklis, R1
Grześkowiak-Melanowska, J1
Vecchi, V2
Maccolini, E1
Oddo Bravetti, G1
Guidelli Guidi, S1
Serra, L1
Kayser, W1
Hansz, J1
Burchardt, K1
Komarnicki, M2
Trepińska, E1
Psuja, P1
Bartolucci, AA2
Liu, C1
Durant, JR3
Gams, RA1
Weinstein, H4
Botnick, L2
Belli, J1
Cassady, JR3
Amiel, JL2
Spielmann, M1
Kerbrat, P1
Droz, JP1
Tursz, T1
Ben Ayed, F1
Auclerc, MF1
Maral, J1
Hawkins, KA1
Schinella, R1
Schwartz, M1
Ramsey, D1
Weintraub, AH1
Silber, R1
Amorosi, EL1
Andrieu, JM19
Ochoa-Molina, ME2
Kuentz, M3
Reyes, F3
Brun, B4
Lebourgeois, JP1
Bierling, P1
Farcet, JP1
Vernant, JP3
Imbert, M1
Le Bezu, M1
Rochant, H3
Dreyfus, B4
Tawil, E1
Mercier, JP1
Denz, H1
Lechleitner, M1
Peschel, C1
Peer, L1
Huber, H1
Kolygin, BA5
Kharatishvili, ZV1
Aisenberg, AC5
Homan, R1
Lechner, K2
Neumann, E2
Moritz, H1
Czembirek, H1
Resch, F1
Wagener, DJ2
Burgers, JM4
Dekker, AW2
Kazem, I1
van Peperzeel, HA1
Qasim, MM1
Sizoo, W3
Somers, R8
Kroese, WF2
Murray, F1
Daly, PA1
Freyne, PJ1
Mazza, P5
Lauria, F6
Sciascia, R3
Emiliani, E3
Fiacchini, M6
Baccarani, M6
Frezza, G1
Dominici, G1
Cantore, M1
Faedi, M1
Patricio, MB1
Ricardo, JA1
Vilhena, M1
Branco, F1
De Ponte, MA1
Cabral, R1
Neves, M1
De Sousa, JV1
Ekert, H4
Waters, KD2
Kovalenko, NS1
Fokina, NT2
Matusewicz, W1
Drzewoski, J1
Robak, T3
Krykowski, E4
Dini, E1
Faux, M1
MacKintosh, FR1
Sullivan, JA4
Johnston, D1
North, L4
Butler, JJ8
Cramer, P4
Tea, N1
Tricot, G2
Flandrin, G2
Schaison, G5
Mantovani, G1
Del Giacco, GS1
Marongiu, F1
Tognella, S1
Carassi, UE1
Weidenmaier, W1
Röttinger, EM1
Gallmeier, WM3
Bruntsch, U3
Waxman, JH2
Terry, YA1
Rees, LH2
Besser, GM2
Tura, S7
Cadman, E1
Bloom, AF1
Prosnitz, L1
Farber, L1
Vera, R2
Bertino, J1
Fischer, D1
Diehl, LF1
Perry, DJ1
Terebelo, H1
Baldwin, PE1
Hurwitz, M1
Kimball, DB1
Dorn, RV1
Simon, RM1
Young, RC22
Frei, E12
Carbone, PP5
Nesse, RM1
Carli, T1
Curtis, GC1
Kleinman, PD1
Green, JA1
Dawson, AA3
Fell, LF1
Murray, S1
Kim, YH1
Fayos, JV1
Fil'kova, EM1
Conrad, FG1
Faguet, GB1
Davis, HC1
McLeod, R1
Estes, RG1
Baĭsogolov, GD1
Casassus, P2
Coscas, Y2
Darmont, J1
Goubeau, C1
Katz, M3
Rahim, MA1
Sarma, SK1
Ahmed, Q1
Rosenstrauch, WJ1
van der Merwe, AM1
King, JB1
van Eeden, PJ1
Steytler, JG1
Weiner, MJ1
Sicular, A1
Blaugrund, SM1
Sattler, SM1
Steel, NR1
Carr, D1
Finney, RD1
Horikoshi, N1
Allan, E1
Bostick, F1
Vanhaelen, C1
Howser, DM1
Nissen, NI13
Nordentoft, AM3
Brincker, H1
Andersen, E2
Jensen, MK1
Nielsen, JB1
Pedersen-Bjergaard, J3
Jensen, TS1
Jensen, KB1
Pedersen, M1
Walbom-Jørgensen, S2
Bayle, C1
Clot, P2
Dana, M4
Brière, J2
Barnes, JM1
Neiman, RS1
Orlow, EL1
Glidewell, OJ4
Bloomfield, CD2
Sullivan, MP4
Chen, T1
Fisher, R1
Fryer, C2
Gehan, E1
Gilchrist, GS4
Hays, D1
Hanson, W2
Heller, R2
Higgins, G1
Kung, F1
Sheehan, W1
Tefft, M1
Ternberg, J2
Wharam, M2
Chan, H2
Freedman, M3
Greenberg, M4
Gribbin, M1
McClure, P2
Saunders, F3
Sonley, M2
Coleman, CN7
Cox, RS3
Cunningham, J1
Mauch, P11
Rosenthal, DS9
Johnston, DA2
Jones, PH1
Hellman, S7
Delbrück, H2
Lelièvre, P1
Lawson, JP1
Friedlaender, GE1
Pezzimenti, JF1
Chapman, RM1
Strickland, P1
Schilsky, RL2
Sherins, RJ5
Wesley, MN2
Streuli, RA2
Ultmann, JE3
Velazquez, WS1
North, LB3
Martin, RG1
Nadiminti, Y1
Wang, JC1
Chou, SY1
Pineles, E1
Tobin, MS1
Timothy, AR2
Stutzman, L5
Brunner, K2
Cuttner, J2
Falkson, G3
Grunwald, H1
Bank, A2
Leone, L2
Seligman, BR1
Silver, RT2
Weiss, RB3
Haurani, F2
Blom, J3
Gordon, RA1
Lookingbill, DP1
Abt, AB1
Albala, MM1
Steinfeld, AD1
Khilnani, MT1
Alaoui, Y1
Baillet, F4
Maylin, C2
Pierquin, B3
Jacobson, RJ1
Klappenbach, RS1
Clinton, C1
de Moor, NG1
Wong, O1
Golomb, HM1
Sweet, DL1
Kotlarek-Haus, S1
Gabryś, K1
Potoczek, S1
Glanzmann, C1
Stahel, R2
Kingreen, D1
Dalal, BI1
Heyman, M1
Phillips, GL3
Horsman, D1
Kidd, P1
Loughran, TP1
Cleary, SF1
Donaldson, SS6
Abboud, J1
Nasrallah, T1
Chahine, G1
Nasnas, R1
Mah, K1
Keane, TJ1
Van Dyk, J1
Braban, LE1
Poon, PY1
Hao, Y1
Tarayre, M2
de Pauw, BE2
Breed, WP2
Verdonck, L1
Siena, S2
Bregni, M2
Lombardi, F2
Gandola, L1
Di Nicola, M1
Magni, M1
Peccatori, F1
Moreau, P2
Milpied, N2
Mechinaud-Lacroix, F1
Mahe, B1
Rapp, MJ1
Le Tortorec, S1
Bourdin, S1
Dupas, B1
Harousseau, JL1
Brusamolino, E5
Lazzarino, M4
Orlandi, E4
Canevari, A2
Morra, E3
Castelli, G3
Alessandrino, EP2
Pagnucco, G4
Astori, C3
Livraghi, A2
Mandard, AM1
Mellink, WA1
Santagostino, A1
Bernasconi, C2
Preti, A1
Swan, F3
Rodriguez, A1
Besa, P1
Allen, PK2
Bernasconi, P1
Koeppel, MC1
Horschowski, N1
Terrier, G1
Andrac, L1
Stoppa, AM1
Signoret, R1
Sayag, J1
Hunger, SP1
Khan, SP1
Arndt, CA1
Smithson, WA1
Chen, MG1
Schomberg, PJ1
Matsumoto, JM1
O'Fallon, WM1
Hermann, R1
Greminger, P1
Dommann-Scherrer, C1
Krestin, GP1
Soncini, F3
Devizzi, L6
Castellani, MR1
Negretti, E3
Crennan, E1
D'Costa, I1
Liew, KH2
Thompson, J1
Laidlaw, C2
Cooper, I2
Quong, G1
Fried, G1
Ben Arieh, Y1
Haim, N4
Dale, J1
Stein, M1
Balzarini, L1
Kozielski, J1
Rauer, R1
Ziora, D1
Spychałowicz, W1
Myint, H1
McGregor, J1
Edwards, R1
Lucie, NP1
Hancock, SL2
Pollicardo, N1
Pungolino, E2
Frassoni, F2
Giordano, D3
Bruni, R2
Spriano, M2
Rossi, E2
Aversa, S1
Chiarion Sileni, V2
Scarzello, G1
Bianco, A2
Pappagallo, GL2
Fiorentino, MV2
Lévy, R1
Colonna, P7
Tourani, JM2
Gastaut, JA1
Raphaël, M1
Taillan, B1
Bendandi, M1
Zaccaria, A1
Zinzani, PL3
Visani, G2
Stefanati, V1
Cantagalli, F1
Mancino, A1
Macchi, S1
Simoncelli, F1
Errante, D1
Dolcetti, R1
Gloghini, A1
Serraino, D1
Franceschi, S1
Boiocchi, M1
Carbone, A2
Reece, DE2
Barnett, MJ2
Shepherd, JD2
Hogge, DE1
Klasa, RJ1
Nantel, SH1
Sutherland, HJ1
Klingemann, HG2
Fairey, RN2
Voss, NJ1
Jekunen, A1
Maiche, A1
Laurila, P1
Franssila, K1
Elomaa, I1
Boice, JD1
Travis, LB1
Tobinai, K2
Gui, W1
Zhen, YP1
Chang, XQ1
Barcos, M2
Radford, JA6
Rohatiner, AZ2
Ryder, WD2
Gupta, RK1
Oza, A2
Arnott, S2
Sullivan, JW1
Cooper, JS1
Martino, R1
Nomdedeu, J1
Brunet, S1
Spector, N1
Costa, MA1
Pulcheri, W1
Salgado, RC1
Nucci, M1
Andrade, CA1
de Morais, JC1
de Castro, O1
Scaletsky, AF1
Brabo, E1
Chintagumpala, MM1
Mahoney, DH1
McClain, K1
Dreyer, ZE1
Fishman, MA1
Carrol, CL1
Steuber, CP1
Behar, RA1
Pieresca, C1
Narni, F1
Grignani, G1
Avanzini, P1
Partesotti, G1
Uematsu, M1
Tarbell, NJ4
Shulman, LN2
Canellos, G1
Bader, SB1
Lepage, E5
Fermand, JP2
Castaigne, S3
Frija, J2
Miot, C2
Lichtman, SM1
Brody, J1
Kaplan, MH1
Susin, M1
Koduru, P1
Goh, JC1
Simmonds, P1
Silberstein, M1
McKendrick, J1
Gerhartz, HH1
Beykirch, M1
Hiller, E1
Wilmanns, W2
Pileri, S1
Burnelli, R1
Bontempi, N1
Comelli, A1
Carli, M1
Rosati, D1
Di Tullio, MT1
Yong, WB1
Wang, H1
Zhu, XM1
Hayat, M4
Burgers, MJ1
Tanguy, A2
Le Fur, R2
Levêque, J1
Meunier, B1
Poulain, P1
Blanchot, J1
Dugast, J1
Le Prise, E1
Grall, JY2
Clark, ST2
Swindell, R3
Rysenga, E1
Linden, MD1
Carey, JL1
Ross, CW1
Schnitzer, B1
Sawdyk, M1
Pautier, P1
Marolleau, JP1
Montillo, M1
Scarpelli, M1
Discepoli, G1
Catarini, M1
Rychlicki, F1
Leoni, P1
Kessinger, A1
Lee, CK3
Levitt, SH1
Onoshi, T1
Robinson, BA1
Colls, BM1
Fitzharris, BM1
Atkinson, CH1
Marcus, KC1
Kalish, LA1
Dietrich, PY1
Cosset, JM3
Bodis, S1
Holmes, SJ1
Whitehouse, RW1
Crowther, DC1
Adams, JE1
Souliotis, VL1
Valavanis, C1
Kyrtopoulos, SA1
Purugganan, R1
Fuller, L1
Romaguera, J1
Rodriguez, M1
Fisher, PM1
Dodwell, DJ2
Bridges, LR1
Cartwright, SC1
Stone, J1
Brandriff, BF1
Gordon, LA1
Carrano, AV1
Liang, JC2
Chorus, AM1
Noyon, R1
van Kerkhoff, EH1
Pinedo, HM1
Bokemeyer, C1
Schmoll, HJ1
van Rhee, J1
Kuczyk, M1
Schuppert, F1
Poliwoda, H1
Delmez, JA1
Safdar, SH1
Kissane, JM1
Avilés, A5
Arévila, N1
Díaz Maqueo, JC1
Gómez, T1
García, R1
Nambo, MJ1
Gosselin, M1
Podgorsak, EB1
Evans, MD1
Pla, M1
Shenouda, G1
Grundstein-Amado, R1
Dhabhar, BN1
Malhotra, H1
Joseph, R1
Garde, S1
Bhasin, S1
Sheth, A1
Advani, SH2
Cascinu, S1
Fedeli, A1
Catalano, G1
Grigoraki, V1
Lilienthal, F1
Binet, JL1
Merle-Béral, H2
Kirshner, JJ1
Parker, B1
Kaźmierczak, M1
Kroll, R1
Fitzgerald, A1
Björkholm, M2
Axdorph, U1
Grimfors, G1
Merk, K1
Johansson, B1
Landgren, O1
Svedmyr, E1
Mellstedt, H1
Holm, G1
Abdallah, JM1
Lombardi, DP1
Kirsch, IR1
Naccache, P1
Koscielny, S1
Bendahmane, B1
Munck, JN1
Cervantes, F1
Briones, J1
Bruguera, M1
Font, C1
Grau, JM1
Rozman, C1
Montserrat, E1
Yuen, AR1
Prencipe, E1
Lerma, E1
Occhini, D2
Gatti, AM1
Nati, S2
Pierluigi, D2
Congiu, M1
Vimercati, R1
Ravetti, JL1
Ifrah, N2
Hunault, M1
Jais, JP2
Desablens, B1
Le Maignan, C1
Glimelius, B2
Kalkner, M1
Gustavsson, A2
Jakobsson, M1
Branehog, I1
Lenner, P1
Heikens, J1
Adriaanse, R1
Berghout, A1
Blumenfeld, Z2
Avivi, I1
Linn, S1
Epelbaum, R2
Ben-Shahar, M3
Kumari, PK1
Chellam, VG1
Madhavan, J1
Ratheesan, K1
Pillai, GR1
Kumar, SR1
Nair, MK1
Swerdlow, AJ3
Barber, JA2
Horwich, A3
Cunningham, D2
Milan, S1
Omar, RZ1
Falchero, L1
Coiffier, B3
Guibert, B1
Souquet, PJ1
Isaac Pinet, S1
Trillet-Lenoir, V1
Harif, M1
Trachli, A1
Quessar, A1
Sehraoui, S1
Benchekroun, S1
Benchemsi, N1
Redei, I1
Mangan, KF1
Ming, PL1
Mullaney, MT1
Rao, PN1
Goldberg, SL1
Klumpp, TR1
Balzarotti, M2
Meurman, JH2
Laine, P2
Keinànen, S1
Pyrhönen, S2
Teerenhovi, L2
Lindqvist, C2
Varterasian, ML1
Aref, A1
Karanes, C1
Stuve, W1
Marjańska-Radziszewska, J1
Zawiła, K1
Cieśla, E1
Zsiros, J1
Bossi, G1
Cerveri, I1
Volpini, E1
Corsico, A1
Baio, A1
Klersy, C2
Arico, M1
Raemaekers, J1
Burgers, M1
Mandard, A1
Breed, W1
Noordijk, E1
Klimo, P5
Adams, G1
Burns, BF1
Meyer, RM1
O'Reilly, SE3
Pater, J1
Quirt, I1
Sadura, A1
Shustik, C1
Skillings, J1
Sutcliffe, S1
Verma, S1
Yoshida, S1
Zee, B1
Schellong, G1
Riepenhausen, M1
Creutzig, U1
Ritter, J1
Harbott, J1
Mann, G1
Gadner, H1
Kamieńska, E1
Crosbie, OM1
Crown, JP1
Nolan, NP1
Murray, R1
Hegarty, JE1
Imrie, KR1
Sheridan, B1
Colwill, R1
Stewart, AK1
McCrae, J1
Danish, R1
Sutton, D1
Romeyer, F1
Keating, A1
Weiner, MA2
Leventhal, B1
Brecher, ML1
Marcus, RB1
Cantor, A2
Gieser, PW1
Kulkarni, SS1
Sastry, PS1
Saikia, TK1
Parikh, PM1
Gopal, R1
Corry, J1
Duffey, PL8
Ihde, DC2
Bastian, AW2
Wittes, RE1
Golden, MA1
Vaughn, DJ1
Crooks, GW1
Holland, GA1
Bavaria, JE1
Ziółko, E1
Young, ML1
Harrington, D1
Beck, T1
Neiman, R1
Oken, MM2
Ritter, M1
Shen-Orr, Z1
Shariki, K1
Tsodikov, A1
Loeffler, M1
Yakovlev, A1
Hutchinson, RJ1
Fryer, CJ1
Davis, PC1
Nachman, J1
Krailo, MD1
O'Brien, RT1
Collins, RD1
Whalen, T1
Reardon, D1
Trigg, ME1
Constine, LS1
Camerini, E1
Fornier, M1
Verderio, P1
Hesseling, PB1
Van Jaarsveld, D1
Van Riet, FA1
Bairey, O1
Gabbay, U1
Blickstein, D1
Stark, P1
Prokocimer, M1
Epstein, O1
Shaklai, M1
Lahav, J1
Dunlop, DJ1
Eatock, MM1
Paul, J2
Anderson, S1
Reed, NS1
Soukop, M2
Lucie, N1
Fitzsimmons, EJ1
Tansey, P1
Warzocha, K1
Bienvenu, J1
Ribeiro, P1
Moullet, I2
Dumontet, C1
Neidhardt-Berard, EM1
André, M1
Blaise, D1
Fleury, J1
Cahn, JY1
Pico, JL1
Bastion, Y2
Nedellec, G1
Attal, M1
Arranz, R1
Gil-Fernández, JJ1
Muñoz, E1
Acevedo, A1
Sobrino, MP1
Fernández-Rañada, JM1
Nyandoto, P1
Muhonen, T1
Santoro, M1
Lunghi, F1
Maurizi-Enrici, R1
Baroni, CD1
Tacik, J1
Eliasińska, A1
Tsushita, K1
Utsumi, M1
Shimoyama, M1
Baron, F1
Hermanne, JP1
Fassotte, MF1
Beguin, Y1
Fillet, G1
Klapper, SR1
Jordan, DR1
McLeish, W1
Pelletier, C1
Yilmaz, U1
Salloum, E1
Tanoue, LT1
Wackers, FJ1
Zelterman, D1
Hu, GL1
Cooper, DL1
Cantin, G1
L'Espérance, B1
Yelle, L2
Desjardins, L1
Couture, F1
Bergeron, M1
Lacroix, L1
Dufresne, J1
Bélanger, D1
Ouellet, PA1
Hewitt, LA1
Pirc, L1
Gyger, M1
Chim, CS1
Kwong, YL1
Lie, AK1
Ho, FC1
Liang, R1
Delain, M1
Cartron, G1
Bout, M1
Benboubker, L1
Linassier, C1
Lamagnere, JP1
Bogusławska-Jaworska, J1
Pisarek, J1
Janik-Moszant, A1
Kołecki, P1
Skomra, S1
Newecka-Samól, T1
Harrison, CN1
Gregory, W3
Devereux, S1
Goldstone, AH1
Hancock, B1
Winfield, D1
MacMillan, AK1
Hoskin, P1
Newland, AC1
Milligan, D1
Linch, DC2
Lucas, JB1
Horwitz, SM1
Sayegh, A1
Fouillard, L1
Laporte, J1
Douay, L1
Lesage, S1
Najman, A1
Gourmelon, P1
Gorin, NC1
Lishner, M2
Manor, Y1
Kitay-Cohen, Y1
Avishay, AE1
Aglietta, M1
Montemurro, F1
Fagioli, F1
Volta, C1
Botto, B1
Cantonetti, M1
Racanelli, V1
Ferrara, R1
Castoldi, GL1
Dammacco, F1
Muwakkit, S1
Geara, F1
Nabbout, B1
Farah, RA1
Shabb, NS1
Hajjar, T1
Khogali, M1
Meddeb, B1
Ben Lakhal, R1
Ben Abid, H1
Hafsia, R1
Hafsia, A1
Sebban, C1
Hennequin, C1
Ferrant, A4
Caillot, D1
Bertè, R1
Petrilli, MP1
Angrilli, F1
Ghirardelli, ML1
Ascari, E2
Tomasević, Z1
Jelić, S1
Tal, R1
Botchan, A1
Hauser, R1
Yogev, L1
Paz, G1
Yavetz, H1
Sauter, C1
Petera, J1
Macharová, H1
Pohanková, R1
Malír, A1
Coupek, P1
Konecný, M1
Patera, J1
Pecina, J1
Drbal, J1
Koukalová, H1
Vásová, I1
Powles, T1
Bower, M1
Choe, JG1
Kong, JS1
Oh, YK1
Edmund, E1
Geissler, K1
Gisslinger, H1
Knöbl, P1
Sperr, W1
Valent, P1
Dieckmann, K1
Chott, A1
Pötter, R1
Jäger, U1
Pérez, JA1
Ramírez, R1
Carpio, D1
Carrasco, C1
Pérez, A1
Avigdor, A1
Hardan, I1
Shpilberg, O1
Raanani, P1
Grotto, I1
Ben-Bassat, I2
Elconin, JH1
Roberts, KB2
Rizzieri, DA1
Vermont, C1
Clough, RW1
Kim, C1
Dodge, RK1
Soriano Guillén , L1
Muñoz Calvo , MT1
Pozo Román , J1
Contra Gómez , T1
Buño Soto , M1
Argente Oliver , J1
Homenda, W1
Hellmann, A1
Maslovsky, I1
Volchek, L1
Blumental, R1
Ducach, A1
Lugassy, G1
Nicolatou-Galitis, O1
Papadaki, T1
Moschovi, M1
Moshovi, M1
Kamma, JJ1
van Vliet-Constantinidou, C1
Tsoumakas, C1
Kattamis, A1
Tzortzatou-Stathopoulou, F1
Tesch, H1
Sieber, M1
Schoemaker, MJ1
Allerton, R1
Vaughan Hudson, G2
Williams, MV1
Cellai, E1
Magrini, SM3
Masala, G1
Alterini, R1
Costantini, AS1
Rigacci, L1
Olmastroni, L1
Papi, MG1
Spediacci, MA1
Innocenti, F1
Bellesi, G1
Ferrini, PR1
Biti, G1
Valtuch, I1
Faraggi, D1
Sharabi-Nov, A1
Ben-Arie, Y1
Cohen, Y1
Colin, P1
de Kerviler, E1
Bouaffia, F1
Kerneis, Y1
Molin, D1
Sundström, C1
Venge, P1
Hull, MC1
Mendenhall, NP1
Colgan, ME1
Zhou, L1
Wang, Q1
Feng, F1
Neri, N1
Cavalli, F1
Franklin, J1
Schlembach, PJ1
Jones, D1
Younes, A1
Mahmood, T1
Mudad, R1
Linfomi, MB1
Delwail, V1
Vettore, L1
Maiolini, E1
Buttolo, Q1
Mauro, PL1
Colle, R1
Johnson, LP1
Rivkin, SE1
Weber, EL1
De Lena, M3
Uslenghi, C1
Naysmith, A1
Hancock, BW3
Cullen, DR1
Richmond, J1
Wilde, CE1
Osieka, R1
Seeber, S2
Schmidt, CG2
Lokich, JJ3
Jaffe, N3
Tullis, J2
Case, DC2
Nisce, L1
Anderson, T2
Walser, A1
Alberto, P2
Garrett, MJ2
Das, S1
Smith, JD1
Freedman, LS1
Dold, U1
Porzig, KJ1
Robertson, A1
Krikorian, JG1
Johnson, SA1
Hawkins, DF1
Fiaccini, M1
Glatstein, EJ2
Wewerka, JR1
Magrath, I3
Henle, W1
Owor, R1
Olweny, C1
Le Blanc, DH1
Trump, DL1
Cowall, DE1
Sieber, SM1
Stopyrowa, J2
Depowski, M2
Strzeszynski, J3
Lewis, BJ1
Rozencweig, M1
Muggia, FM1
Glidewell, O3
Sawitsky, A1
Coleman, M3
Harley, JB1
Seligman, B1
Cornell, C1
Henry, P1
Senn, HJ2
Martz, G1
Maurice, P1
Shapiro, L1
James, GW1
Briere, JF1
Gustafson, J1
Schimpff, SC1
Diggs, C1
Greenberger, JS1
Weichselbaum, RR1
Botnick, LE1
Goodman, R3
Filler, R1
Levi, JA1
Madoc-Jones, H1
Fernandez, CH1
Piro, A1
Rosenthal, D2
Goldstein, M1
Desforges, JF1
Rutherford, CJ1
Hubbard, SP1
Simon, R1
Smith, PG1
Wald, N1
Ali, NO1
Janes, WO1
Hoogstraten, B2
Perlberg, HJ1
Kramer, S3
Piro, AJ1
Sinniah, D1
Lin, HP1
Peters, V1
Kluin-Neleman, JC1
Neleman, FA1
Meuwissen, OJ1
Maes, RA1
Vinokurova, NA1
Chekharina, EA1
Volterrani, F1
Sigurtà, D1
Severini, A1
Roeser, HP1
Roberts, SJ1
Kynaston, B1
Whitaker, SV1
Hocker, GA1
Poleksic, S1
Yeung, KY1
Peto, J1
Whitehouse, JM1
Royal, JE1
Seeler, RA1
Horner, RJ1
Chaffey, JT1
Moloney, WC3
Babini, L1
Franchini, A1
Katongole-Mbidde, E1
Kiire, C1
Lwanga, SK1
Chabner, BA2
Goodman, RL2
Neretto, G1
Giovanelli, E1
Agricola, R1
Furno, F1
Zieliński, T1
Krajewska, B1
Solska, E1
Karnicka-Młodkowska, H1
Rath, P1
Aghai, E2
Many, A2
Hulu, N1
Ramot, B2
Brenner, H1
Klein, HO1
O'Brien, PH1
Wallace, K1
Rambo, VB1
Barbieri, E2
Gobbi, M2
Oluboyede, OA1
Esan, GJ1
Farney, RJ1
Morris, AH1
Armstrong, JD1
Hammer, S1
Mazurowa, A1
Pluzańska, A2
Dmochowska, M1
Polkowska-Kulesza, E1
Skorek, TO1
Fajndt, S1
Boguszewska, E1
Jacquillat, Cl2
Dickey, JM1
Duchamp, C1
Clément, R1
Juin, P1
Mazeron, JJ2
Clay, A1
Swain, A1
Trounce, JR1
Williams, CJ1
Flint, A1
Pinon, G1
Gemon-Auclerc, MF2
Chastang, C2
Bauters, F1
Jouet, JP2
Caulier, MT1
Wurtz, A1
Ribet, M1
Goudemand, M1
Fortuny, I1
Vosika, G1
Kennedy, BJ1
Fischer, JJ3
Fischer, DB1
Weller, SA1
Gunale, S1
Hardiman, P1
Stott, P1
Huang, A1
Zelkowitz, L1
Kukrika, M1
Tucker, W1
Wilms, K1
Koos, T1
Atkinson, MK1
McElwain, TJ2
Peckham, MJ2
Thomas, PP1
Viollier, AF1
Jedrzejczak, WW1
Siekierzyński, M1
Czarnecki, C1
Dziuk, E1
Odegaard, A1
Lamvik, J1
Jacobs, C2
Lanzkowsky, P1
Shende, A1
Karayalcin, G1
Aral, I1
Grant, MD1
O'Connell, MJ1
Brace, KC1
Byhardt, RW1
Greene, WH1
Sahakian, GJ2
Chastang, CL1
Chelloul, N2
Shepard, TH1
Mellman, WJ1
Borromeo, VD1
Wilner, FR1
Axelrod, AR1
Schneider, JR1
Moores, RR1
Chan, YK1
Dorfman, RF1
Johnson, L1
Falkson, HC1
Búzás, E1
Rák, K1
Garçon, C1
Chantalou, JP1
Delobel, J1
Izrael, V1
Weisgerber, C2
De Heaulme, M1
Longueville, J1
Syenave, P1
Beauduin, M1
Maisin, H1
Focan, C3
Bricteux, N2
Lemaire, M2
Hugues, J3
Michaux, JL4
Hulhoven, R1
Rodhain, J1
Cornu, G1
Naets, E1
Dutriéux-Fauchet, MC1
Stenuit, L1
Sokal, G2
Lichtenfeld, JL1
Asbjornsen, G1
Molne, K1
Klepp, O1
Aakvaag, A1
Weinstein, P1
Greenwald, ES1
Grossman, J1
Friedman, M1
Kim, TH1
Panahon, AM1
Haanen, C2
Hart, AA1
Wollner, N1
Pfreundschuh, M2
Lathan, B1
Löffler, M1
Rüffer, U1
Hasenclever, D1
Fischer, RI1
Kozai, Y1
Ohyama, T1
Kodo, H1
Tomori, G1
Robert, M1
Averous, M1
Lavabre-Bertrand, T1
Iborra, F1
Rebillard, X1
Guiter, J1
Grasset, D1
Tenovuo, J1
Murtomaa, H1
Morales, MD1
González, FA1
Villegas, A1
del Potro, E1
Díaz Mediavilla, J1
Martínez, R1
Alvarez, A1
Colomé, JA1
Díaz-Maqueo, JC2
Ayala, JR1
Cortés, HD1
García, EL2
Virgolini, L1
De Maglio, A1
Yahalom, J3
Gaynor, J2
Caravelli, J4
Bajorunas, D1
House, KW1
Simon, SR1
Pugh, RP1
Tombolini, V1
Capua, A1
Pompili, E1
Chan, PD1
Berk, MA1
Kucuk, O1
Singh, S1
Ganesan, TS2
Perry, N1
D'Ardenne, J1
Shand, WS1
de Campos, ES1
Zulian, GB2
Mermillod, B1
Langer, CJ1
Keller, SM1
Erner, SM1
Oberlin, O6
Leverger, G4
Pacquement, H1
Raquin, MA1
Chompret, A1
Habrand, JL3
Terrier-Lacombe, MJ1
Bey, P4
Bertrand, Y1
Rubie, H1
Propert, KJ1
Henderson, ES2
Green, MR1
Gottlieb, A1
Brouet, JC1
Machiels, JP1
Martiat, P1
Doyen, C1
Bosly, A1
Kornblith, AB1
Anderson, J1
Cella, DF1
Tross, S1
Zuckerman, E1
Cherin, E1
Kosty, MP1
Biti, GP3
Cartoni, C3
Douglas, AJ1
Hudson, BV1
Bennett, MH2
MacLennan, KA2
Comer, M1
Harvey, AR1
Smith, LM1
Evans, JW1
Mori, M1
Brown, JM1
Marmont, AM1
Tesoro Tess, JD1
Djulbegovic, B1
Hendler, FJ1
Hadley, T1
Woodcock, TM1
Oza, AM1
Dorreen, M1
Johnson, PW1
Waxman, J1
Lim, J1
Wright, J1
Dadiotis, L1
Barbounis, V1
Marín, J1
Lasa, R1
Egurbide, I1
Etxebeste, MA1
Bengoetxea, E1
Angulo, P1
Antigüedad, M1
Furundarena, JR1
Peinado, F1
Navarro, E1
Allavena, C1
Conroy, T2
Aletti, P1
White, AD1
Jones, BM1
Clark, RE1
Jacobs, A1
Sen, P1
Bailey, NM1
Bezwoda, WR1
Dansey, R1
Bezwoda, MA1
Gaynor, JJ1
Merke, DP1
Chapman, D2
McClain, KL1
Heise, R1
Day, DL1
Woods, WG1
Aeppli, D1
Shanley, DJ1
Lerud, KS1
Luetkehans, TJ1
Feuer, EJ1
Kessler, LG1
Baker, SG1
Triolo, HE1
Green, DT1
al-Idrissi, HY1
Ibrahim, EM1
Talavera, A1
Guzmán, R1
Lohri, A1
Barnett, M1
Reece, D1
Voss, N1
Hoskins, P1
Gianni, L1
Foà, R1
Gavosto, F1
Goodrick, MJ1
Daniel, F1
Prentice, AG1
Copplestone, JA1
Tyrrell, CJ1
Phares, JC1
Dabrowska, M1
Kemona, H4
Prokopowicz, J4
Kretowska, J1
Kiluk, S4
Caggana, M2
Liber, HL1
Kelsey, KT2
Leventhal, BG1
Marcus, R1
Brecher, M1
Chauvenet, A1
Carlier, P1
Congiu, A1
Bacigalupo, A1
Damasio, E1
Tigaud, JD1
Magnan, A1
Jacquème, P1
Sudan, N1
Redding, E1
Blanc, AP1
Poirier, R1
Zepeda, G1
Cruz, J1
Najbar, A1
Radwańska, U1
Kaczmarek, M1
Ochocka, M2
Stańczak, E1
Gutiérrez, J1
Osorio, G1
García, H1
Vacarezza, R1
Cao, C1
Zemlickis, D1
Degendorfer, P1
Panzarella, T2
Koren, G1
Bellesi, GP2
Bosi, A2
Giannarelli, D1
Hovgaard, DJ1
Ranson, MR1
Johnson, RJ1
Błasińska-Morawiec, M1
Płuzańska, A2
Mrówka, I1
Harding, MJ1
McNulty, LJ1
Lee, F1
Brown, A1
Rosenberg, W1
Johnston, PG1
Ruscetti, FW1
Connaghan, DG1
Sullivan, FJ1
O'Brien, P1
Crow, J1
Brada, M1
Ashley, S1
Bergsagel, D1
Basco, V1
Brown, T3
Bush, R1
Gillies, J1
Israels, L1
Miller, A1
Rideout, D1
Whitelaw, D1
Russo, A1
Hill, JB1
Tournaye, H1
Camus, M1
Bollen, N1
Wisanto, A1
Van Steirteghem, AC1
Devroey, P1
Redman, JR1
Rodriguez, MA1
Dixon, D1
Silvermintz, K1
Vaughan Hudson, B1
Haybittle, JL1
Urba, WJ1
Raubitschek, A1
Petru, E1
Schmähl, D1
Jensen, BV1
Carlsen, NL1
Thompson, L1
Li, XJ1
Zhao, BL1
Hou, JW1
Xin, WJ1
Xie, RF1
Chen, YR1
Hayes, TG1
Rabin, VR1
Rosen, T1
Zubler, MA1
Payen, C1
Fermanian, J1
Millward, MJ1
Cohney, SJ1
Byrne, MJ1
Ryan, GF1
Ortin, TT1
Shostak, CA1
Lavey, RS1
Roach, M1
Brophy, N1
Cox, R1
Varghese, A1
Cohen, MH1
Brooks, BJ1
Hendler, NB1
Alvarez, S1
Ancalmo, N1
Grinton, SF1
Givens, SS1
Doyle, J2
Berry, M1
Blanchette, V1
Doherty, M1
Talbot, JA1
Tsatsoulis, A3
Grabinski, M1
Robertson, WR3
Testa, NG1
Johnston, J1
Kennedy, P1
Hays, DM1
Emerson, JD1
Moses, LE1
Bestetti, O1
Appelbaum, FR1
Sullivan, KM1
Thomas, ED1
Buckner, CD1
Clift, RA1
Deeg, HJ1
Neiman, PE1
Sanders, JE1
Stewart, P1
Storb, R1
Shirakawa, S2
Tanaka, I1
Kita, K2
Lowenthal, RM1
Jestrimski, KW1
Inagaki, J1
Dumont, J1
Villarreal, CJ1
Delfino, A1
LaMonte, CS1
Yeh, SD1
Kholin, AV4
Tsiatis, A1
Rusthoven, JJ2
Berner, J1
Kowalczyński, M1
Dowgier-Witczak, I1
Chmielowska, E1
Woźniak, L1
Pagnoni, AM1
Musumeci, R1
Crippa, F1
Tilly, H1
Menard, JF1
Barbot, A1
Piguet, H1
Verlicchi, F1
Bandini, G1
Watchie, J1
Raffin, TA1
Raubitschek, AA1
Fahey, T1
Van Kessel, A1
Van Bunningen, BN2
Van Leeuwen, EF1
Vicente, J1
Lemerle, J4
Zori Comba, A1
Zittoun, R3
Audebert, A2
Rojouan, J3
David, B1
Blanc, CM1
Hoerni, B3
Buzaid, AC1
Lippman, SM1
Wysocka, J3
Schiffer, CA1
Scott, J1
Cadman, EC1
Zucker, JM1
Olive, D2
Sagher, D1
Karrison, T1
Schwartz, JL1
Larson, R1
Meier, P1
Strauss, B1
Pekacki, A1
Hayabuchi, N1
Jingu, K1
Miyoshi, M1
Hirata, H1
Masuda, K1
Shibuya, T1
Nishimura, J1
Komiyama, S1
Ishii, E1
Kikuchi, M1
Trédaniel, J1
Gerota, I1
Dionet, C1
Vilcoq, J1
Madelain, M1
Dutou, L1
Lefur, R1
Thierry, P1
Le Floch, O1
García Alfonso, P1
Flores Sañudo, E1
Carrión Galindo, R1
Jara Sánchez, C1
Cosín Ochaita, J1
Congiu, AM1
Gaozza, E1
Ricci, P1
Meloni, G1
Mangoni, L1
Coser, P1
Giguere, JK1
Douglas, DM1
Lupton, GP1
Baker, JR1
Tubiana, M2
Van der Schueren, E2
Mefferd, JM1
Albisinni, U1
Ammendolia, I1
Tondi, L1
Milanowski, A1
Kulus, M1
Peiffert, D1
Witz, F1
Fay, JW1
Herzig, GP1
Herzig, RH1
Wolff, SN1
Gulati, S1
Shank, B1
Clarkson, B1
Fuks, Z1
Merke, D1
Bonnet, M1
Dufillot, D1
de Lumley, L1
Schaadt, M1
McDougall, IR1
Parker, BR1
Shochat, SJ1
Silingardi, V1
Frassoldati, A1
Barbieri, F1
Palomba, G1
Mauri, C1
Housset, M1
Dessard-Diana, B1
Michel-Langlet, P1
Alapetite, C1
Matsumoto, N1
Yoshimoto, K1
Okagawa, K1
Kosaka, M1
Saito, S1
Chauffert, B1
Lorcerie, B1
André, F1
Besancenot, JF1
Martin, F1
Noguchi, Y1
Hasegawa, Y1
Nakazawa, M1
Yoda, Y1
Abe, T1
Mori, N1
Hamoir, V1
Binon, J1
Pillai, GN1
Suon, SZ1
van Rijswijk, RE1
de Meijer, AJ1
Verbeek, J1
Koza, I1
Bohunický, L1
Svancárová, L1
Mardiak, J1
Gyárfás, J1
Madanat, FF1
Culine, S1
Diebold, J2
Audebert, AA1
Chomette, G1
Prudhomme de Saint-Maur, P1
Bernadou, A2
Ohnoshi, T2
Hayashi, K2
Ueno, K1
Tada, A1
Murashima, M1
Mizuta, J1
Tagawa, S1
Kimura, I1
Pavlidis, N1
Nikolaou, N1
Tolis, C1
Orfanos, S1
Tolis, G1
Takagi, T1
Sawada, U1
Kuraishi, Y1
Kondo, M1
Suzuki, H1
Oyama, A1
Mirimanoff, RO1
Cionini, L1
Mungai, V1
Ponticelli, P1
Meadows, LM1
Rosse, WR1
Moore, JO1
Crawford, J1
Laszlo, J1
Kaufman, RE1
Shaw, MT1
Jacobs, SR1
Ghouadni, R1
Zouaoui-Benhadji, Z1
Afiane, M1
Kubisz, P2
Belhadj-Merzoug, K1
Krisch, C1
Laugier, A1
Druker, BJ1
Malou, M1
Zouaoui, Z1
Abad, MT1
Touhami, M1
Faid, L1
Cuzick, J1
Bell, BA1
Esseltine, DW1
Freeman, CR1
Smith, PJ1
Toogood, I1
Mauger, D1
Takaue, Y1
Ramirez, I1
Cleary, KR1
van Eys, J1
Chao, N1
Levine, J1
Ahmed, R1
Smith, D1
Shalet, S1
Sullivan-Halley, JA1
Homeida, M1
Mukhtar, ED1
Daneshmend, T1
Omer, A1
St John, J1
Morris, ID1
Burger, HG1
De Kretser, DM1
Lynn, WA1
Marcus, RE1
Bennett, B1
Moore, NR1
Iurlo, A1
Mecucci, C1
Van Orshoven, A1
Boogaerts, M1
Van den Berghe, H1
Gregory, WM1
Schuler, D1
Kardos, G1
Révész, T1
Friedlander, RJ1
Powlis, WD1
Goffman, T2
De Vita, VT2
Battegay, M1
Obrist, R1
Obrecht, JP1
Zandecki, M1
Dupriez, B1
Laï, JL1
Fenaux, P1
Facon, T1
Lepelley, P1
Estienne, MH1
Huart, JJ1
Janjan, NA1
Wilson, JF1
Gillin, M1
Schewe, K1
Cold, S1
Clausen, NT1
Zaniboni, A1
Simoncini, E1
Marpicati, P1
Montini, E1
Marini, G2
Willett, CG1
Linggood, RM1
Leong, JC1
Miketic, LM1
Stracher, MA1
Skates, SJ1
Kushner, DC1
Boccaccio, P1
Rosa, F1
Casciaro, S1
D'Elia, P1
Romagnoli, M1
Ghio, R1
Kanaev, SV6
Malinin, AP6
Cruickshank, D1
Worotniuk, V1
Matthews, JP1
España, P1
Bonilla, F1
Yebra, M1
Diego, J1
Alvarez de Mon, M1
Marazuela, M1
Durántez, A1
Armitage, J1
Moravec, D1
Hutchins, M1
Howe, D1
Sorensen, S1
Dowling, M1
Okerbloom, J1
Pevnick, W1
Henkelmann, GC1
van der Werf, SD1
van Berge Henegouwen, GP1
Bronkhorst, FB1
Werre, JM1
Wells, JD1
Huskison, WT1
Davenport, OL1
de Gramont, A1
Louvet, C1
Krulik, M2
Smadja, N1
Donadio, D1
Laporte, JP1
Brissaud, P1
Delâge, JM1
Drolet, Y1
Rioux, E1
Rowland, KM1
Murthy, A1
Wesley, M1
Tarbell, N1
Skarin, A1
Sans-Sabrafen, J1
Pedro Olivé, C1
Buxó Costa, J1
Pardo Peret, P1
Rodríguez Ferrera, JC1
Woessner, S1
Galofré, M1
Rodríguez Méndez, F1
Chikrizov, SI3
Ryoo, MC1
Kagan, AR1
Wollin, M1
Nussbaum, H1
Chan, PY1
Hintz, BL1
Rao, AR1
McMahon, J1
Blaustein, JC1
Lewkow, L1
Crnkovich, MJ1
Leopold, K1
Sauer, MV1
Macaso, TM1
Ishida, EH1
Giudice, L1
Marshall, JR1
Buster, JE1
Ciocca Vasino, MA1
Cametti, G1
Urgesi, A1
Bertini, M1
Canta, M1
Monetti, U1
Bosio, C1
Jayme, A1
Lyding, JM1
Tseng, A1
Newman, A1
Collins, S1
Shea, W1
Le Pors, P1
Tschupp, MJ1
de Queiroz, D1
Grosbois, B1
Lemoine, H1
Schubert, B1
Bazex, J1
Gurney, HP1
Phadke, K1
Friedenberg, WR1
Dirks, P1
Beltaos, E1
Mazza, JJ1
Hoehn, JL1
Greenlaw, RH1
Russ, HH1
Schloesser, LL1
Griffiths, JD1
Segal, GM1
Duckert, LG1
King, DJ1
Bullock, I1
Watt, JL1
Carroll, WL1
Berberich, FR1
Glader, BE1
Singh, AK1
Kobayashi, T1
Ohno, T1
Hautekeete, ML1
Berneman, ZN1
Bieger, R1
Stevens, WJ1
Bridts, C1
Buyssens, N1
Peetermans, ME1
Jochelson, MS1
Weinstein, HJ1
Haines, IE1
Schwarz, MA1
Dewit, L1
Bartelink, H1
Cirrincione, C1
Redman, J1
Cunningham, I1
Baumgartner, G1
Duschet, P1
Schwarz, T1
Partsch, H1
Gschnait, F1
Stacher, A2
Bubman, I1
Kirchhoff, LV1
Morioka, H1
deBellis, N1
Bender, BL1
Mayernik, DG1
Edington, H1
Salwitz, J1
Roth, JA1
Pass, H1
Bourke, JP1
Fennelly, JJ1
Duggan, J1
Boyle, E1
McCabe, M1
Warde, P1
Conroy, R1
Greenberg, P1
Parker, RG1
Northrop, MF1
Simko, TG1
Blayney, DW1
Greene, MH1
Postal, MG1
Lanzillo, JH1
Moylan, DJ1
Mohiuddin, M1
Kim, HC1
Nosher, J1
Haas, A1
Sweeney, W1
Lewis, R1
Shetty, PA1
Damle, SR1
Shahane, AD1
Schreiber, DP1
Parlier, Y1
Höffken, K1
Ippisch, A1
Pfeiffer, R1
Becher, R1
Perri, RT1
Allen, JI1
Limas, C1
Kay, NE1
Enriquez, R1
Papac, R1
Frau, A1
Montalar, J1
Slanina, J1
Wannenmacher, M1
Spratler, J1
Blijham, GH1
Vermeulen, A1
Mendes de Leon, DE1
Dinshaw, K1
Pande, S1
Advani, S1
Ramakrishnan, G1
Nair, C1
Talvalkar, G1
Rao, DN1
Notani, P1
Rao, R1
Desai, P1
Bo, YK1
Hirose, J1
Chohtoh, S1
Nishijima, H1
Kobayashi, A1
Kamimura, R1
Takashima, T1
Yoshida, T1
Musto, P1
Lucchi, T1
Barbieri, D1
Ferraresi, P1
Lanza, F1
Moe, PJ1
MacKenzie, R1
Cooper, D1
Cox, EB1
Shakhtarina, SV1
Behrens, BC1
Vaughan Williams, CA1
Leslie, NT1
Ersbøll, J1
Sørensen, HM1
Keiding, N1
Larsen, SO1
Philip, P1
Larsen, MS1
Schultz, H1
Flexner, JM1
Schein, PS1
Beretta, G1
Fossati-Bellani, F1
Goldsmith, MA1
Carter, SK2
Desser, RK1
al-Mondhiry, H1
Lacher, MJ1
Connolly, CE1
McLaren, JH1
Mbidde, EK1
Nkwocha, J1
Hancock, PE1
Ledlie, EM1
Trepel, F1
Stockhusen, G1
Rastetter, J1
Begemann, H1
Huart, M1
Anderson, CB1
Philpott, GW1
Ferguson, TB1
Mannheimer, C1
Sharer, LR1
Barondess, JA1
Gray, GF1
Winokur, SH1
Casirola, G1
Ippoliti, G1
Ferrari, E1
Cridland, MD1
Jardon-Jeghers, C1
Schabel, FM1
Goldin, A1
Van Thiel, DH1
Myers, GH1
Lawhorn, TI1
Stone, HH1
Martin, JD1
Wiltshaw, E2
Millett, Y1
Solomon, J1
Jacobs, EM2
Lukes, RJ1
Weiner, JM1
Donohue, DM1
Rubin, P3
Galvanek, EG1
Brace, K1
Serpick, AA3
Block, JB2
Arseneau, JC2
Christensen, BE1
Livingston, RB1
DiBiasio, AG1
Rubens, RD1
Boesen, E1
Galton, DA1
Fairley, GH5
William, LA2
Panettiere, F1
Luce, JK4
Talley, R1
Monto, RW2
Lenhard, RE2
Ibrahim, E1
Steele, TH1
Moore, MR1
Bull, JM1
Habib, MA1
Donaldson, JC1
Burningham, RA1
Hunter, A1
Smithers, DW1
Constanzi, JJ1
Talley, RW1
Hewlett, JS1
Delaney, FC1
Johnson, RE1
Ellman, L1
Davis, J1
Lichtenstein, NS1
DeVitra, VT1
DeWys, D1
Grundmann, E1
Fritzsche, R1
Nison, DW1
Kende, G1
Peters, FC1
Zippin, C1
Lutz-Honders, M1
Cleton, FJ1
van Dongen, JA1
Glazebrook, GA1
el-Akkad, SM1
Shakir, MA1
Bethlenfalvay, NC1
Bergin, JJ1
Rana, C1
Madigan, JP1
Motteram, R1
Maritz, JS1
Turner, CN1
Renzi, G1
Lesage, R1
DeConti, RC1
Kaplan, SR1
Calabresi, P1
Greenberg, LH1
Wong, S1
Richardson, AP1
Dollinger, MR1
Tanaka, M1
Kunii, A1
Yamada, K1
Pawlowski, J1
Gaelen, LH1
Levitan, S1
Rywlin, AM1
Recher, L1
Hoffman, EP1
Owens, AH1
Alison, RE1
Whitelaw, DM1
Nicholson, WM1
Beard, ME1
Vartan, CP1
Scott, RB1
Wasastjerna, C1
Kiely, JM1
Harrison, EG1
Cross, RM1
Dixon, FW1
Bishop, RC1
Berkman, T1
Stern, OS1
Tulgan, H1
Budnitz, J1
Haidak, G1
Gordon, HW1
Wilson, WW1
Beutler, E1
Lefkowitz, ER1
Silberman, HR1
McGinn, TG1
Kremer, WB1
Poe, RH1
Gable, CE1
Jarrold, T1
Pecchini, F1
Dall'Aglio, P1

Clinical Trials (12)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized Phase III Trial of ABVD Versus Stanford V (+/-) Radiation Therapy in Locally Extensive and Advanced Stage Hodgkin's Disease[NCT00003389]Phase 3854 participants (Actual)Interventional1999-06-17Completed
Hematopoietic Stem Cell Transplantation for Treatment of Multiple Sclerosis in Sweden - a Register-based Retrospective Observational Study[NCT05029206]174 participants (Actual)Observational2021-05-05Completed
"Prospective Non Randomized Study With Chemotherapy in Patients With Hodgkin's Disease and HIV Infection: Stanford V Regimen For Low Risk Patients, EBVP Regimen For High Risk Patients"[NCT00003262]Phase 230 participants (Anticipated)Interventional1997-05-31Active, not recruiting
Phase III Randomized Trial of Adjuvant Involved-Field Radiotherapy vs No Adjuvant Therapy Following Remission Induction With MOPP/ABV Hybrid Chemotherapy in Patients With Stage III/IV Hodgkin's Disease[NCT00002462]Phase 3615 participants (Actual)Interventional1989-09-30Active, not recruiting
Protocol H8 for a Prospective Controlled Trial in Clinical Stage I-II Supradiaphragmatic Hodgkin's Disease. Evaluation of Treatment Efficacy and (Long Term) Toxicity in Three Different Prognostic Subgroups [H8 Trial][NCT00379041]Phase 31,158 participants (Anticipated)Interventional1993-09-01Active, not recruiting
A Phase II Pilot Study of Short Term (12 Week) Combination Chemotherapy (Stanford V) in Unfavorable Hodgkin's Disease[NCT00002715]Phase 250 participants (Anticipated)Interventional1989-04-30Completed
Optimization of the Primary Therapy for Patients With Hodgkin's Lymphoma and Evaluation of the Positron Emission Tomography (PET) as a Diagnostic Tool for Primary Staging and Assessment of the Effects of the Therapy[NCT00188149]Phase 4300 participants Interventional2000-05-31Recruiting
Ovarian Tissue Freezing For Fertility Preservation In Women Facing A Fertility Threatening Medical Diagnosis Or Treatment Regimen: A Study By The National Physicians Cooperative of the Oncofertility Consortium At Northwestern University[NCT00902720]Phase 425 participants (Anticipated)Interventional2009-05-31Recruiting
Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional Trial[NCT00924131]157 participants (Anticipated)Observational2009-04-17Completed
Maternal Cancer Diagnosis and Treatment During Pregnancy:a Registry for Maternal, Fetal, and Neonatal Outcomes With Longitudinal Follow up of Child Development and Maternal Psychological Well Being[NCT02749474]400 participants (Anticipated)Observational [Patient Registry]2003-07-31Recruiting
A Multicentric Randomized Trial Comparing the Bronchial Artery Embolization Combined With Medical Measures and the Medical Measures Alone in the Treatment of Non-severe Acute Hemoptysis of Mild-to-moderate Abundance[NCT01278199]73 participants (Actual)Interventional2011-11-30Completed
Phase I/II Trial of Yttrium-90-labeled Daclizumab (Anti-CD25) Radioimmunotherapy With High-dose BEAM Chemotherapy and Autologous Hematopoietic Stem Cell Rescue in Recurrent and Refractory Hodgkin's Lymphoma[NCT01468311]Phase 1/Phase 26 participants (Actual)Interventional2011-10-11Terminated (stopped due to Poor enrollment and ability to radioconjugate Daclizumab. Neither Center for Cancer Research (CCR) or Nuclear Medicine/Radiology wanted to do the facilities upgrade and hire personnel needed to radioconjugate the drug at the Clinical Center.)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

5-year Overall Survival

Overall survival is defined as the time from randomization to death or last known alive. The 5-year survival rate is the probability a patient survives 5 years. (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years

InterventionProportion of patients (Number)
Arm A (ABVD)0.88
Arm B (Stanford V)0.88

Failure-free Survival at 5 Years

"Failure-free survival is defined as the time from randomization to the earlier of progression/relapse or death. The 5-year failure-free survival is the probability a patient is failure-free and survives 5 years.~Progression is defined as an increase in size of 25% of the sum of the products of the pretreatment measurements or appearance of new lesions. Significant enlargement of the liver or spleen is evidence of progression. A significant increase in size is defined as > 2.0 cm in distance between costal margin and the inferior margin of either organ.~Relapse is defined as the re-appearance of any clinical evidence of Hodgkin's disease in a patient who has had a complete response. Relapse for partial responders is defined as progressive disease relative to disease status during the partial remission." (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5

InterventionProportion of patients (Number)
Arm A (ABVD)0.74
Arm B (Stanford V)0.71

Incidence of Second Cancers

Number of patients who developed second primary cancers (NCT00003389)
Timeframe: Assessed every 2 months if patient is < 1 year from study entry, every 3 months for the second year, every 4 months for the third year, every 6 months for years 4 and 5, and yearly for 5 years

Interventionparticipants (Number)
Arm A (ABVD)15
Arm B (Stanford V)19

Complete Response Rate

Complete response rate is defined as the time it takes a participant to achieve a complete response. Response is assessed by the Revised Response Criteria for Malignant Lymphoma. Complete response requires all of the following: complete disappearance of all detectable clinical evidence of disease and disease related symptoms if present before therapy. A post treatment residual mass is permitted as long as it is positron emission tomography (PET) negative. If a pretreatment PET scan was negative, all lymph nodes and nodal masses must have regressed on computed tomography (CT) to normal size (<1.5 cm in their greatest transverse diameter for nodes >1.5 cm before therapy); Previously involved nodes that were 1.1 to 1.5 cm in their long axis and more than 1.0 cm in their short axis before treatment must have decreased to <1.0 cm in their short axis after treatment. (NCT01468311)
Timeframe: 20 months post autologous stem cell transplant

Interventionmonths (Median)
Yttrium-90-labeled Daclizumab + Chemotherapy7.5

Disease Free Survival (DFS)

DFS is defined as the amount of time participants remain disease free. (NCT01468311)
Timeframe: DFS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years

Interventionmonths (Median)
Yttrium-90-labeled Daclizumab + Chemotherapy36

Number of Participants With A Dose Limiting Toxicity

Patients who develop either a Common Terminology Criteria in Adverse Events (CTCAE) v4.0 grade 3 or greater non-hematologic toxicity, with the exception of fatigue, of more than 5 days duration possibly, probably or definitely related to the infusion of 90Y-daclizumab prior to the start of Carmustine, Etoposide, Cytarabine, [Ara-C, Cytosine Arabinoside] and Melphalan (BEAM) chemotherapy (Day - 6) will have developed by definition a dose-limiting toxicity (DLT). (NCT01468311)
Timeframe: 30 months

InterventionParticipants (Count of Participants)
Yttrium-90-labeled Daclizumab + Chemotherapy0

Number of Participants With Adverse Events

Here is the number of participants with serious and non-serious adverse events assessed by the Common Terminology Criteria in Adverse Events (CTCAE v4.0). A non-serious adverse event is any untoward medical occurrence. A serious adverse event is an adverse event or suspected adverse reaction that results in death, a life threatening adverse drug experience, hospitalization, disruption of the ability to conduct normal life functions, congenital anomaly/birth defect or important medical events that jeopardize the patient or subject and may require medical or surgical intervention to prevent one of the previous outcomes mentioned. (NCT01468311)
Timeframe: 30 months

InterventionParticipants (Count of Participants)
Yttrium-90-labeled Daclizumab + Chemotherapy3

Overall Survival

Overall survival is defined as the time from the date of registration to the date of death due to any cause or if no death occurs to the last documented information on the patient. (NCT01468311)
Timeframe: OS is evaluated at day 100 post autologous stem cell transplant, then 1-4 times yearly for 5 years

Interventionmonths (Median)
Yttrium-90-labeled Daclizumab + Chemotherapy36

Reviews

103 reviews available for mechlorethamine and Granuloma, Hodgkin

ArticleYear
Hodgkin Lymphoma on Hemodialysis: A Review of Treatment and Recommendations.
    Clinical lymphoma, myeloma & leukemia, 2022, Volume: 22, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brentuximab Vedotin; Cyclophosphamide; Da

2022
[Treatment strategy of Hodgkin lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2014, Volume: 55, Issue:10

    Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; B

2014
Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond.
    American journal of hematology, 2016, Volume: 91, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbazine; Di

2016
Treatment of Hodgkin lymphoma: the past, present, and future.
    Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cycl

2008
Breast cancer after treatment of Hodgkin's lymphoma: general review.
    International journal of radiation oncology, biology, physics, 2008, Dec-01, Volume: 72, Issue:5

    Topics: Adolescent; Adult; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N

2008
Standard therapy of advanced Hodgkin lymphoma.
    Hematology. American Society of Hematology. Education Program, 2009

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Therapy; Cy

2009
Gray zone lymphoma: better treated like hodgkin lymphoma or mediastinal large B-cell lymphoma?
    Current hematologic malignancy reports, 2012, Volume: 7, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

2012
[Dropped Head Syndrome after whiplash injury in a patient treated for a Hodgkin's lymphoma by mantle field radiotherapy].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2013, Volume: 17, Issue:1

    Topics: Accidents, Traffic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cervical Plexus; Cerv

2013
Advanced Hodgkin's disease: ABVD is better, yet is not good enough!
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-15, Volume: 21, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz

2003
[Hodgkin's disease manifesting as paraneoplastic limbic encephalitis].
    La Revue de medecine interne, 2003, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Diagnosis, Differential; Doxorubi

2003
[Hematologic tumors].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2003, Volume: 30, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dacarbazine

2003
Perspectives of the management of childhood lymphoma: experience at Tygerberg Hospital, Western Cape, South Africa.
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2005, Volume: 32, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Transfusion; Child; Combined

2005
[Primary treatment of advanced Hodgkin's disease].
    Orvosi hetilap, 2005, Jan-30, Volume: 146, Issue:5

    Topics: Age Factors; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophospha

2005
Will BEACOPP be the standard for high risk Hodgkin lymphoma patients in advanced stages?
    Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis, 2007, Volume: 37, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamid

2007
ABVD chemotherapy in the treatment of Hodgkin's disease.
    Cancer treatment reviews, 1982, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc

1982
[The practice of chemotherapy with the DeVita protocol].
    Deutsche medizinische Wochenschrift (1946), 1982, Jul-09, Volume: 107, Issue:27

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazin

1982
Chemotherapy strategies to improve the control of Hodgkin's disease: the Richard and Hinda Rosenthal Foundation Award Lecture.
    Cancer research, 1982, Volume: 42, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor

1982
[Recent developments in chemotherapy of malignant diseases].
    Wiener klinische Wochenschrift, 1982, Dec-10, Volume: 94, Issue:23

    Topics: Anthraquinones; Antibodies, Monoclonal; Antineoplastic Agents; Antineoplastic Combined Chemotherapy

1982
The cure of Hodgkin's disease with drugs.
    Advances in internal medicine, 1983, Volume: 28

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as

1983
Chemotherapy in the treatment of Hodgkin's disease.
    Seminars in hematology, 1983, Volume: 20, Issue:1

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor

1983
Hodgkin's disease.
    The Medical clinics of North America, 1984, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes;

1984
Non-Hodgkin's lymphoma occurring after Hodgkin's disease. Four new cases and a review of the literature.
    Cancer, 1984, Feb-01, Volume: 53, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1984
The reproductive potential of young men and women with Hodgkin's disease.
    Obstetrical & gynecological survey, 1984, Volume: 39, Issue:8

    Topics: Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Congenital Abnormalities; Female;

1984
Perspectives in cancer research Survival of patients with Hodgkin's disease.
    European journal of cancer, 1980, Volume: 16, Issue:3

    Topics: Clinical Trials as Topic; Hodgkin Disease; Humans; Mechlorethamine; Random Allocation; Time Factors

1980
Hodgkin's disease: biology, treatment, prognosis.
    Blood, 1981, Volume: 57, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Giant Cell Tumors;

1981
[Current therapy concepts in early and intermediate stages of Hodgkin diseases in adults].
    Praxis, 1995, Oct-10, Volume: 84, Issue:41

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

1995
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
    Bulletin du cancer, 1995, Volume: 82, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1995
[Hodgkin's disease and pregnancy. 3 case reports and a review of the literature].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1993, Volume: 22, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Bone Marrow Examination; C

1993
Lymphomatoid papulosis and Hodgkin's disease: report of a case.
    Dermatology (Basel, Switzerland), 1994, Volume: 189, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin D

1994
[Diffuse thymus hyperplasia following chemotherapy for nodular sclerosing Hodgkin lymphoma].
    Schweizerische medizinische Wochenschrift, 1994, Sep-24, Volume: 124, Issue:38

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Diagnosis, Differential; Doxorubic

1994
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy

1995
[High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Combined Modality Therapy; Cyt

1995
[Recent progress in the chemotherapy of malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase III as Topic; Cyclophosphamid

1995
[Chemotherapy of patients with Hodgkin's disease].
    Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1994, Jun-10, Volume: 83, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy;

1994
Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
    Nouvelle revue francaise d'hematologie, 1993, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1993
The case against the routine use of radiation therapy in advanced-stage Hodgkin's disease.
    Cancer investigation, 1996, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami

1996
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7 Suppl 4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1996
Hodgkin's disease: management of first relapse.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1996
Treatment of Hodgkin's disease: the role of radio- and/or chemotherapy in advanced stages.
    Bailliere's clinical haematology, 1996, Volume: 9, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dr

1996
[Malignant mesothelioma of the pleura following radiotherapy of Hodgkin disease].
    Bulletin du cancer, 1996, Volume: 83, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Hodgkin Disease; Humans;

1996
Aortic dissection in a patient receiving chemotherapy for Hodgkin's disease--a case report.
    Angiology, 1997, Volume: 48, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aorta; Aortic Aneurysm; Aortic Dissection; Ao

1997
[Outcome of 70 patients diagnosed with Hodgkin's disease after first-line and salvage treatment: experience at one center].
    Sangre, 1998, Volume: 43, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined

1998
[The management of Hodgkin's disease with chemotherapy or combined modality treatment].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1998, Volume: 25, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1998
Problems in Hodgkin's disease management.
    Blood, 1999, Feb-01, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1999
HIV-associated Hodgkin's disease.
    International journal of STD & AIDS, 2000, Volume: 11, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; CD4 Lymphocyt

2000
Hodgkin's disease: clinical presentation and treatment.
    Cancer treatment and research, 2001, Volume: 104

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

2001
Treatment of advanced stage Hodgkin's disease.
    Oncology, 2001, Volume: 60, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Dacarbazine; Doxo

2001
Is escalated BEACOPP a standard therapy for advanced Hodgkin's disease?
    The hematology journal : the official journal of the European Haematology Association, 2000, Volume: 1, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Clinical Trials, Phase III

2000
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
    Current problems in cancer, 1977, Volume: 1, Issue:7

    Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H

1977
Chemotherapy of Hodgkin's disease.
    Clinics in haematology, 1979, Volume: 8, Issue:3

    Topics: Bleomycin; Drug Therapy, Combination; Hodgkin Disease; Humans; Long-Term Care; Mechlorethamine; Pred

1979
The action of antitumor agents: a double-edged sword?
    Medical and pediatric oncology, 1977, Volume: 3, Issue:2

    Topics: Alkylating Agents; Animals; Antineoplastic Agents; Azathioprine; Burkitt Lymphoma; Choriocarcinoma;

1977
The chemotherapy of Hodgkin's disease: past experiences and future directions.
    Cancer, 1978, Volume: 42, Issue:2 Suppl

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H

1978
Issues of controversy in radiation therapy and combined modality approaches to Hodgkin's disease.
    Clinics in haematology, 1979, Volume: 8, Issue:3

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neoplasm Staging; P

1979
Human models of human diseases; breast cancer and the lymphomas.
    International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:10

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Disease Models, Animal; Drug Therapy, Combination;

1979
Evaluation and treatment of Hodgkin's disease in the 70's.
    Connecticut medicine, 1975, Volume: 39, Issue:11

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Prognosis; Remission, Spontaneou

1975
Chemotherapy-induced myocardial infarction in a young man with Hodgkin's disease.
    Clinical cardiology, 1992, Volume: 15, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Huma

1992
Chemotherapy for Hodgkin's disease and aggressive non-Hodgkin's lymphoma. More is better, or is it?
    Drugs, 1992, Volume: 44, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chemotherapy, Adjuvant;

1992
Thymic hyperplasia with hemorrhage simulating recurrent Hodgkin disease after chemotherapy-induced complete remission.
    Cancer, 1992, Oct-15, Volume: 70, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbazine; Doxorubicin;

1992
The management of Hodgkin's disease in relapse after primary radiation therapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Neoplasm S

1992
Combined-modality therapy for the treatment of Hodgkin's disease.
    Frontiers of radiation therapy and oncology, 1992, Volume: 26

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1992
Combined chemotherapy and radiotherapy for Hodgkin's disease.
    Oncology (Williston Park, N.Y.), 1992, Volume: 6, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy;

1992
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Important advances in oncology, 1992

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality

1992
Can MOPP be replaced in the treatment of advanced Hodgkin's disease?
    Seminars in oncology, 1990, Volume: 17, Issue:1 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1990
Chemotherapy of Hodgkin's disease.
    Nouvelle revue francaise d'hematologie, 1990, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine;

1990
Hodgkin's disease in children: correlation of clinical characteristics, staging procedures, and treatment at the University of Minnesota.
    The American journal of pediatric hematology/oncology, 1990,Summer, Volume: 12, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1990
Is there an effective salvage therapy for advanced Hodgkin's disease?
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1991
Primary and salvage chemotherapy in advanced Hodgkin's disease: the Milan Cancer Institute experience.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1991
[Treatment of relapses and failures in disseminated Hodgkin's disease].
    Presse medicale (Paris, France : 1983), 1991, Nov-02, Volume: 20, Issue:35

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine;

1991
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
    Revue de pneumologie clinique, 1991, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine;

1991
Cytotoxic chemotherapy-induced second primary neoplasms: clinical aspects.
    Neoplasma, 1991, Volume: 38, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hod

1991
Hodgkin's disease presenting in the skin: case report and review of the literature.
    Journal of the American Academy of Dermatology, 1990, Volume: 22, Issue:5 Pt 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Eczema; Hodgkin Disease; Humans; Male; Mechlorethami

1990
Increased risk of secondary acute nonlymphocytic leukemia after extended-field radiation therapy combined with MOPP chemotherapy for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th

1990
Pulmonary toxicity following MOPP chemotherapy.
    Australian and New Zealand journal of medicine, 1990, Volume: 20, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Dyspnea; Female; Hodgkin Disease; Humans; Lung

1990
Corticosteroid drugs: their role in oncological practice.
    The Medical journal of Australia, 1986, Jan-20, Volume: 144, Issue:2

    Topics: Adrenal Cortex Hormones; Animals; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast

1986
Chemotherapy of malignant lymphomas.
    Seminars in oncology, 1985, Volume: 12, Issue:4 Suppl 6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance

1985
[Drug therapy of malignant lymphoma].
    Rinsho hoshasen. Clinical radiography, 1985, Volume: 30, Issue:11

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleo

1985
[Results of the treatment of lymphogranulomatosis].
    Terapevticheskii arkhiv, 1986, Volume: 58, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami

1986
Current approaches to the treatment of advanced-stage Hodgkin's disease.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 1986, Sep-01, Volume: 135, Issue:5

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality The

1986
[Rescue treatment in Hodgkin's disease].
    Sangre, 1987, Volume: 32, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1987
Salvage therapy of advanced Hodgkin's disease. Critical appraisal of curative potential.
    The American journal of medicine, 1987, Volume: 83, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine;

1987
[The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
    Nouvelle revue francaise d'hematologie, 1988, Volume: 30, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine;

1988
Treatment of advanced Hodgkin's disease.
    Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top

1989
[Immediate hematological toxicity during combination chemotherapy-radiotherapy of Hodgkin's disease].
    Bulletin du cancer, 1989, Volume: 76, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cell Count

1989
[A suggested program of combined treatment of Hodgkin's disease in children].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1988, Dec-12, Volume: 43, Issue:50

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Dacarba

1988
Recent issues in chemotherapy for Hodgkin's disease.
    Current opinion in oncology, 1989, Volume: 1, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Drug Administration Sched

1989
Current management and controversies. The chemotherapist's view.
    Cancer treatment and research, 1989, Volume: 41

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu

1989
[Current status of chemotherapy in the treatment of malignant lymphomas].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1989
Semantics and the chemotherapy of Hodgkin's disease--resistance is not relapse: alternative chemotherapy lacks effectiveness for disease not totally responsive to initial MOPP treatment.
    Cancer investigation, 1988, Volume: 6, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Resistance; Hodgk

1988
The chemotherapy of lymphomas: looking back, moving forward--the Richard and Hinda Rosenthal Foundation award lecture.
    Cancer research, 1987, Nov-15, Volume: 47, Issue:22

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphoma; Mechlore

1987
[Acute lymphoblastic leukemia, Burkitt-cell type, after Hodgkin's disease. Study of 2 cases].
    Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H

1987
Hodgkin's disease: long-term effects of therapy.
    Medical and pediatric oncology, 1986, Volume: 14, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone and Bones; Brain; Female; Genitalia, Fem

1986
Early-stage Hodgkin's disease: current approaches to treatment.
    Canadian Medical Association journal, 1985, Aug-01, Volume: 133, Issue:3

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fem

1985
[Current methods of treating patients with lymphogranulomatosis, stages I and II].
    Voprosy onkologii, 1985, Volume: 31, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease;

1985
Current management of Hodgkin's disease.
    Drugs, 1985, Volume: 30, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1985
Combination chemotherapy of advanced Hodgkin's disease. A review.
    Cancer, 1974, Volume: 33, Issue:1

    Topics: Bleomycin; Carmustine; Cyclohexanes; Cyclophosphamide; Drug Evaluation; Drug Therapy, Combination; H

1974
The sensitivity of Hodgkin's disease to chemotherapeutic agents administered singly.
    Series haematologica (1968), 1973, Volume: 6, Issue:2

    Topics: Adrenal Cortex Hormones; Alopecia; Antineoplastic Agents; Bleomycin; Blood Platelet Disorders; Carmu

1973
[Cytostatic chemotherapy in lymphogranulomatosis].
    Medizinische Klinik, 1973, Jul-27, Volume: 68, Issue:30

    Topics: Antineoplastic Agents; Bleomycin; Carmustine; Chlorambucil; Cyclohexanes; Cyclophosphamide; Doxorubi

1973
Combined radiotherapy and chemotherapy in the treatment of Hodgkin's disease.
    Series haematologica (1968), 1973, Volume: 6, Issue:2

    Topics: Adult; Antineoplastic Agents; Blood Sedimentation; Cyclophosphamide; Drug Therapy, Combination; Fema

1973
Chemotherapy in solid tumors of childhood.
    Oncology, 1972, Volume: 26, Issue:2

    Topics: Abdominal Neoplasms; Adolescent; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Eye Neopla

1972
Recently recognized complications of cancer chemotherapy.
    Annals of the New York Academy of Sciences, 1974, Volume: 230

    Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Death, Sudden; Drug Therapy, Combination;

1974
Single-agent therapy for Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Carmustine;

1973
Dilemmas in the treatment of Hodgkin's disease.
    Folia medica Neerlandica, 1971, Volume: 14, Issue:2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine

1971
Combination chemotherapy in malignant diseases.
    Journal of the Royal College of Physicians of London, 1971, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Agents; Asparaginase; Carmustine; Child; Cyclophosphamide; Cytarabine; Cytosin

1971

Trials

224 trials available for mechlorethamine and Granuloma, Hodgkin

ArticleYear
Randomized Phase III Trial Comparing ABVD Plus Radiotherapy With the Stanford V Regimen in Patients With Stages I or II Locally Extensive, Bulky Mediastinal Hodgkin Lymphoma: A Subset Analysis of the North American Intergroup E2496 Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2015, Jun-10, Volume: 33, Issue:17

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant

2015
The Stanford V regimen is effective in patients with good risk Hodgkin lymphoma but radiotherapy is a necessary component.
    British journal of haematology, 2009, Volume: 144, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2009
Radiation therapy compared with chemotherapy for consolidation of chemotherapy-induced remission of advanced Hodgkin lymphoma: a study by the Eastern Co-operative Oncology Group (E1476) with >20 years follow-up.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazi

2009
Comparative study of two mechlorethamine, vincristine, procarbazine, and prednisone derived chemotherapeutic protocols for the management of pediatric Hodgkin lymphoma (HL): single-center 5-year experience.
    Leukemia & lymphoma, 2010, Volume: 51, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

2010
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox

2011
Efficacy of abbreviated Stanford V chemotherapy and involved-field radiotherapy in early-stage Hodgkin lymphoma: mature results of the G4 trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2013, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

2013
Randomized phase III trial of ABVD versus Stanford V with or without radiation therapy in locally extensive and advanced-stage Hodgkin lymphoma: an intergroup study coordinated by the Eastern Cooperative Oncology Group (E2496).
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-20, Volume: 31, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2013
The efficacy and tolerability of adriamycin, bleomycin, vinblastine, dacarbazine and Stanford V in older Hodgkin lymphoma patients: a comprehensive analysis from the North American intergroup trial E2496.
    British journal of haematology, 2013, Volume: 161, Issue:1

    Topics: Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dac

2013
Plasma Epstein-Barr virus DNA predicts outcome in advanced Hodgkin lymphoma: correlative analysis from a large North American cooperative group trial.
    Blood, 2013, May-02, Volume: 121, Issue:18

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2013
Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.
    Blood, 2002, Sep-15, Volume: 100, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active;

2002
An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Cancer, 2002, Dec-15, Volume: 95, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; beta 2-M

2002
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Feb-15, Volume: 21, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Confidence Intervals; Dacarbazine;

2003
Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    The New England journal of medicine, 2003, Jun-12, Volume: 348, Issue:24

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2003
High-dose therapy and autologous stem-cell transplantation versus conventional therapy for patients with advanced Hodgkin's lymphoma responding to front-line therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Jun-15, Volume: 21, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distributio

2003
Comparison of MOPP versus ABVD as salvage therapy in patients who relapse after radiation therapy alone for Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival

2004
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
    Pediatric blood & cancer, 2004, Volume: 43, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

2004
Efficacy of a modified Stanford V regimen in patients with advanced Hodgkin's lymphoma.
    Haematologica, 2004, Volume: 89, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Eto

2004
Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease.
    Acta haematologica, 2004, Volume: 112, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2004
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2005
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jan-15, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2006
Long-term results and competing risk analysis of the H89 trial in patients with advanced-stage Hodgkin lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte (GELA).
    Blood, 2006, Jun-15, Volume: 107, Issue:12

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Com

2006
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jul-01, Volume: 24, Issue:19

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2006
POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group.
    Journal of pediatric hematology/oncology, 2006, Volume: 28, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin;

2006
[Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Dacarbaz

2006
Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2007, Jan-01, Volume: 67, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2007
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD).
    Hematology (Amsterdam, Netherlands), 2007, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Amenorrhea; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocol

2007
Treatment planning and delivery of involved field radiotherapy in advanced Hodgkin's disease: results from a questionnaire-based audit for the UK Stanford V regimen vs ABVD clinical trial quality assurance programme (ISRCTN 64141244).
    The British journal of radiology, 2007, Volume: 80, Issue:958

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg

2007
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    The New England journal of medicine, 2007, Nov-08, Volume: 357, Issue:19

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2007
BCVPP chemotherapy for advanced Hodgkin's disease: evidence for greater duration of complete remission, greater survival, and less toxicity than with a MOPP regimen. Results of the Eastern Cooperative Oncology Group study.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Blood Cell Count; Carmustine; Clinical Trials

1984
The eight-drug/radiation therapy program (MOPP/ABDV/RT) for advanced Hodgkin's disease: a follow-up report.
    Cancer, 1980, Jul-15, Volume: 46, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration S

1980
Combination chemotherapy for stage IV Hodgkin's disease (Report no 14).
    Clinical radiology, 1981, Volume: 32, Issue:5

    Topics: Bleomycin; Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Neopla

1981
A Southwest Oncology Group: chemotherapy versus chemotherapy plus radiotherapy in treatment of stage III Hodgkin's disease.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1982, Volume: 80

    Topics: Bleomycin; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Follow

1982
Alternating drug combinations in the treatment of advanced Hodgkin's disease.
    The New England journal of medicine, 1982, Apr-01, Volume: 306, Issue:13

    Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th

1982
More than MOPP for advanced Hodgkin's disease?
    The New England journal of medicine, 1982, Apr-01, Volume: 306, Issue:13

    Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Therapy,

1982
ABVD chemotherapy in the treatment of Hodgkin's disease.
    Cancer treatment reviews, 1982, Volume: 9, Issue:1

    Topics: Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistanc

1982
Combined modality therapy for advanced Hodgkin's disease: long-term followup data.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female

1982
Conclusions from clinical trials of the Southwest Oncology Group.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Antibiotics, Antineoplastic; Bleomycin; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combina

1982
Cyclic delivery of MOPP and ABVD combinations in Stage IV Hodgkin's disease: rationale, background studies, and recent results.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Th

1982
Comparison of adriamycin-containing chemotherapy (MOP-BAP) with MOPP-Bleomycin in the management of advanced Hodgkin's disease. A Southwest Oncology Group Study.
    Cancer, 1983, Apr-15, Volume: 51, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin;

1983
Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
    Cancer, 1983, Apr-15, Volume: 51, Issue:8

    Topics: Adolescent; Adult; Agranulocytosis; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Prot

1983
The cure of Hodgkin's disease with drugs.
    Advances in internal medicine, 1983, Volume: 28

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as

1983
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations.
    The American journal of medicine, 1984, Volume: 76, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top

1984
Vinblastine, bleomycin, and cis-platin as salvage therapy for MOPP treated patients with Hodgkin's lymphoma.
    Cancer investigation, 1984, Volume: 2, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topi

1984
Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
    Cancer treatment reports, 1983, Volume: 67, Issue:5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Top

1983
A randomised study of adjuvant chemotherapy after mantle radiotherapy in supradiaphragmatic Hodgkin's disease PS IA-IIB: a report from the Manchester lymphoma group.
    British journal of cancer, 1984, Volume: 49, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C

1984
The effects of prior radiation therapy and age on the frequency and duration of complete remission among various four-drug treatments for advanced Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:7

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combin

1984
A randomized study comparing chemotherapy alone with chemotherapy followed by radiotherapy in patients with pathologically staged IIIA Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T

1984
Combined modality in Hodgkin's disease. Comparison of six versus three courses of MOPP with clinical and surgical restaging.
    Cancer, 1984, Dec-01, Volume: 54, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T

1984
Acute myelogenous leukemia as a second malignant neoplasm following the successful treatment of advanced Hodgkin's disease.
    Cancer, 1983, Dec-15, Volume: 52, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Female; Hodgkin

1983
The treatment of stage IIIA Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1983
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
    Cancer, 1982, Dec-01, Volume: 50, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Drug Therapy, Combination;

1982
Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.
    Annals of internal medicine, 1980, Volume: 92, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Follow-Up

1980
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomy.
    Radiology, 1981, Volume: 141, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Disease;

1981
[Hodgkin's disease: treatment of clinical stages II3+A, IB, IIB, IIIA and IIIB with short chemotherapy (3 MOPP, or 3 CVPP), splenectomy and limited irradiation. Results after 4 years of a prospective protocol including 94 patients].
    Bulletin du cancer, 1982, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Dru

1982
A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Bangladesh Medical Research Council bulletin, 1982, Volume: 8, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Drug Therapy, Co

1982
Perspectives in cancer research Survival of patients with Hodgkin's disease.
    European journal of cancer, 1980, Volume: 16, Issue:3

    Topics: Clinical Trials as Topic; Hodgkin Disease; Humans; Mechlorethamine; Random Allocation; Time Factors

1980
Radiotherapy versus radiotherapy plus chemotherapy in stages I and II Hodgkin's disease. A prospective, randomized study by the Danish National Hodgkin Study Group, LYGRA.
    Scandinavian journal of haematology, 1980, Volume: 25, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Femal

1980
[Chemotherapy-selective nodal irradiation in Hodgkin's disease clinical stages IA-IIIB. Results of a prospective clinical trial including 334 patients (author's transl)].
    Bulletin du cancer, 1981, Volume: 68, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; D

1981
Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Cyclophosphamide; Drug Therapy,

1982
Effect of age on therapeutic response and survival in advanced Hodgkin's disease.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination

1982
Intergroup Hodgkin's disease in children study of stages I and II: a preliminary report.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgkin Disease;

1982
Hodgkin's disease in children: treatment results with MOPP and low-dose, extended-field irradiation.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination; Hodgk

1982
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPP.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymph Nodes; Mechloretham

1982
Radiotherapy versus combined modality treatment of stage I and II Hodgkin's disease.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm S

1982
Radiotherapy or chemotherapy as the initial treatment for stage IIIA Hodgkin's disease (Report no 13).
    Clinical radiology, 1981, Volume: 32, Issue:5

    Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Neopl

1981
The management of stage IIIA Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1980, Volume: 6, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di

1980
A new effective four-drug combination of CCNU (1-[2-chloroethyl]-3-cyclohexyl-1-nitrosourea) (NSC-79038), vinblastine, prednisone, and procarbazine for the treatment of advanced Hodgkin's disease.
    Cancer, 1980, Aug-15, Volume: 46, Issue:4

    Topics: Adult; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemat

1980
Hodgkin's disease in the very young.
    International journal of radiation oncology, biology, physics, 1994, Jan-01, Volume: 28, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo

1994
Quantitative effect of combined chemotherapy and fractionated radiotherapy on the incidence of radiation-induced lung damage: a prospective clinical study.
    International journal of radiation oncology, biology, physics, 1994, Feb-01, Volume: 28, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Combined Modality

1994
A randomized study in stage IIIB and IV Hodgkin's disease comparing eight courses of MOPP versus an alteration of MOPP with ABVD: a European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group and Groupe Pierre-et-Marie-Curie cont
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1994
Early intensive therapy with autotransplantation for high-risk Hodgkin's disease.
    Leukemia & lymphoma, 1993, Volume: 12, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1993
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1994
ABVD/MOPP and low-dose involved-field radiotherapy in pediatric Hodgkin's disease: the Stanford experience.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:10

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Coho

1994
Vancouver hybrid: preliminary experience in the treatment of Hodgkin's disease in childhood and adolescence.
    Mayo Clinic proceedings, 1994, Volume: 69, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1994
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1994
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:9

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality

1994
Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:5

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Di

1995
Human immunodeficiency virus associated Hodgkin's disease: report of 45 cases from the French Registry of HIV-Associated Tumors.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Adult; AIDS-Related Opportunistic Infections; Antineoplastic Combined Chemotherapy Protocols; Bleomy

1995
High-dose cyclophosphamide, carmustine (BCNU), and etoposide (VP16-213) with or without cisplatin (CBV +/- P) and autologous transplantation for patients with Hodgkin's disease who fail to enter a complete remission after combination chemotherapy.
    Blood, 1995, Jul-15, Volume: 86, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bo

1995
Etoposide, vinblastine, and doxorubicin: an active regimen for the treatment of Hodgkin's disease in relapse following MOPP. Cancer and Leukemia Group B.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Doxorubici

1995
Results of a randomized trial comparing MVPP chemotherapy with a hybrid regimen, ChlVPP/EVA, in the initial treatment of Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free

1995
Optimal treatment of early-stage Hodgkin disease.
    Radiology, 1993, Volume: 186, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1993
Combined chemotherapy-radiotherapy in advanced Hodgkin's disease: results of a prospective clinical trial with 70 stage IIIB-IV patients.
    International journal of radiation oncology, biology, physics, 1993, Jun-15, Volume: 26, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1993
Chemotherapy dose and survival in advanced Hodgkin's disease.
    Acta haematologica, 1993, Volume: 89, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response Relatio

1993
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients.
    Cancer, 1993, Sep-15, Volume: 72, Issue:6

    Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr

1993
Clinical staging versus laparotomy and combined modality with MOPP versus ABVD in early-stage Hodgkin's disease: the H6 twin randomized trials from the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1993
Gonadal function following chemotherapy for Hodgkin's disease: a comparative study of MVPP and a seven-drug hybrid regimen.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Doxorub

1995
Improved survival in patients with limited stage IIIA Hodgkin's disease treated with combined radiation therapy and chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

1994
Etoposide in combination as first-line chemotherapy for advanced Hodgkin disease. A Cancer and Leukemia Group B study.
    Cancer, 1993, Mar-01, Volume: 71, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Etoposide

1993
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year results.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1996
Fixed versus response-adapted MOPP/ABVD chemotherapy in Hodgkin's disease. A prospective randomized trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

1995
ABMT recommended for relapsed Hodgkin's disease, but better overall survival not yet proved.
    Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1996
Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: an update.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1996, Volume: 7 Suppl 4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapy.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant

1996
Treatment of Hodgkin's disease: the Swedish National Care Programme experience.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:1-2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

1996
Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
    Human reproduction (Oxford, England), 1996, Volume: 11, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Combined

1996
Chemotherapy in Hodgkin's disease.
    Indian pediatrics, 1996, Volume: 33, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1996
Treatment of childhood Hodgkin's disease without radiotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther

1997
Patients with stage III/IV Hodgkin's disease in partial remission after MOPP/ABV chemotherapy have excellent prognosis after additional involved-field radiotherapy: interim results from the ongoing EORTC-LCG and GPMC phase III trial. The EORTC Lymphoma Co
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorub

1997
Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:4

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Ca

1997
Low risk of secondary leukemias after chemotherapy without mechlorethamine in childhood Hodgkin's disease. German-Austrian Pediatric Hodgkin's Disease Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Child

1997
A phase I study of interleukin-6 after autologous bone marrow transplantation for patients with poor prognosis Hodgkin's disease.
    Leukemia & lymphoma, 1997, Volume: 25, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi

1997
Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo

1997
Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:11

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modali

1997
[A trial of applying an oily suspension of bleomycin endolymphatically in patients with Hodgkin's disease of the extraperitoneal lymph nodes].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1997, Volume: 3, Issue:13

    Topics: Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Proto

1997
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease significantly improves failure-free and overall survival: the 8-year results of the intergroup trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dis

1998
Inhibin A concentrations in the sera of young women during and after chemotherapy for lymphoma: correlation with ovarian toxicity.
    American journal of reproductive immunology (New York, N.Y. : 1989), 1998, Volume: 39, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1998
MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther

1998
Randomized multicentre trial of filgrastim as an adjunct to combination chemotherapy for Hodgkin's disease. West of Scotland Lymphoma Group.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1998, Volume: 10, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Chemotherapy,

1998
Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Disease-Free Survival; Doxor

1998
MOPP versus ABVD and low-dose versus high-dose irradiation in Hodgkin's disease at intermediate and advanced stages: analysis of a meta-analysis by clinicians.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1999
Assessment of cardiac and pulmonary function in adult patients with Hodgkin's disease treated with ABVD or MOPP/ABVD plus adjuvant low-dose mediastinal irradiation.
    Cancer investigation, 1999, Volume: 17, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1999
Two different schedules for integrating filgrastim as adjuvant therapy in the treatment of patients with advanced stage Hodgkin's lymphoma receiving MOPP/ABV hybrid chemotherapy.
    Cancer chemotherapy and pharmacology, 1999, Volume: 43, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Filgrastim; Granulocyte C

1999
Intensive therapy with autologous stem cell transplantation as first-line therapy in poor-risk Hodgkin's disease and analysis of predictive factors of outcome.
    Leukemia & lymphoma, 1999, Volume: 34, Issue:3-4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival;

1999
Childhood stage IV Hodgkin disease: therapeutic results of the Polish pediatric leukemia/lymphoma study group.
    Medical and pediatric oncology, 1999, Volume: 33, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1999
Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.
    Cancer, 2000, Jan-15, Volume: 88, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2000
[Results of a prospective protocol for the treatment of adult Hodgkin's disease].
    La Tunisie medicale, 1999, Volume: 77, Issue:12

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; D

1999
Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the groupe d'études des lymphomes de l'Adulte H89 trial.
    Blood, 2000, Apr-01, Volume: 95, Issue:7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

2000
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
    Haematologica, 2000, Volume: 85, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

2000
Stanford V regimen and concomitant highly active antiretroviral therapy is feasible and active in patients with Hodgkin's disease and HIV infection.
    AIDS (London, England), 2000, Jul-07, Volume: 14, Issue:10

    Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Etop

2000
Agreement rates among single photon emission computed tomography using gallium-67, computed axial tomography and lymphangiography for Hodgkin disease and correlation of image findings with clinical outcome.
    Cancer, 2000, Sep-15, Volume: 89, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Citrates;

2000
Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
    Cancer, 2001, Aug-01, Volume: 92, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin;

2001
European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.
    Cancer, 2002, Mar-15, Volume: 94, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Diseas

2002
ABVD versus stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Daca

2002
Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
    Cancer, 1975, Volume: 36, Issue:1

    Topics: Adolescent; Adult; Bleomycin; Child; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female;

1975
Initial treatment of stage IIIA Hodgkin's disease. Comparison of radiotherapy with combined chemotherapy. British National Lymphoma Investigation.
    Lancet (London, England), 1976, Nov-06, Volume: 2, Issue:7993

    Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; La

1976
Eight-drug combination chemotherapy (MOPP and ABDV) and local radiotherapy for advanced Hodgkin's Disease.
    Cancer treatment reports, 1976, Volume: 60, Issue:9

    Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin D

1976
The treatment of Hodgkin's disease: emphasizing programs at the Clinic Center, National Institutes of Health.
    Current problems in cancer, 1977, Volume: 1, Issue:7

    Topics: Adult; Bleomycin; Bone Marrow; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; H

1977
Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
    Cancer treatment reports, 1977, Volume: 61, Issue:5

    Topics: Adolescent; Adult; Aged; Bleomycin; Child; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug

1977
ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
    Cancer treatment reports, 1978, Volume: 62, Issue:3

    Topics: Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combin

1978
Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    Cancer chemotherapy and pharmacology, 1979, Volume: 2, Issue:2

    Topics: Adult; Aged; Antineoplastic Agents; Bleomycin; Clinical Trials as Topic; Dacarbazine; Doxorubicin; D

1979
Combined modality therapy of Hodgkin's disease: a report on the Stanford Trials.
    Cancer, 1978, Volume: 42, Issue:2 Suppl

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease;

1978
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children.
    Acta paediatrica Scandinavica, 1978, Volume: 67, Issue:3

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Clinical Trials as Topic; Drug Evaluatio

1978
The chemotherapy of Hodgkin's disease: past experiences and future directions.
    Cancer, 1978, Volume: 42, Issue:2 Suppl

    Topics: Antineoplastic Agents; Clinical Trials as Topic; Drug Therapy, Combination; History, 19th Century; H

1978
A comparative study of a BCNU containing 4-drug program versus MOPP versus 3-drug combinations in advanced Hodgkin's disease: a cooperative study by the Cancer and Leukemia Group B.
    Cancer, 1979, Volume: 43, Issue:1

    Topics: Adult; Antineoplastic Agents; Carmustine; Clinical Trials as Topic; Drug Therapy, Combination; Femal

1979
Alternating chemotherapy and irradiation in the treatment of advanced Hodgkin's disease.
    Cancer, 1979, Volume: 43, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Bone Marrow; Clinical Trials as Topic; Drug Therapy, Combi

1979
The chemotherapy--radiotherapy sequence in the management of Hodgkin's disease. Results of a clinical trial.
    European journal of cancer, 1979, Volume: 15, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Drug Therapy, Combination

1979
Combined modality treatment of Hodgkin's disease confined to lymph nodes. Results eight years later.
    The American journal of medicine, 1979, Volume: 67, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Dru

1979
The therapeutic implications of splenic involvement in stage IIIA Hodgkin's disease.
    Cancer, 1977, Volume: 39, Issue:5

    Topics: Abdomen; Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lymph

1977
New assessment of the prognostic significance of histopathology in Hodgkin's disease for laparotomy-negative stage I and stage II patients.
    Cancer, 1977, Volume: 39, Issue:5

    Topics: Adolescent; Adult; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hodgkin Disease; Hum

1977
Randomised trial of two-drug and four-drug maintenance chemotherapy in advanced or recurrent Hodgkin's disease. Medical Research Council's working party on lymphomas.
    British medical journal, 1979, Apr-28, Volume: 1, Issue:6171

    Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore

1979
Long term follow-up of combination chemotherapy-radiotherapy of stage III Hodgkin's disease: a Cancer and Acute Leukemia Group B study.
    Cancer, 1979, Volume: 43, Issue:4

    Topics: Adult; Aged; Antineoplastic Agents; Blood Cell Count; Blood Platelets; Bone Marrow; Drug Administrat

1979
delta 9-Tetrahydrocannabinol (THC) as an antiemetic in patients treated with cancerchemotherapy; a double-blind cross-over trial against placebo.
    Veterinary and human toxicology, 1979, Volume: 21, Issue:5

    Topics: Adult; Antiemetics; Antineoplastic Agents; Double-Blind Method; Dronabinol; Drug Therapy, Combinatio

1979
The management of stages I, II, and III Hodgkin's disease with combined radiotherapy and chemotherapy.
    Cancer, 1975, Volume: 35, Issue:1

    Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr

1975
[Treatment of Hodgkin's disease stages I, II, and III].
    Nouvelle revue francaise d'hematologie; blood cells, 1977, Volume: 18, Issue:2

    Topics: Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarbazine; Splenectomy; Time Fa

1977
Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation.
    British medical journal, 1975, Aug-16, Volume: 3, Issue:5980

    Topics: Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechl

1975
A combined modality approach to the treatment of Hodgkin's disease. Preliminary results of a prospectively randomized clinical trial.
    Cancer, 1975, Volume: 35, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Cobalt Radioisotopes; Drug Therapy, Combination; Ev

1975
[Polychemotherapy of Hodgkin's disease (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1975, Apr-11, Volume: 100, Issue:15

    Topics: Adolescent; Adult; Age Factors; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Ma

1975
A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Cancer, 1975, Volume: 36, Issue:4

    Topics: Drug Evaluation; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretham

1975
Combined modality therapy for localized Hodgkin's disease. A seven-year update of an early study.
    Oncology, 1975, Volume: 32, Issue:5-6

    Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Hum

1975
Role of additional radiotherapy in advanced stages of Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphami

1992
Four cycles of chemotherapy and regional radiation therapy for clinical early-stage and intermediate-stage Hodgkin's disease.
    Cancer, 1992, Feb-15, Volume: 69, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1992
Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:10

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Ch

1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    The New England journal of medicine, 1992, Nov-19, Volume: 327, Issue:21

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm

1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    The New England journal of medicine, 1992, Nov-19, Volume: 327, Issue:21

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm

1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    The New England journal of medicine, 1992, Nov-19, Volume: 327, Issue:21

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm

1992
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD.
    The New England journal of medicine, 1992, Nov-19, Volume: 327, Issue:21

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Adm

1992
Hodgkin's disease, clinical stages I, II A-B and IIIA. Results of brief chemotherapy followed by irradiation.
    Nouvelle revue francaise d'hematologie, 1992, Volume: 34, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
A prospective randomized study of two alternating, non cross-resistant chemotherapies for advanced Hodgkin's disease.
    Acta clinica Belgica, 1992, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Dacarbazine; Doxorubic

1992
Comparison of psychosocial adaptation and sexual function of survivors of advanced Hodgkin disease treated by MOPP, ABVD, or MOPP alternating with ABVD.
    Cancer, 1992, Nov-15, Volume: 70, Issue:10

    Topics: Adaptation, Psychological; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarba

1992
Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: evidence of a more difficult rescue for patients relapsed after chemotherapy.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1992
The use of combination chemotherapy in the treatment of early stage Hodgkin's disease.
    Important advances in oncology, 1992

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality

1992
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female;

1990
Chemotherapy of Hodgkin's disease.
    Nouvelle revue francaise d'hematologie, 1990, Volume: 32, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine;

1990
Alternating versus hybrid MOPP-ABVD in Hodgkin's disease: the Milan experience.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba

1991
Management of relapse and survival in advanced stage Hodgkin's disease: the EORTC experience.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death;

1991
Treatment of advanced-stage Hodgkin's disease: alternating noncrossresistant MOPP/CABS is not superior to MOPP.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:8

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dose-Re

1991
Autologous bone marrow transplantation as adjuvant treatment for high-risk Hodgkin's disease in first complete remission after MOPP/ABVD protocol.
    Bone marrow transplantation, 1991, Volume: 8, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1991
Extended-field radiotherapy is superior to MOPP chemotherapy for the treatment of pathologic stage I-IIA Hodgkin's disease: eight-year update of an Italian prospective randomized study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans;

1992
Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with Hodgkin's disease: a phase I/II study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Dose-

1992
[Late results of the treatment of advanced Hodgkin's disease by the MOPP/COPP programs (chlormethine or cyclophosphamide, vincristine, procarbazine and prednisone)].
    Polskie Archiwum Medycyny Wewnetrznej, 1991, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; H

1991
Will doxorubicin-containing regimens replace MOPP and its variants?
    Leukemia, 1991, Volume: 5 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Hodgkin Disease; Humans; Mechlorethamin

1991
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1991
British National Lymphoma Investigation randomised study of MOPP (mustine, Oncovin, procarbazine, prednisolone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease--long term results.
    British journal of cancer, 1991, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up S

1991
Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies;

1991
A randomised study of adjuvant MVPP chemotherapy after mantle radiotherapy in pathologically staged IA-IIB Hodgkin's disease: 10-year follow-up.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1991
Chemotherapy alone for the treatment of early-stage Hodgkin's disease.
    European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:11-12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethami

1990
The intergroup Hodgkin's disease in children. A study of stages I and II.
    Cancer, 1990, Mar-15, Volume: 65, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgki

1990
A note on the Wilcoxon-Mann-Whitney test for 2 X kappa ordered tables.
    Biometrics, 1985, Volume: 41, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biometry; Bleomycin; Clinical Trials as Topic; Dacar

1985
Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.
    European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic

1985
Autologous bone marrow transplantation in Hodgkin's disease.
    Revue francaise de transfusion et immuno-hematologie, 1985, Volume: 28, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1985
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
    Cancer treatment reports, 1986, Volume: 70, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic

1986
Long-term follow-up of cardiac function in patients with Hodgkin's disease treated with mediastinal irradiation and combination chemotherapy including doxorubicin.
    Cancer treatment reports, 1986, Volume: 70, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Pressure; Clinical Trials as

1986
Alternating non-cross-resistant combination chemotherapy or MOPP in stage IV Hodgkin's disease. A report of 8-year results.
    Annals of internal medicine, 1986, Volume: 104, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox

1986
MOPP/ABVD chemotherapy for advanced Hodgkin's disease.
    Annals of internal medicine, 1986, Volume: 104, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Dacarbaz

1986
Evaluation of therapeutic modalities in the control of Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1986, Volume: 12, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali

1986
[Treatment of Hodgkin's disease in children. Results of the Polish Group for the Treatment of Leukemia and Neoplastic Diseases in Children].
    Pediatria polska, 1986, Volume: 61, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin

1986
Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP plus radiotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

1987
[Treatment of Hodgkin's disease in children with chemotherapy and low-dose radiation].
    Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1987
Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

1988
Initial chemotherapy and low-dose radiation in limited fields in childhood Hodgkin's disease: results of a joint cooperative study by the French Society of Pediatric Oncology (SFOP) and Hôpital Saint-Louis, Paris.
    International journal of radiation oncology, biology, physics, 1988, Volume: 15, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1988
Toward comprehensive management tailored to prognostic factors of patients with clinical stages I and II in Hodgkin's disease. The EORTC Lymphoma Group controlled clinical trials: 1964-1987.
    Blood, 1989, Volume: 73, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined

1989
Treatment of advanced Hodgkin's disease.
    Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top

1989
Hodgkin's disease: the Milan Cancer Institute experience with MOPP and ABVD.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba

1989
Hodgkin's disease in children: adaptation of treatment to risk factors.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin

1989
[Controversy regarding the treatment of Hodgkin's disease].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1989, Apr-03, Volume: 44, Issue:14

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Clinical Trials as Topic; C

1989
Clinical investigations of children with Hodgkin's disease at Stanford University Medical Center. A preliminary overview using low-dose irradiation and alternating ABVD/MOPP chemotherapy.
    Cancer treatment and research, 1989, Volume: 41

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Clin

1989
Current management and controversies. The chemotherapist's view.
    Cancer treatment and research, 1989, Volume: 41

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Hodgkin Disease; Hu

1989
Relationship of histological subtypes to prognosis in early stage Hodgkin's disease: a review of 312 cases in a controlled clinical trial. The Groupe Pierre et Marie Curie.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; C

1989
[Chemotherapy of stage III-IV Hodgkin's disease. A retrospective analysis of the 53 cases collected from 9 institutions in Japan].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubic

1989
MOPP chemotherapy versus extended-field radiotherapy in the management of pathological stages I-IIA Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1989
Treatment with MOPP or ChlVPP chemotherapy only for all stages of childhood Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:12

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chlorambucil; C

1988
Failure to preserve fertility in patients with Hodgkin's disease.
    Cancer chemotherapy and pharmacology, 1987, Volume: 19, Issue:2

    Topics: Amenorrhea; Animals; Antineoplastic Combined Chemotherapy Protocols; Buserelin; Dogs; Female; Follic

1987
The adjuvant role of two cycles of MOPP and low-dose lung irradiation in stage IA through IIB Hodgkin's disease: preliminary results.
    International journal of radiation oncology, biology, physics, 1988, Volume: 14, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Follow-Up Studies; Hodgkin

1988
Intercurrent death after Hodgkin disease therapy in radiotherapy and adjuvant MOPP trials.
    Annals of internal medicine, 1988, Aug-01, Volume: 109, Issue:3

    Topics: Actuarial Analysis; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Clinica

1988
Comparison of total nodal irradiation versus combined sequence of mantle irradiation with mechlorethamine, vincristine, procarbazine, and prednisone in clinical stages I and II Hodgkin's disease: experience of the European Organization for Research and Tr
    NCI monographs : a publication of the National Cancer Institute, 1988, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1988
Twenty years of MOPP therapy for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as T

1986
Randomised study of MOPP (mustine, Oncovin, procarbazine, prednisone) against LOPP (Leukeran substituted for mustine) in advanced Hodgkin's disease. British National Lymphoma Investigation.
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 1986, Volume: 7, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Trials as

1986
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
    The American journal of medicine, 1986, Volume: 80, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1986
Extended versus involved fields irradiation combined with MOPP chemotherapy in early clinical stages of Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1985
The evolution and summary results of the Stanford randomized clinical trials of the management of Hodgkin's disease: 1962-1984.
    International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Trials as Topic; Combine

1985
Treatment selection for stage IIIA Hodgkin's disease patients.
    International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality T

1985
Hodgkin's disease in childhood and adolescence: results of chemotherapy-radiotherapy in clinical stages IA-IIB.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:11

    Topics: Actuarial Analysis; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Tria

1985
Maintenance chemotherapy for advanced Hodgkin's disease in remission.
    Lancet (London, England), 1973, Jun-16, Volume: 1, Issue:7816

    Topics: Blood Cell Count; Blood Platelets; Hodgkin Disease; Humans; Lymphocytes; Mechlorethamine; Nitrosoure

1973
Treatment of early Hodgkin's disease.
    Lancet (London, England), 1967, Jan-07, Volume: 1, Issue:7480

    Topics: Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine

1967
Combination chemotherapy and survival in advanced Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Benzoates; Clinical Trials as Topic; Evaluation Studies as Topic; Follow-Up S

1973
Chemotherapy of lymphoma with mechlorethamine and vinblastine.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Adult; Blood Cell Count; Blood Platelet Disorders; Clinical Trials as Topic; Evaluation Studies as T

1973
Combination radiotherapy and chemotherapy in the treatment of early Hodgkin's disease.
    Oncology, 1973, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Child; Clinical Trials as Topic; Cobalt Radioisotopes; Drug Therapy, Combination;

1973
International Symposium on Hodgkin's Disease. Session 5. Treatment. Current status of clinical trials: Stanford experience, 1962-72.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Biopsy; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Gold Colloid, Radioa

1973
Chemotherapy of Hodgkin's disease in studies by acute leukemia group B.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Carmustine; Chlorambucil; Evaluation Studies as Topic; Hodgkin Disease; Human

1973
Chemotherapy of Hodgkin's disease. Maintenance therapy vs no maintenance after remission induction with combination chemotherapy.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Adult; Age Factors; Antineoplastic Agents; Benzoates; Blood Cell Count; Bone Marrow; Evaluation Stud

1973
Combination chemotherapy-radiotherapy for stage 3 Hodgkin's disease. An acute leukemia group B study.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Adult; Age Factors; Blood Cell Count; Blood Platelets; Bone Marrow; Evaluation Studies as Topic; Fem

1973
Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B.
    JAMA, 1973, Sep-03, Volume: 225, Issue:10

    Topics: Adult; Age Factors; Benzoates; Drug Synergism; Female; Hodgkin Disease; Humans; Leukocytes; Male; Me

1973
Combination chemotherapy in advanced Hodgkin's disease. Induction and maintenance of remission.
    Annals of internal medicine, 1973, Volume: 79, Issue:3

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age

1973
Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin's disease and the lymphomas.
    JAMA, 1968, Feb-05, Volume: 203, Issue:6

    Topics: Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Dosage Forms; Follow-Up Studies; Hodgkin D

1968
Chemotherapeutic implications of staging in Hodgkin's disease.
    Cancer research, 1971, Volume: 31, Issue:11

    Topics: Animals; Chlorambucil; Clinical Trials as Topic; Cyclophosphamide; Drug Combinations; Follow-Up Stud

1971

Other Studies

908 other studies available for mechlorethamine and Granuloma, Hodgkin

ArticleYear
Pharmacokinetics and safety of bendamustine in the BEABOVP regimen for the treatment of pediatric patients with Hodgkin lymphoma.
    Cancer chemotherapy and pharmacology, 2023, Volume: 92, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bendamustine Hydrochloride; Child; Doxorubicin; Hodg

2023
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2020, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

2020
Long-Term Outcomes of Patients With Early Stage Nonbulky Hodgkin Lymphoma Treated With Combined Modality Therapy in the Stanford V Trials (the G4 and G5 Studies).
    International journal of radiation oncology, biology, physics, 2021, 06-01, Volume: 110, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Combined Modality Therapy; Cyclophospham

2021
Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    British journal of cancer, 2017, Jul-25, Volume: 117, Issue:3

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Colon; Colo

2017
[Effectiveness and toxicity of MOPP, ABVD, BEACOPP chemotherapy in first-diagnosed Hodgkin lymphoma with a poor prognosis].
    Voprosy onkologii, 2013, Volume: 59, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

2013
Treatment of Hodgkin lymphoma: a 50-year perspective.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2014, Jan-20, Volume: 32, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Clinical Trials as Top

2014
Thyroid malignancies in survivors of Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2014, Mar-01, Volume: 88, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

2014
Hodgkin's lymphoma rectosigmoid in a patient with ulcerative colitis on long-term azathioprine therapy.
    BMJ case reports, 2014, May-20, Volume: 2014

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Azathioprine; Colitis, Ulcerative; Hodgkin Dis

2014
Impact of lymphoma treatments on spermatogenesis and sperm deoxyribonucleic acid: a multicenter prospective study from the CECOS network.
    Fertility and sterility, 2014, Volume: 102, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Combined Mod

2014
Hodgkin lymphoma--a survey of children and adolescents treated in Sweden 1985-2009.
    Acta oncologica (Stockholm, Sweden), 2015, Volume: 54, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

2015
Fifty years from Paris: the remarkable story of the lymphomas.
    International journal of radiation oncology, biology, physics, 2015, May-01, Volume: 92, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Congresses as Topic; History, 19th Century; History,

2015
[The effectiveness and toxicity of therapy in primary Hodgkin's lymphoma with extranodal lesions].
    Voprosy onkologii, 2015, Volume: 61, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo

2015
[Effect of brentuximab vedotin combined with chlormethine hydrochloride on the treatment of 6 patients with relapsed and refractory Hodgkin lymphoma].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2015, Volume: 36, Issue:7

    Topics: Antineoplastic Agents, Alkylating; Brentuximab Vedotin; Hodgkin Disease; Humans; Immunoconjugates; M

2015
Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era.
    British journal of haematology, 2015, Volume: 171, Issue:4

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Bleomycin; Clinical T

2015
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
    Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2016, Volume: 18, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox

2016
PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, 08-10, Volume: 34, Issue:23

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Bleomycin; C

2016
McFarland W, Granville NB, Dameshek W. Autologous bone marrow infusion as an adjunct in therapy of malignant disease. Blood. 1959;14(5):503-521.
    Blood, 2016, Apr-14, Volume: 127, Issue:15

    Topics: Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; History, 20th Century

2016
Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
    International journal of radiation oncology, biology, physics, 2017, 01-01, Volume: 97, Issue:1

    Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Agents; Antineoplastic Combined Chemotherapy

2017
[Features of clinical course of combination chemotherapy for liver involvement in Hodgkin's disease].
    Voprosy onkologii, 2008, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide

2008
Prognostic factors in children with Hodgkin disease.
    Pediatric blood & cancer, 2008, Volume: 51, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre

2008
The treatment of lymphogranulomatosis with nitrogen mustard gas
    Nordisk medicin, 1948, Jan-09, Volume: 37, Issue:2

    Topics: Hodgkin Disease; Mechlorethamine

1948
Studies in Hodgkin's syndrome; nitrogen mustard therapy.
    The Journal of laboratory and clinical medicine, 1948, Volume: 33, Issue:8

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Syndrome

1948
Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated by nitrogen mustard, a derivative of mustarditis.
    Bruxelles medical, 1948, Aug-08, Volume: 28, Issue:32

    Topics: Hodgkin Disease; Mechlorethamine

1948
Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
    Cancer, 1948, Volume: 1, Issue:3

    Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mustard Plant; Nitrogen

1948
Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
    Southern medical journal, 1948, Volume: 41, Issue:2

    Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco

1948
Nitrogen mustard in the treatment of Hodgkin's disease; a case report with discussion.
    Texas reports on biology and medicine, 1948, Volume: 6, Issue:1

    Topics: Ethylamines; Hodgkin Disease; Mechlorethamine

1948
Six cases of Paltauf-Sternberg lymphogranulomatosis and two analogous conditions treated with nitrogen mustard, a derivative of hyperperitis.
    Le Scalpel, 1948, Sep-04, Volume: 101, Issue:36

    Topics: Hodgkin Disease; Mechlorethamine

1948
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.
    Annals of hematology, 2009, Volume: 88, Issue:7

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Dacarbaz

2009
[Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child;

2008
Vanishing bile duct syndrome and Hodgkin disease: a case series and review of the literature.
    Journal of pediatric hematology/oncology, 2008, Volume: 30, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cholestasis; Combined Modality The

2008
[Concomitant pulmonary Langerhans cell histiocytosis and malignant lymphoma: report of two cases].
    Journal de radiologie, 2009, Volume: 90, Issue:1 Pt 1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Combined Modality Therapy;

2009
[Use of risk-adapted programs of treatment of Hodgkin's disease in children and adolescents].
    Voprosy onkologii, 2008, Volume: 54, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Pr

2008
Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
    The Journal of clinical endocrinology and metabolism, 2009, Volume: 94, Issue:6

    Topics: Adolescent; Adult; Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Compo

2009
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
    Anticancer research, 2009, Volume: 29, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com

2009
Acute promyelocytic leukemia after Stanford V plus radiotherapy for advanced Hodgkin lymphoma.
    Leukemia & lymphoma, 2009, Volume: 50, Issue:7

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin

2009
The combination of thalidomide, cyclophosphamide and dexamethasone is potentially useful in highly resistant Hodgkin's lymphoma.
    European journal of haematology, 2010, Volume: 84, Issue:3

    Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemo

2010
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy.
    International journal of radiation oncology, biology, physics, 2009, Dec-01, Volume: 75, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Cohort Studies; Combine

2009
[Multivariate analysis of risk of cardiac complications in Hodgkin's lymphoma].
    Voprosy onkologii, 2009, Volume: 55, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Female; Heart;

2009
Long-term follow-up of survival in Hodgkin's lymphoma.
    The New England journal of medicine, 2009, Dec-10, Volume: 361, Issue:24

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Follow-Up Studi

2009
A case of Hodgkin's disease treated with nitrogen mustard.
    West London medical journal, 1947, Volume: 52, Issue:1

    Topics: Ethylamines; Hodgkin Disease; Mechlorethamine

1947
Nitrogen mustards in Hodgkin's disease; report on 21 cases and four of other reticuloses.
    Lancet (London, England), 1947, Jun-28, Volume: 1, Issue:6461

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Peptide Nucleic Acids

1947
Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
    Annals of internal medicine, 1947, Volume: 27, Issue:4

    Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine

1947
Clinical experiences with nitrogen mustard in Hodgkin's disease.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1947, Mar-22, Volume: 21, Issue:6

    Topics: Ethylamines; Hodgkin Disease; Mechlorethamine

1947
Hodgkin's lymphoma: Richter's transformation of chronic lymphocytic leukemia involving the liver.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Oct-10, Volume: 28, Issue:29

    Topics: Antineoplastic Agents, Alkylating; Female; Hodgkin Disease; Humans; Leukemia, Lymphocytic, Chronic,

2010
Parathyroid adenoma and chondrosarcoma after treatment of pediatric Hodgkin disease.
    Journal of pediatric hematology/oncology, 2010, Volume: 32, Issue:7

    Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool; Chondrosarcoma

2010
Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    Journal of the American Medical Association, 1946, Sep-21, Volume: 132

    Topics: Amines; Gas Poisoning; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechloret

1946
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
    Anticancer research, 2010, Volume: 30, Issue:10

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Com

2010
Locoregional treatment for breast carcinoma after Hodgkin's lymphoma: the breast conservation option.
    International journal of radiation oncology, biology, physics, 2012, Feb-01, Volume: 82, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms

2012
Impact of different treatment approaches on pregnancy outcomes in 99 women treated for Hodgkin lymphoma.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Abortion, Spontaneous; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Congenital

2012
Persistent genomic instability in peripheral blood lymphocytes from Hodgkin lymphoma survivors.
    Environmental and molecular mutagenesis, 2012, Volume: 53, Issue:4

    Topics: Adult; Aneuploidy; Case-Control Studies; Chromosomal Instability; Chromosome Aberrations; Chromosome

2012
Incidence, predictors and significance of severe toxicity in patients with human immunodeficiency virus-associated Hodgkin lymphoma.
    Leukemia & lymphoma, 2012, Volume: 53, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy

2012
[Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2012, Volume: 16, Issue:7

    Topics: Adolescent; Anemia, Aplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiomyopa

2012
[Clinical analysis of childhood and adolescent Hodgkin's lymphoma: a report of 88 cases].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2012, Volume: 34, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

2012
The impact of drug shortages on children with cancer--the example of mechlorethamine.
    The New England journal of medicine, 2012, Dec-27, Volume: 367, Issue:26

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Disease-Fr

2012
Risk of therapy-related secondary leukemia in Hodgkin lymphoma: the Stanford University experience over three generations of clinical trials.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2013, Feb-10, Volume: 31, Issue:5

    Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Californ

2013
Long-term results of conventional-dose salvage chemotherapy in patients with refractory and relapsed Hodgkin's disease (Croatian experience).
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:10

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Croatia; Dacarba

2002
Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bioma

2002
Postpneumonectomy-like syndrome after chemoradiation therapy for lymphoma.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2002, Volume: 13, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba

2002
Analysis of treatment results in advanced Hodgkin's disease: the case for adjuvant radiotherapy.
    International journal of radiation oncology, biology, physics, 2003, Jul-01, Volume: 56, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom

2003
Radiation therapy in the treatment of Hodgkin's disease--do you see what I see?
    Journal of the National Cancer Institute, 2003, Jul-02, Volume: 95, Issue:13

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Chemotherapy, Adjuvant;

2003
[Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    Accademia medica, 1952, Volume: 67, Issue:4

    Topics: Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds

1952
[Treatment of malignant granuloma with nitrogen mustard].
    Polski tygodnik lekarski, 1952, Jun-09, Volume: 7, Issue:23

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1952
Combined nitrogen mustard and single dose irradiation treatment of lymphomata and other malignant tumors.
    Virginia medical monthly, 1952, Volume: 79, Issue:10

    Topics: Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Neoplasms; Radiotherapy Dosage

1952
New therapy for leukemia, polycythemia, and lymphoma.
    California medicine, 1953, Volume: 78, Issue:2

    Topics: Aminopterin; Chronic Disease; Hodgkin Disease; Humans; Leukemia; Lymphoma; Mechlorethamine; Multiple

1953
[Effect of x-rays and nitrogen mustard in the therapy of Hodgkin's disease].
    Journal de medecine de Lyon, 1952, Oct-20, Volume: 33, Issue:787

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Rays

1952
[Role of nitrogen mustard in the therapy of malignant lymphogranulomatosis].
    Journal de medecine de Lyon, 1952, Oct-20, Volume: 33, Issue:787

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1952
Use of nitrogen mustards during acute hepatitis.
    Journal of the American Medical Association, 1953, May-30, Volume: 152, Issue:5

    Topics: Acute Disease; Hepatitis; Hepatitis A; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Diagnosis and therapy of Hodgkin's disease; study of 110 cases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1952, Dec-25, Volume: 28, Issue:95

    Topics: Cortisone; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; Triethyleneme

1952
[Nitrogen mustard therapy of proliferative blood diseases; methods, experiences as well as application possibilities in therapy of carcinoma].
    Wiener medizinische Wochenschrift (1946), 1953, Jan-03, Volume: 103, Issue:1

    Topics: Hematologic Diseases; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymp

1953
[Therapeutic effect of small doses of chloroethylaminohydrochloride associated with roentgenotherapy in blastomatosis].
    Casopis lekaru ceskych, 1953, Mar-06, Volume: 92, Issue:10

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Ray Therapy

1953
The use of nitrogen mustard in the management of two pregnant lymphoma patients.
    Blood, 1953, Volume: 8, Issue:6

    Topics: Disease Management; Fetus; Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds; P

1953
[Treatment of symptomatic hemolytic anemias].
    Acta haematologica, 1953, Volume: 9, Issue:4

    Topics: Anemia, Hemolytic; Hodgkin Disease; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin;

1953
HODGKIN'S disease: diagnosis and treatment.
    The Medical journal of Australia, 1953, Jun-27, Volume: 1, Issue:26

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine

1953
[Effect of x-rays and nitrogen mustards in the treatment of Hodgkin's disease].
    Journal de radiologie, d'electrologie & archives d'electricite medicale, 1953, Volume: 34, Issue:1-2

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy; X-Rays

1953
[Role of nitrogen mustard in the treatment of malignant lymphogranuloma].
    Journal de radiologie, d'electrologie & archives d'electricite medicale, 1953, Volume: 34, Issue:1-2

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Pulmonary Hodgkin's disease; treatment and evolution with nitrogen mustards].
    Revista clinica espanola, 1953, May-31, Volume: 49, Issue:4

    Topics: Hodgkin Disease; Lung Neoplasms; Mechlorethamine; Nitrogen Mustard Compounds

1953
[The treatment of Hodgkin's diseases].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1953, Jun-20, Volume: 29, Issue:40

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1953
[Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards].
    La Medicina colonial, 1953, Volume: 21, Issue:6

    Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Considerations on therapeutic effect of chloramine and colchicine in Hodgkin's disease].
    Clinica nuova; rassegna del progresso medico internazionale, 1953, Feb-07, Volume: 16, Issue:6

    Topics: Chloramines; Colchicine; Hodgkin Disease; Mechlorethamine

1953
Treatment of Hodgkin's disease and the lymphosarcomas.
    Journal of the American Medical Association, 1954, Jan-09, Volume: 154, Issue:2

    Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compound

1954
[Histopathological aspect of the lymph nodes in Hodgkin's disease treated with nitrogen mustards].
    Medicina, 1953, Volume: 21, Issue:2:2

    Topics: Blood; Hodgkin Disease; Lymph Nodes; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Nitrogen mustard and Hodgkin's disease; case report].
    Portugal medico, 1953, Volume: 37, Issue:11

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Treatment of Hodgkin's disease with nitrogen mustards].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1954, Feb-20, Volume: 30, Issue:13

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1954
[Efficacy of nitrogen mustard on iridocyclitis in Hodgkin's disease].
    Bulletin des societes d'ophtalmologie de France, 1953, Volume: 9

    Topics: Hodgkin Disease; Iridocyclitis; Mechlorethamine; Nitrogen Mustard Compounds

1953
[Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
    Haematologica, 1953, Volume: 37, Issue:11

    Topics: Ethylamines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma,

1953
[Malignant lymphogranulomatosis (Hodgkin's diseases) with cutaneous initiation: total remission under combined treatment with radio-therapy and nitrogen mustard].
    Prensa medica argentina, 1954, Feb-19, Volume: 41, Issue:8

    Topics: Combined Modality Therapy; Hodgkin Disease; Manipulation, Osteopathic; Mechlorethamine; Nitrogen Mus

1954
Biological actions and therapeutic applications of nitrogen mustard.
    The Quarterly journal of medicine, 1954, Volume: 23, Issue:90

    Topics: Hodgkin Disease; Leukemia; Leukemia, Myeloid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitr

1954
[Treatment of malignant lymphogranulomatosis with intraarterial injections of nitrogen mustards and chloramphenicol].
    Revue medicale de Liege, 1954, Feb-15, Volume: 9, Issue:4

    Topics: Chloramphenicol; Hodgkin Disease; Humans; Injections, Intra-Arterial; Mechlorethamine; Nitrogen Must

1954
[Experimental and clinical studies on the toxic and therapeutic effect of both nitrogen mustard compounds, trichlortriethylamine and dichloro-diethylamine].
    Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete, 1953, Aug-01, Volume: 8, Issue:15

    Topics: Biomedical Research; Diethylamines; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1953
Beta-Naphthyl-di-chloroethylamine in the treatment of malignant diseases, particularly Hodgkin's disease.
    Acta medica Scandinavica, 1954, Volume: 149, Issue:5

    Topics: Hodgkin Disease; Hydrocarbons, Aromatic; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard

1954
Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
    The British journal of radiology, 1954, Volume: 27, Issue:320

    Topics: Cortisone; Hodgkin Disease; Lymphocytes; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen

1954
[Beta-Naphthyl-di-chlorethylamine therapy of malignant conditions, especially Hodgkin's disease].
    Ugeskrift for laeger, 1954, Jun-24, Volume: 116, Issue:25

    Topics: Hodgkin Disease; Mechlorethamine; Naphthalenes; Neoplasms; Nitrogen Mustard Compounds

1954
[Therapeutic use of embichin].
    Klinicheskaia meditsina, 1954, Volume: 32, Issue:6

    Topics: Hodgkin Disease; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds

1954
[Treatment of Hodgkin's disease in children].
    Pediatrie, 1954, Volume: 9, Issue:5

    Topics: Child; Hodgkin Disease; Infant; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1954
[Triethylene melamine treatment of leukemia and lymphogranulomatosis].
    Turk Tip Cemiyeti mecmuasi, 1954, Volume: 20, Issue:6

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis; Triethylenemela

1954
[The combination of radiotherapy and N-lost therapy].
    Strahlentherapie, 1955, Volume: 97, Issue:1

    Topics: Hodgkin Disease; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Radiotherapy

1955
Indication of the use of beta-naphthyl-di-2-chloroethylamine, in Hodgkin's disease and Leukemia.
    Acta - Unio Internationalis Contra Cancrum, 1955, Volume: 11, Issue:2

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1955
[Our experiences in treatment with nitrogen mustard].
    Zdravstveni vestnik, 1954, Volume: 23, Issue:11-12

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1954
Immediate and remote results of chloroethylamine treatment of Hodgkin's disease.
    British medical journal, 1956, Feb-04, Volume: 1, Issue:4961

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1956
[Malignant lymphogranuloma (Hodgkin's disease) and leprosy concomitant in the same patient; treatment with nitrogen mustard].
    El Dia medico, 1955, Dec-26, Volume: 27, Issue:95

    Topics: Hodgkin Disease; Leprosy; Mechlorethamine; Nitrogen Mustard Compounds

1955
[Remarquable results with yperite nitrate in two cases of Hodgkin's disease].
    Journal de medecine de Bordeaux et du Sud-Ouest, 1956, Volume: 133, Issue:1

    Topics: Hodgkin Disease; Mechlorethamine; Mustard Gas; Nitrates; Nitrogen Mustard Compounds; Nitrogen Oxides

1956
Evaluation of CB 1348 in Hodgkin's disease and allied disorders.
    A.M.A. archives of internal medicine, 1956, Volume: 97, Issue:6

    Topics: Arylsulfonates; Chlorambucil; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1956
Clinical trial of a new nitrogen-mustard compound.
    Lancet (London, England), 1956, May-26, Volume: 270, Issue:6926

    Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds

1956
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
    Voprosy onkologii, 1956, Volume: 2, Issue:5

    Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus

1956
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
    Voprosy onkologii, 1956, Volume: 2, Issue:5

    Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus

1956
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
    Voprosy onkologii, 1956, Volume: 2, Issue:5

    Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus

1956
[Changes of phosphorus metabolism in the lymph nodes in lymphogranulomatosis by means of radioactive phosphorus in the treatment with embichin].
    Voprosy onkologii, 1956, Volume: 2, Issue:5

    Topics: Hodgkin Disease; Lymph Nodes; Mechlorethamine; Phosphorus

1956
[Trials of treatment by p-(di-2-chloroethylamino)phenylbutyric acid in Hodgkin's disease, chronic lymphoid leukemia and different sarcomas of lymphatic tissue; study of one hundred cases].
    Revue francaise d'etudes cliniques et biologiques, 1956, Volume: 1, Issue:10

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Lymphoid; Lymphoid Tiss

1956
[Use of sanamycin and triethylenemelanine or of nitrogranulogen in malignant granuloma].
    Polski tygodnik lekarski, 1956, Nov-05, Volume: 11, Issue:45

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Hodgkin Disease; Mechloreth

1956
[Treatment of hematologic neoplasms with nitrogen oxide mustards].
    Deutsche medizinische Wochenschrift (1946), 1957, Feb-15, Volume: 82, Issue:7

    Topics: Hematologic Neoplasms; Hodgkin Disease; Leukemia; Lymphoma; Mechlorethamine; Mustard Plant; Nitrogen

1957
[Treatment of Hodgkin's disease, chronic lymphoid leukosis and various lymphosarcomas with p-(di-2-chloroethyl) aminophenylbutyric acid].
    Le Sang, 1957, Volume: 28, Issue:1

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit

1957
[Apparent cure of iridocyclitis of Hodgkin's disease obtained with nitrogen mustard & maintained for 3 1/2 years].
    Bulletin des societes d'ophtalmologie de France, 1957, Issue:1

    Topics: Hodgkin Disease; Iridocyclitis; Mechlorethamine; Nitrogen Mustard Compounds

1957
Therapeutic results in treatment of Hodgkin's disease with CB 1348 and R-48.
    Blood, 1957, Volume: 12, Issue:8

    Topics: Chlorambucil; Hodgkin Disease; Mechlorethamine; Naphthalenes; Nitrogen Mustard Compounds

1957
[Action of cytotoxic drugs in Hodgkin-Sternberg malignant granuloma; electrophoretic changes in blood].
    Giornale di clinica medica, 1957, Volume: 38, Issue:2

    Topics: Antineoplastic Agents; Electrophoresis; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1957
[Therapeutic use of embikhin in lymphogranulomatosis].
    Voprosy onkologii, 1955, Volume: 1

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1955
Hodgkin's disease: a revised clinical classification and an approach to the treatment of its localized form.
    Stanford medical bulletin, 1957, Volume: 15, Issue:3

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1957
[Clinical experiences with a new drug, chlorambucil (CB 1348), in malignant lymphogranuloma].
    Casopis lekaru ceskych, 1957, Sep-13, Volume: 96, Issue:37

    Topics: Chlorambucil; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1957
[Chronic hodgkinian pericarditis with large effusion; favorable effect of nitrogen mustard by intrapericardial route].
    La Presse medicale, 1957, Dec-25, Volume: 65, Issue:94

    Topics: Heart Neoplasms; Hodgkin Disease; Mechlorethamine; Medical Records; Neoplasms; Nitrogen Mustard Comp

1957
[Preliminary data on application of dopamine lymphogranulomatosis].
    Voprosy onkologii, 1957, Volume: 3, Issue:5

    Topics: Dopamine; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Uracil

1957
Intermittent obstructive jaundice in Hodgkin's disease: report of a case.
    The Journal-lancet, 1958, Volume: 78, Issue:3

    Topics: Hodgkin Disease; Humans; Jaundice; Jaundice, Obstructive; Mechlorethamine; Nitrogen Mustard Compound

1958
[Diagnosis ex juvantibus with azoiprite of Hodgkin's disease].
    La Riforma medica, 1957, Nov-02, Volume: 71, Issue:44

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1957
[Therapy of Hodgkin's disease (lymphogranulomatosis)].
    Annales paediatrici. International review of pediatrics, 1958, Volume: 190, Issue:6

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis

1958
[Therapy of malignant diseases of the lymphatic and reticular systems with a nitrogen mustard derivative].
    Arzneimittel-Forschung, 1958, Volume: 8, Issue:6

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Mannitol; Mechlorethamine; Neoplasms; Nitrogen Mustar

1958
[P-bis-(beta-chloroethyl) aminophenylalanine (sarcolysin) in antiblastic chemotherapy with special reference to lymphatic blood diseases].
    Haematologica, 1958, Volume: 43, Issue:4

    Topics: Hodgkin Disease; Humans; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret

1958
[Late results in the chemotherapy of lymphogranulomatosis].
    Voprosy onkologii, 1958, Volume: 4, Issue:2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1958
[Trial therapy of leukoses, lymphogranulomas & malignant tumors with urethane, chloroethylamine & other clinical compounds].
    Izvestiia na meditsinskite instituti. [Bulletin des instituts de medecine]. Bulgarska akademiia na naukite. Otdelenie za biologicheski i meditsinski nauki, 1957, Volume: 14

    Topics: Antineoplastic Agents; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compo

1957
Changes in the urinary excretion of metabolites during treatment with nitrogen mustard and triethylenemelamine.
    British journal of cancer, 1958, Volume: 12, Issue:3

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Triethylenemelamine

1958
[Use of embichin in lymphogranulomatosis in children].
    Pediatriia, 1958, Volume: 23, Issue:9

    Topics: Child; Hodgkin Disease; Humans; Infant; Mechlorethamine; Sarcoidosis

1958
A CLINICAL study of the comparative effect of nitrogen mustard and DON in patients with bronchogenic carcinoma, Hodgkin's disease, lymphosarcoma, and melanoma.
    Journal of the National Cancer Institute, 1959, Volume: 22, Issue:2

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Hodgkin Disease; Humans; Leucine; Lymphoma; Lymphoma

1959
The histopathological changes induced by the nitrogen mustards in the lymphomas: a brief review of the literature.
    Rhode Island medical journal, 1959, Volume: 42, Issue:4

    Topics: Hodgkin Disease; Lymphoma; Mechlorethamine; Nitrogen Mustard Compounds

1959
Radiotherapy for advanced Hodgkin's disease.
    The New England journal of medicine, 2003, Sep-18, Volume: 349, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H

2003
[The treatment of Hodgkin's disease by short cures with nitrogen mustards. Apropos of 15 cases].
    Helvetica medica acta, 1961, Volume: 28

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1961
Massive nitrogen mustard therapy in Hodgkin's disease with protection of bone marrow by tourniquets.
    Blood, 1960, Volume: 16

    Topics: Bone Marrow; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Tourniquets

1960
Combined radiation and nitrogen mustrad therapy in Hodgkin's disease as compared with radiation therapy alone.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1959, Volume: 82

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen; Nitrogen Mustard Compounds

1959
A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin's disease and lymphosarcoma.
    Cancer chemotherapy reports, 1962, Volume: 16

    Topics: Antineoplastic Agents; Carcinoma, Bronchogenic; Cyclophosphamide; Hodgkin Disease; Lung Neoplasms; L

1962
[Data on the therapy of lymphogranulomatosis].
    Magyar radiologia, 1962, Volume: 14

    Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Hodgkin Disease; Mannomusti

1962
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. IX. Further clinical reports, 1960-1962.
    Journal of the South Carolina Medical Association, 1963, Volume: 59

    Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1963
Nitrogen mustards in the management of Hodgkin's disease and the leukemias. VII. Clinical reports, 1959-62.
    American journal of pharmacy and the sciences supporting public health, 1962, Volume: 134

    Topics: Disease Management; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1962
The effect of nitrogen mustard and maintenance chlorambucil in the treatment of advanced Hodgkin's disease.
    Cancer chemotherapy reports, 1963, Volume: 27

    Topics: Chlorambucil; Hodgkin Disease; Humans; Mechlorethamine

1963
THE MALIGNANT LYMPHOMAS.
    The American journal of nursing, 1963, Volume: 63

    Topics: Adrenal Cortex Hormones; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma

1963
SUBACUTE CEREBELLAR DEGENERATION WITH HODGKIN'S DISEASE.
    Archives of neurology, 1963, Volume: 9

    Topics: Ataxia; Cerebellar Diseases; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Nerve

1963
[EVALUATION OF THE CURRENT THERAPEUTIC TRENDS IN HODGKIN'S DISEASE. CRITICAL REVIEW AND CASUISTIC CONTRIBUTION].
    Archivio di patologia e clinica medica, 1963, Volume: 40

    Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Bone Marrow Trans

1963
HODGKIN'S DISEASE IN PREGNANCY.
    American journal of obstetrics and gynecology, 1963, Dec-01, Volume: 87

    Topics: Female; Hodgkin Disease; Mechlorethamine; Neoplasms; Pregnancy; Pregnancy Complications; Triethylene

1963
ROLE OF CHEMOTHERAPY IN THE MANAGEMENT OF EARLY HODGKIN'S DISEASE.
    The American journal of roentgenology, radium therapy, and nuclear medicine, 1963, Volume: 90

    Topics: Bone Marrow Examination; Chlorambucil; Disease Management; Histological Techniques; Histology; Hodgk

1963
FURTHER COMPARATIVE TRIAL OF TRIETHYLENE THIOPHOSPHORAMIDE AND MECHLORETHAMINE IN PATIENTS WITH MELANOMA AND HODGKIN'S DISEASE.
    Journal of chronic diseases, 1964, Volume: 17

    Topics: District of Columbia; Hodgkin Disease; Mechlorethamine; Melanoma; New York; Thiotepa; Toxicology

1964
A STUDY OF THE MECHANISMS OF GRANULOCYTOPENIA.
    Annals of the New York Academy of Sciences, 1964, Feb-28, Volume: 113

    Topics: Agranulocytosis; Anemia; Anemia, Macrocytic; Carcinoma; Carcinoma, Bronchogenic; Child; Hodgkin Dise

1964
HODGKIN'S DISEASE AND SALMONELLA TYPHIMURIUM INFECTION.
    JAMA, 1964, May-18, Volume: 188

    Topics: Chloramphenicol; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Neoplasms; Salmonella I

1964
[EARLY DIAGNOSIS AND MEDICAL THERAPY OF MALIGNANT TUMORS].
    Il Cancro, 1963, Volume: 16

    Topics: Antineoplastic Agents; Busulfan; Colchicine; Early Diagnosis; Hodgkin Disease; Mechlorethamine; Merc

1963
EXCRETION OF TRYPTOPHAN METABOLITES IN DIFFERENT FORMS OF HAEMOBLASTOSIS.
    Clinica chimica acta; international journal of clinical chemistry, 1964, Volume: 9

    Topics: Cortisone; Cyclophosphamide; Genetic Diseases, X-Linked; Hodgkin Disease; Humans; Kynurenic Acid; Ky

1964
RETINOPATHY OF OBSCURE (TOXIC?) ORIGIN IN HODGKIN'S DISEASE.
    American journal of ophthalmology, 1964, Volume: 57

    Topics: Anemia; Chloramphenicol; Chlorpromazine; Eye; Glutethimide; Herpes Zoster; Herpes Zoster Ophthalmicu

1964
[ANTINEOPLASTIC PREPARATIONS USED AS A MEANS OF PROTECTION AGAINST THE FREE ELEMENTS IN THE BLOOD AND CONTAMINATION BY NEOPLASTIC CELLS, IN OPERATIVE INTERVENTIONS].
    Minerva medica, 1963, Nov-03, Volume: 54

    Topics: Antineoplastic Agents; Carcinoma; Cyclophosphamide; Hodgkin Disease; Humans; Mechlorethamine; Melano

1963
COMPRESSION OF THE SPINAL CORD IN PATIENTS WITH MALIGNANT LYMPHOMA.
    Radiology, 1964, Volume: 82

    Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Mechloret

1964
THE EFFECT OF NITROGEN MUSTARD ON THE DISTRIBUTION OF RADIOIRON IN MAN.
    Cancer, 1964, Volume: 17

    Topics: Bone Marrow; Breast Neoplasms; Erythropoiesis; Hodgkin Disease; Humans; Iron; Iron Isotopes; Liver;

1964
[THERAPEUTIC RESULTS IN MALIGNANT GRANULOMA].
    Pediatria polska, 1964, Volume: 39

    Topics: Child; Hodgkin Disease; Humans; Infant; Mechlorethamine; Neoplasms

1964
[DATA ON THE MECHANISM OF ACTION OF DEGRANOL].
    Magyar onkologia, 1964, Volume: 8

    Topics: Breast Neoplasms; Erythrocytes; Female; Hodgkin Disease; Humans; Mannomustine; Mechlorethamine; Phot

1964
[HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
    Nagasaki Igakkai zasshi = Nagasaki medical journal, 1964, Volume: 39

    Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Dactinomycin; Geriatrics; Hodgkin Dise

1964
HODGKIN'S DISEASE OF THE LUNG WITH CAVITATION.
    The American review of respiratory disease, 1964, Volume: 89

    Topics: Antineoplastic Agents; Chlorambucil; Diagnosis, Differential; Hodgkin Disease; Lung Neoplasms; Mechl

1964
[HODGKIN'S DISEASE; LACRIMAL LOCALIZATION].
    Archives d'ophtalmologie et revue generale d'ophtalmologie, 1964, Volume: 24

    Topics: Hodgkin Disease; Lacrimal Apparatus; Mechlorethamine; Neoplasms; Pathology; Surgical Procedures, Ope

1964
PATHOGENESIS OF AMYLOIDOSIS.
    Acta pathologica et microbiologica Scandinavica, 1964, Volume: 61

    Topics: Adenocarcinoma; Adrenocorticotropic Hormone; Agammaglobulinemia; Amyloid; Amyloidosis; Arthritis; Ar

1964
LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg

1964
ABDOMINAL PERFUSION FOR CANCER CHEMOTHERAPY USING HYPOTHERMIA AND HYPERTHERMIA.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Abdomen; Antineoplastic Agents; Chemotherapy, Cancer, Regional Perfusion; Colonic Neoplasms; Cycloph

1964
LYMPHANGIOGRAPHY FOR MALIGNANT DISEASES IN CHILDREN.
    JAMA, 1964, May-11, Volume: 188

    Topics: Adolescent; Child; Hodgkin Disease; Humans; Infant; Leukemia; Leukemia, Myeloid; Lymph Nodes; Lympha

1964
PNEUMOCYSTIS CARINII PNEUMONIA. CASE STUDIES WITH ELECTRON MICROSCOPY.
    American journal of clinical pathology, 1964, Volume: 41

    Topics: Chlorambucil; Chloramphenicol; Cytomegalovirus Infections; Diagnosis, Differential; Digoxin; Electro

1964
NONSURGICAL TREATMENT OF PULMONARY CANCER.
    Modern treatment, 1964, Volume: 1

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Adrenal Cortex Hormones; Alkylating Agents; Antineoplastic Agen

1964
ENDOREDUPLICATION IN LEUCOCYTE CHROMOSOMES. PRELIMINARY REPORT OF ITS RELATION TO CANCER AND WHOLE-BODY IRRADIATION.
    Lancet (London, England), 1964, Sep-05, Volume: 2, Issue:7358

    Topics: Breast Neoplasms; Chromosome Aberrations; Chromosome Disorders; Chromosomes; Cobalt Isotopes; Coloni

1964
THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
    Applied therapeutics, 1964, Volume: 6

    Topics: Adrenal Cortex Hormones; Busulfan; Chlorambucil; Cortisone; Cyclophosphamide; Hodgkin Disease; Human

1964
NECROTIZING TOXOPLASMIC ENCEPHALITIS AND HERPETIC PNEUMONIA COMPLICATING TREATED HODGKIN'S DISEASE. REPORT OF A CASE.
    The New England journal of medicine, 1965, Jan-07, Volume: 272

    Topics: Alkylating Agents; Antineoplastic Agents; Cyclophosphamide; Encephalitis; Herpesviridae Infections;

1965
CYTOTOXIC DRUGS IN BRONCHIAL CARCINOMA.
    Lancet (London, England), 1964, Dec-19, Volume: 2, Issue:7373

    Topics: Antineoplastic Agents; Bronchial Neoplasms; Carcinoma, Bronchogenic; Drug Therapy; Hodgkin Disease;

1964
[CONTRIBUTION TO THE CYTOSTATIC TREATMENT OF LYMPHOGRANULOMATOSIS].
    Zeitschrift fur arztliche Fortbildung, 1964, May-01, Volume: 58

    Topics: Cytostatic Agents; Hodgkin Disease; Humans; Mannomustine; Mechlorethamine; Quinine; Radiography; Sar

1964
ASSOCIATION OF HERPES ZOSTER WITH LEUKEMIA AND LYMPHOMA IN CHILDREN.
    Clinical pediatrics, 1965, Volume: 4

    Topics: Adrenal Cortex Hormones; Alkylating Agents; Child; Cyclophosphamide; Drug Therapy; Herpes Zoster; Ho

1965
LONG-TERM RESULTS OF X-RAY TREATMENT IN MALIGNANT DISEASE OF THE LYMPHO-RETICULAR SYSTEM.
    Acta - Unio Internationalis Contra Cancrum, 1964, Volume: 20

    Topics: Classification; England; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Non-Hodg

1964
RADIATION AND DRUG INDUCED HYALINIZATION OF THE STOMACH.
    Archives of pathology, 1965, Volume: 79

    Topics: Antineoplastic Agents; Child; Chlorambucil; Cyclophosphamide; Drug Therapy; Ganglioneuroma; Gastroin

1965
ACTIVE TUBERCULOSIS IN LEUKEMIA. MALIGNANT LYMPHOMA AND MYELOFIBROSIS.
    Archives of pathology, 1965, Volume: 79

    Topics: Alkylating Agents; Aminopterin; Busulfan; Hodgkin Disease; Humans; Leukemia; Leukemia, Lymphoid; Leu

1965
LOW BACK PAIN: AN UNUSUAL CAUSE OF A COMMON COMPLAINT.
    JAMA, 1965, Jun-21, Volume: 192

    Topics: Back Pain; Drug Therapy; Hodgkin Disease; Humans; Low Back Pain; Lumbosacral Region; Mechlorethamine

1965
[Histological picture in treated cases of malignant lymphogranuloma].
    Archivio italiano di anatomia e istologia patologica, 1954, Volume: 27, Issue:6

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1954
[Symptomatic psychosis in nitrogen-mustard treatment of a lymphogranulomatosis].
    Der Nervenarzt, 1955, Feb-20, Volume: 26, Issue:2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Mental Disorders; Mustard Plant; Nitrogen; Nitrogen Mustar

1955
[Combination of microdosage of chloralkylamines with roentgen irradiation in the treatment of hemoblastoses and hemoblastomas].
    Casopis lekaru ceskych, 1952, Nov-14, Volume: 91, Issue:45-46

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphatic Vessels; Mechlorethamine

1952
About Combined N-Lost Urethane Therapy for Chronic Myeloses.
    Wiener klinische Wochenschrift, 1955, May-20, Volume: 67, Issue:20

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Urethane

1955
Hodgkin's disease treated with nitrogen mustard and radiation, complicated by osteomyelitis of the mandible.
    Oral surgery, oral medicine, and oral pathology, 1960, Volume: 13

    Topics: Disease; Hodgkin Disease; Mandible; Mandibular Diseases; Mechlorethamine; Nitrogen Mustard Compounds

1960
Treatment of malignant lymphomas and lymphadenoses with leukeran.
    Neoplasma, 1959, Volume: 6

    Topics: Chlorambucil; Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Mechlorethamine; Nitrogen Mus

1959
[A severe case of lymphographylomatosis successfully treated with dopan].
    Problemy gematologii i perelivaniia krovi, 1959, Volume: 4

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Uracil; Uracil Mustard

1959
[The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
    Prensa medica argentina, 1959, Oct-09, Volume: 46

    Topics: Hodgkin Disease; Humans; Lymphoma; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma,

1959
New nitrogen mustards in the management of Hodgkin's disease.
    American journal of pharmacy and the sciences supporting public health, 1960, Volume: 132

    Topics: Disease Management; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1960
Clinical evaluation of the effect of degranol.
    Neoplasma, 1959, Volume: 6

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphocytes; Mannitol; Mannomustine; Mechlorethamine;

1959
[Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
    La Semana medica, 1961, Jul-31, Volume: 119

    Topics: Chlorambucil; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodg

1961
[Evaluation of immediate results in the treatment of lymphogranulomatosis with dopan and degranol].
    Voprosy onkologii, 1962, Volume: 8(4)

    Topics: Antineoplastic Agents; Hodgkin Disease; Mannomustine; Mechlorethamine; Nitrogen Mustard Compounds; U

1962
Management of human leukemias and Hodgkin's disease with Dopan (uracil mustard).
    Journal of the South Carolina Medical Association, 1962, Volume: 58

    Topics: Disease Management; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds;

1962
Revascularization for acute coronary occlusion in a young woman following radiation.
    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2003, Volume: 9, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Coronar

2003
[Second malignancies following Hodgkin's disease treatment in Tunisia. Retrospective study of 26 cases observed at the institute Salah-Azaïz].
    Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique, 2003, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do

2003
Impact of chest wall and lung invasion on outcome of stage I-II Hodgkin's lymphoma after combined modality therapy.
    International journal of radiation oncology, biology, physics, 2003, Dec-01, Volume: 57, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2003
Decreasing the number of MOPP courses reduces gonadal damage in survivors of childhood Hodgkin disease.
    Pediatric blood & cancer, 2004, Volume: 42, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

2004
Nitrogen mustards in the treatment of neoplastic disease.
    Advances in internal medicine, 1950, Volume: 4

    Topics: Hodgkin Disease; Leukemia; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Mycosis

1950
Hodgkin's disease.
    The American journal of roentgenology and radium therapy, 1950, Volume: 64, Issue:6

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1950
[Case of very severe lymphogranuloma treated with nitrogen mustard].
    Atti della Accademia dei fisiocritici in Siena. Sezione medico-fisica, 1950, Volume: 18, Issue:2

    Topics: Hodgkin Disease; Mechlorethamine

1950
[Efficacy and limitations of karyoklastic therapy of leukosis, lymphogranulomatosis, and malignant tumors in childhood].
    Kinderarztliche Praxis, 1950, Volume: 18

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoidosis; Uret

1950
[Nitrogen mustard therapy of lymphogranulomatosis].
    Medizinische Klinik, 1950, Sep-15, Volume: 45, Issue:37

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis

1950
[Nitrogen mustard therapy of malignant tumors].
    Das Deutsche Gesundheitswesen, 1950, Nov-30, Volume: 5, Issue:48

    Topics: Carcinoma; Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds

1950
The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
    Journal of the National Cancer Institute, 1950, Volume: 11, Issue:2

    Topics: Amines; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Phosph

1950
Trial of beta-naphthyl-di-2-chloroethylamine in leukaemia, Hodgkin's disease, and allied disorders.
    Lancet (London, England), 1951, Jan-20, Volume: 1, Issue:6647

    Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Treatment of Hodgkin's disease by deep radiotherapy and nitrogen mustard].
    Journal de radiologie, d'electrologie & archives d'electricite medicale, 1950, Volume: 31, Issue:7-8

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1950
[Modern means in the diagnosis and therapy of Hodgkin's disease].
    Gazette medicale de France, 1951, Volume: 58, Issue:3

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radiotherapy

1951
[Therapy of malignant lymphogranuloma of Hodgkin; personal contribution on the effect of the methyl and naphtyl derivatives of nitrogen mustard].
    Gazzetta medica italiana, 1951, Volume: 110, Issue:2

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Chloronaphthylamine in the treatment of malignant lymphogranuloma and chronic leukemia].
    Haematologica, 1950, Volume: 34, Issue:10

    Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1950
[Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
    Rivista di patologia e clinica, 1951, Volume: 6, Issue:1

    Topics: Amines; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas

1951
Nitrogen mustard and radium therapy in Hodgkin's disease. [Hebrew text; English summary].
    Harefuah, 1951, Apr-15, Volume: 40, Issue:7-8

    Topics: Ethnicity; Hodgkin Disease; Humans; Language; Mechlorethamine; Nitrogen Mustard Compounds; Radium

1951
[Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
    Arquivos de clinica, 1951, Volume: 12, Issue:3

    Topics: Hodgkin Disease; Leukemia; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compou

1951
Trisethylene-imino-s-triazine (triethylene melamine or TEM) in the treatment of neoplastic diseases.
    California medicine, 1951, Volume: 75, Issue:1

    Topics: Animals; Hodgkin Disease; Humans; Lung Neoplasms; Lymphoma; Mechlorethamine; Mice; Neoplasms; Nitrog

1951
[Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
    Accademia medica, 1950, Volume: 65, Issue:12

    Topics: Cystitis; Hodgkin Disease; Lymphogranuloma Venereum; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplas

1950
The principles of radiation therapy of lymphoblastoma.
    The Journal of the Egyptian Medical Association, 1951, Volume: 34, Issue:5

    Topics: Hodgkin Disease; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Nitrogen Mustard Compounds; Sarco

1951
Clinical experience with nitrogen mustard in Hodgkin's disease.
    The British journal of radiology, 1951, Volume: 24, Issue:285

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
The treatment of Hodgkin's disease.
    The Practitioner, 1951, Volume: 167, Issue:1001

    Topics: Arsenic; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Radioisotopes

1951
A quantitative evaluation of the contribution of nitrogen mustard to the therapeutic management of Hodgkin's disease.
    Annals of internal medicine, 1951, Volume: 35, Issue:6

    Topics: Disease Management; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    Acta radiologica, 1951, Volume: 36, Issue:6

    Topics: Hodgkin Disease; Leukemia; Leukemia, Lymphoid; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Nit

1951
[Nitrogen mustard therapy of malignant granuloma, leukemia and neoplasms].
    Haematologica, 1951, Volume: 35, Issue:10

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds

1951
[Treatment of malignant lymphogranuloma and chronic leukemia with chloroethylnaphthylamine].
    Radioterapia, radiobiologia e fisica medica, 1951, Volume: 7

    Topics: Chronic Disease; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Pathologic anatomy and physiology of Hodgkin's disease treated with nitrogen mustard].
    Zentralblatt fur allgemeine Pathologie u. pathologische Anatomie, 1951, Nov-22, Volume: 88, Issue:1-2

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Treatment of Hodgkin's disease with naphthyl amine compounds].
    Athena; rassegna mensile di biologia, clinica e terapia, 1952, Volume: 18, Issue:2

    Topics: Amines; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1952
Toxic psychosis following nitrogen mustard therapy.
    The Journal of nervous and mental disease, 1952, Volume: 115, Issue:4

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds; Psychotic Disorders

1952
[Therapeutic results with nitrogen mustards].
    Klinische Medizin; osterreichische Zeitschrift fur wissenschaftliche und praktische Medizin, 1951, Nov-01, Volume: 6, Issue:11

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Immunity, blood proteins and leucocyte picture in malignant granuloma; effect of nitrogen mustards therapy].
    Il Policlinico. Sezione medica, 1952, Volume: 59, Issue:1

    Topics: Blood Proteins; Hodgkin Disease; Leukocytes; Mechlorethamine; Nitrogen Mustard Compounds

1952
[Chloronaphthyne in the treatment of malignant granuloma; advantage of rectal therapy].
    Rivista di patologia e clinica, 1951, Volume: 6, Issue:8

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1951
[Nitrogen mustards in the treatment of children].
    L' Ospedale maggiore, 1952, Volume: 40, Issue:1

    Topics: Disease; Hodgkin Disease; Lymph Nodes; Lymphatic Diseases; Mechlorethamine; Nitrogen Mustard Compoun

1952
Therapeutic options in patients with lymphoma and severe liver dysfunction.
    Mayo Clinic proceedings, 2004, Volume: 79, Issue:2

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Antibodies, Monoclona

2004
Pediatric Hodgkin's disease.
    The Journal of the Kentucky Medical Association, 2004, Volume: 102, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

2004
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
    International journal of radiation oncology, biology, physics, 2004, Jul-01, Volume: 59, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera

2004
[Therapy with nitrogen mustard compounds in some cases of malignant lymphogranulomatosis].
    Minerva medica, 1949, Sep-08, Volume: 40, Issue:44 Pt 2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1949
[Cases of malignant lymphogranuloma treated with methilbis-beta-chloroethyl-amine chlorhydrate].
    Minerva medica, 1949, Sep-08, Volume: 40, Issue:44 Pt 2

    Topics: Amines; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1949
[A case of lymphogranuloma treated with a nitrogen mustard compound (chloramine)].
    Minerva medica, 1949, Sep-08, Volume: 40, Issue:44 Pt 2

    Topics: Chloramines; Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1949
[Immediate results of chlorethylamine therapy in a case of Hodgkin's disease].
    Revista clinica espanola, 1949, Dec-31, Volume: 35, Issue:6

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1949
[Action of chloramine in two cases of leukemic myelosis and in a case of malignant lymphogranuloma].
    Minerva medica, 1949, Sep-08, Volume: 40, Issue:44 Pt 2

    Topics: Chloramines; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds

1949
[Three cases of Hodgkin lymphogranuloma, treated with azoto-iprite].
    Minerva medica, 1949, Sep-08, Volume: 40, Issue:44 Pt 2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1949
A trial of beta-naphthyldi-2-chloroethylamine in leukemia, Hodgkin's disease, and allied diseases.
    Lancet (London, England), 1950, May-13, Volume: 1, Issue:6611

    Topics: Arylsulfonates; Ethylamines; Hodgkin Disease; Leukemia; Mechlorethamine; Nitrogen Mustard Compounds;

1950
[Nitrogen mustard therapy in several cases of anaplasia].
    Rassegna internazionale di clinica e terapia, 1950, Mar-31, Volume: 30, Issue:6

    Topics: Anaplasia; Hodgkin Disease; Liver; Mechlorethamine; Mediastinum; Neoplasms; Nitrogen Mustard Compoun

1950
[Critical observations on the treatment of lymphogranulomatosis with nitrogen mustards].
    Arztliche Wochenschrift, 1950, Apr-15, Volume: 5, Issue:13-14

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis

1950
The role of nitrogen mustard therapy in the treatment of lymphomas and leukemias.
    The American journal of medicine, 1950, Volume: 8, Issue:6

    Topics: Hodgkin Disease; Leukemia; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds; Sarcoma

1950
Haematological results of nitrogen mustard therapy in case of abnormal Hodgkin's disease.
    Canadian journal of medical technology, 1950, Volume: 12, Issue:2

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Nitrogen Mustard Compounds

1950
[Deep radiotherapy associated with nitrogen mustard in the treatment of malignant lymphogranulomatosis].
    Journal de radiologie, d'electrologie & archives d'electricite medicale, 1950, Volume: 31, Issue:1-2

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; X-Ray Therapy

1950
Treatment of Hodgkin's disease with roentgen irradiation and nitrogen mustards.
    The American journal of roentgenology and radium therapy, 1950, Volume: 64, Issue:1

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1950
Nitrogen mustards in the treatment of malignant disease.
    Texas state journal of medicine, 1950, Volume: 46, Issue:7

    Topics: Hodgkin Disease; Mechlorethamine; Neoplasms; Nitrogen Mustard Compounds

1950
[Roentgen resistant lymphogranulomatosis treated with trichlorotriethylamine hydrochloride, with special reference to following modifications in the hemopoietic system].
    Medizinische Monatsschrift, 1950, Volume: 4, Issue:7

    Topics: Hematopoietic System; Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds; Sarcoidosis

1950
[Over 30-year experience of Polish Pediatric Leukemia/Lymphoma Study Group for treatment of Hodgkin's disease in children and adolescents: improvement curability and decrease of serious complications].
    Przeglad lekarski, 2004, Volume: 61 Suppl 2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child

2004
Acquisition of a Ph chromosome with minor BCR/ABL fusion in treatment-related myelodysplastic syndrome with chromosome 7 abnormalities in a patient treated for Hodgkin disease.
    Cancer genetics and cytogenetics, 2005, Volume: 159, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chromosome Aberrations; Chromosome

2005
Survival in Hodgkin's disease patients--report of 25 years of experience at the Milan Cancer Institute.
    European journal of cancer (Oxford, England : 1990), 2005, Volume: 41, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Dacarbazine; Disea

2005
Secondary transitional cell carcinoma and nitrogen mustard treatment.
    Urology, 2005, Volume: 65, Issue:6

    Topics: Adolescent; Antineoplastic Agents, Alkylating; Carcinoma, Transitional Cell; Hodgkin Disease; Humans

2005
Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
    International journal of radiation oncology, biology, physics, 2005, Nov-15, Volume: 63, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; H

2005
Long-term follow-up of salvage radiotherapy in Hodgkin's lymphoma after chemotherapy failure.
    International journal of radiation oncology, biology, physics, 2005, Dec-01, Volume: 63, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr

2005
Gemcitabine-induced radiation recall dermatitis in a patient with resistant Hodgkin lymphoma.
    American journal of hematology, 2005, Volume: 80, Issue:1

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidin

2005
Comparison of MOPP/MOPP +/- RT vs. MOPp/ABVD +/- RT in poor prognosis Hodgkin's disease. Long-term results.
    Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1989
Benign pleural schwannoma secondary to radiotherapy for Hodgkin disease.
    American journal of clinical oncology, 2005, Volume: 28, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Basal Cell; Combin

2005
[Clinical analysis of reactive thymic hyperplasia following chemotherapy for childhood malignant lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

2006
Hodgkin's lymphoma in adolescents.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Jun-01, Volume: 24, Issue:16

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; British Columbia; Chem

2006
[Comparison of preliminary results of involved-field with extended field radiotherapy combined with chemotherapy for early stage Hodgkin's disease].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2006, Volume: 28, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

2006
[Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Ai zheng = Aizheng = Chinese journal of cancer, 2006, Volume: 25, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Pr

2006
Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2006, Volume: 12, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

2006
Survival and late effects in children with Hodgkin's lymphoma treated with MOPP/ABV and low-dose, extended-field irradiation.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Dec-20, Volume: 24, Issue:36

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

2006
Malignant fibrous histiocytoma following radiation therapy and chemotherapy for Hodgkin's lymphoma.
    International journal of clinical oncology, 2007, Volume: 12, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Chemotherapy, Adju

2007
[Our experiences in treating patients with Hodgkin disease in the last decade].
    Orvosi hetilap, 2007, Apr-15, Volume: 148, Issue:15

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Ad

2007
Hodgkin lymphoma among patients infected with HIV in post-HAART era.
    Clinical lymphoma & myeloma, 2007, Volume: 7, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiretroviral Therapy, Highly Active; Bleomy

2007
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2007, Sep-01, Volume: 25, Issue:25

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease Progression; Doxorubicin;

2007
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:10

    Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemot

2007
Treatment-related risk factors for premature menopause following Hodgkin lymphoma.
    Blood, 2008, Jan-01, Volume: 111, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

2008
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
    Human reproduction (Oxford, England), 2007, Volume: 22, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Do

2007
[Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
    Ai zheng = Aizheng = Chinese journal of cancer, 2007, Volume: 26, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co

2007
Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
    The American journal of the medical sciences, 1949, Volume: 217, Issue:2

    Topics: Amines; Ethylamines; Hodgkin Disease; Humans; Leukemia; Lung Diseases; Lung Neoplasms; Lymphoma; Lym

1949
The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
    Annals of internal medicine, 1949, Volume: 30, Issue:2

    Topics: Ethylamines; Hodgkin Disease; Lymphoma; Lymphoma, Non-Hodgkin; Mechlorethamine; Neoplasms; Sarcoma

1949
Histopathologic observations in cases of Hodgkin's disease treated with nitrogen mustard.
    The American journal of pathology, 1949, Volume: 25, Issue:2

    Topics: Ethylamines; Hodgkin Disease; Mechlorethamine

1949
Nitrogen mustard therapy in Hodgkin's disease; analysis of 50 consecutive cases.
    Blood, 1949, Volume: 4, Issue:4

    Topics: Hodgkin Disease; Mechlorethamine

1949
The clinical effect of nitrogen mustard on Hodgkin's disease.
    American journal of clinical pathology, 1949, Volume: 19, Issue:4

    Topics: Ethylamines; Hodgkin Disease; Mechlorethamine

1949
Nitrogen mustards; Treatment of hodgkin's disease and related conditions.
    Belgisch tijdschrift voor geneeskunde, 1948, Oct-01, Volume: 4, Issue:19

    Topics: Hodgkin Disease; Humans; Mechlorethamine

1948
Methyl-bis (beta-chloroethyl)amine in large doses in the treatment of neoplastic diseases.
    California medicine, 1949, Volume: 71, Issue:2

    Topics: Amines; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasms; Nitrogen Mus

1949
Nitrogen mustard therapy with special reference to Hodgkin's disease.
    British medical journal, 1949, Sep-17, Volume: 2, Issue:4628

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1949
Nitrogen mustard treatment of Hodgkin's disease.
    Virginia medical monthly, 1949, Volume: 76, Issue:10

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1949
Treatment of lymphogranuloma malignum and related conditions with methyl bis-chloroethylamine (nitrogen mustard).
    Nederlands tijdschrift voor geneeskunde, 1949, Aug-06, Volume: 93, Issue:32

    Topics: Hodgkin Disease; Mechlorethamine; Nitrogen Mustard Compounds

1949
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease.
    The New England journal of medicine, 2008, Feb-14, Volume: 358, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

2008
Systemic chemotherapy for cancer: from weapon to treatment.
    The Lancet. Oncology, 2008, Volume: 9, Issue:3

    Topics: Antineoplastic Agents, Alkylating; Chemical Warfare Agents; Female; History, 20th Century; Hodgkin D

2008
Hypersensitivity to nitrogen mustards in the form of erythema multiforme. A unique adverse reaction.
    Archives of internal medicine, 1967, Volume: 120, Issue:4

    Topics: Chlorambucil; Drug Hypersensitivity; Erythema Multiforme; Hodgkin Disease; Humans; Male; Mechloretha

1967
Action of elatericin A on human leukemic and normal lymphocytes.
    Journal of the National Cancer Institute, 1967, Volume: 38, Issue:1

    Topics: Aminopterin; Animals; Antineoplastic Agents; Azirines; Cathartics; Cell Nucleus; Chlorambucil; Cyclo

1967
[Treatment of Hodgkin's disease by polychemotherapy combining nitrogen mustard, vincristine, methylhydrazine and prednisone].
    La Presse medicale, 1967, Dec-09, Volume: 75, Issue:52

    Topics: Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vincristine

1967
Gonadal damage in Hodgkin's disease from cancer chemotherapeutic regimens.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1984, Volume: 7

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Castration; Dacarbazin

1984
[Acute non-lymphatic leukemia after treatment of Hodgkin's lymphoma with chemotherapy and radiotherapy].
    Revista medica de Chile, 1984, Volume: 112, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabine; Dacarbazine; Daunorubi

1984
Adriamycin, bleomycin, DIC, CCNU, and prednisone (ABDIC) chemotherapy in MOPP-resistant Hodgkin's disease.
    Cancer, 1980, Dec-01, Volume: 46, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Dacarbazine; Doxorubicin; Drug Administra

1980
Chemotherapy of Hodgkin's disease.
    Journal of the Royal College of Physicians of London, 1980, Volume: 14, Issue:1

    Topics: Antineoplastic Agents; Bleomycin; Chlorambucil; Drug Administration Schedule; Drug Therapy, Combinat

1980
Prognosis of Hodgkin's disease: patients who fail to remit or who relapse after combination chemotherapy.
    Clinical oncology, 1980, Volume: 6, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Child, Preschool; Drug Therapy, Co

1980
The treatment of advanced hodgkin's disease.
    Blut, 1981, Volume: 43, Issue:2

    Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Male; Mechl

1981
Treatment failures and severe complications in children with Hodgkin's disease.
    Folia haematologica (Leipzig, Germany : 1928), 1981, Volume: 108, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin

1981
Salvage chemotherapy with ABVD in MOPP-resistant Hodgkin's disease.
    Annals of internal medicine, 1982, Volume: 96, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleo

1982
Absence of treatment-induced second neoplasms after ABVD in Hodgkin's disease.
    Blood, 1982, Volume: 59, Issue:3

    Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Bleomycin; Child; Child, Preschool; Daca

1982
[Lymphomas. Treatment of malignant lymphomas. Current observations and future prospects].
    Revue medicale de Bruxelles, 1982, Volume: 3, Issue:4

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide;

1982
Alternating drug combinations for advanced Hodgkin's disease.
    The New England journal of medicine, 1982, Sep-09, Volume: 307, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor

1982
Lasting Hb F reactivation and Hb A2 reduction induced by the treatment of Hodgkin's disease in a woman heterozygous for beta-thalassemia and the Swiss type of the heterocellular hereditary persistence of Hb F.
    Acta haematologica, 1982, Volume: 67, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fetal Hemoglobin; Globins; Hemoglobin

1982
Twelve years of experience with cytotoxic therapy in malignant tumors of the neck and head.
    Archives of oto-rhino-laryngology, 1982, Volume: 234, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide;

1982
Factors affecting relapse following chemotherapy for Hodgkin's disease.
    Clinical radiology, 1982, Volume: 33, Issue:6

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dru

1982
Hodgkin's disease in renal transplant recipients.
    Cancer, 1983, Jan-15, Volume: 51, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Drug Therapy, Combination; Hodgkin Diseas

1983
Treatment of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
    European journal of cancer & clinical oncology, 1982, Volume: 18, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin;

1982
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV).
    Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; H

1983
Treatment of 49 unrandomized patients with advanced Hodgkin's disease.
    Tumori, 1983, Oct-31, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1983
MOPP treatment of resistant Hodgkin's disease following ABVD failure.
    Tumori, 1983, Oct-31, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Do

1983
Bone and soft tissue sarcomas in the follow-up of Hodgkin's disease.
    Tumori, 1983, Oct-31, Volume: 69, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Child,

1983
Adriamycin combinations as salvage therapy in advanced MOPP-resistant Hodgkin's disease.
    Australian and New Zealand journal of medicine, 1983, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Resi

1983
Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Res

1983
Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
    Annals of internal medicine, 1984, Volume: 101, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1984
[Hodgkin's disease: analysis of a reduction of chemotherapy].
    Presse medicale (Paris, France : 1983), 1983, Sep-24, Volume: 12, Issue:33

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th

1983
Subacute sensory neuropathy with remission: an association with lymphoma.
    Journal of neurology, neurosurgery, and psychiatry, 1982, Volume: 45, Issue:1

    Topics: Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Hypesthesia; Mechlorethamine; Middle Age

1982
Burkitt cell leukemia following treatment of Hodgkin's disease: report of a case and review of the literature.
    American journal of hematology, 1984, Volume: 17, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Hodgkin Disease; Humans; Leuke

1984
Landmark article Sept. 21, 1946: Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    JAMA, 1984, May-04, Volume: 251, Issue:17

    Topics: History, 20th Century; Hodgkin Disease; Humans; Leukemia; Lymphoma, Non-Hodgkin; Mechlorethamine; Ne

1984
The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease.
    Cancer, 1983, Sep-15, Volume: 52, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chorionic

1983
Ovarian function in young women in long-term remission after treatment for Hodgkin's disease stage I or II.
    Scandinavian journal of haematology, 1984, Volume: 32, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Estrad

1984
Acute graft-versus-host disease resulting from normal donor blood transfusions.
    Acta haematologica, 1984, Volume: 71, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Graft vs Host Disease; Histocompatibi

1984
Hodgkin's disease in children. A ten-year experience in South Africa.
    Cancer, 1984, Jan-15, Volume: 53, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Follow-

1984
[Treatment of recurrences of lymphogranulomatosis].
    Meditsinskaia radiologiia, 1984, Volume: 29, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1984
A decision-analysis methodology for consideration of morbidity factors in clinical decision-making.
    American journal of clinical oncology, 1984, Volume: 7, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Decision Making; Hodgkin Disease; Huma

1984
Comparison of treatments for symptomatic Hodgkin's lymphoma employing decision analysis.
    American journal of clinical oncology, 1984, Volume: 7, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Decision Making; Health Service

1984
[Aseptic necrosis of the femur head as a complication of intensive cytostatic, glucocorticoid and radiation therapy of lymphogranulomatosis].
    Voprosy onkologii, 1984, Volume: 30, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Femur Head Necrosis; Gluc

1984
[Various disputable problems of ambulatory treatment of tumors of the blood system].
    Terapevticheskii arkhiv, 1984, Volume: 56, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Doxorubicin; Hodgkin

1984
Antibody-dependent cellular cytotoxicity in some lymphoreticular diseases.
    Tumori, 1984, Feb-29, Volume: 70, Issue:1

    Topics: Antibody-Dependent Cell Cytotoxicity; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphami

1984
Autoimmune neutropenia, hemolytic anemia, and reticulocytopenia in Hodgkin's disease.
    Annals of internal medicine, 1984, Volume: 100, Issue:5

    Topics: Adult; Agranulocytosis; Anemia, Hemolytic, Autoimmune; Antineoplastic Combined Chemotherapy Protocol

1984
Hodgkin's disease in children. Results of therapy in a mixed group of 178 clinical and pathologically staged patients over 13 years.
    Cancer, 1984, Jul-15, Volume: 54, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1984
Recovery of spermatogenesis after treatment for Hodgkin's disease: limiting dose of MOPP chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined M

1984
Second malignant neoplasms complicating Hodgkin's disease: the National Cancer Institute experience.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine

1984
Composite lymphoma: a case report.
    Irish journal of medical science, 1984, Volume: 153, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma

1984
[CVP or C-MOPP combination chemotherapy in the treatment of advanced Hodgkin's disease and non-Hodgkin's lymphoma (intermediate grade of working formulation)].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1984, Volume: 25, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hum

1984
[Second tumor following Hodgkin's disease].
    Padiatrie und Padologie, 1984, Volume: 19, Issue:3

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child, Presc

1984
[Treatment of Hodgkin's disease including the staging laparotomy].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1984, Volume: 25, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1984
Non-Hodgkin lymphoma following Hodgkin's disease. A case report.
    Blut, 1984, Volume: 49, Issue:4

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Hodgkin Dis

1984
[Experience with the management of patients with therapy-resistant Hodgkin's disease].
    Orvosi hetilap, 1984, Nov-04, Volume: 125, Issue:45

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Comb

1984
The management of stage II supradiaphragmatic Hodgkin's disease at St. Bartholomew's Hospital. A retrospective review of 114 previously untreated patients over 14 years.
    Cancer, 1984, Dec-15, Volume: 54, Issue:12

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1984
Acute allergic reaction due to vincristine sulfate. A case report.
    Oncology, 1984, Volume: 41, Issue:6

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Drug Hyperse

1984
[Effect of splenectomy on the leukocyte count during the treatment of children with Hodgkin's disease].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1984, Sep-01, Volume: 37, Issue:17

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease

1984
Transient optic neuropathy secondary to MOPP chemotherapy in Hodgkin's disease: report of a case.
    Tumori, 1984, Dec-31, Volume: 70, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; Humans; Mechloretham

1984
MVPP chemotherapy combined with radiotherapy in the treatment of Hodgkin's disease in children: long-term results.
    The American journal of pediatric hematology/oncology, 1984,Winter, Volume: 6, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1984
Hodgkin's disease.
    Cancer treatment reviews, 1984, Volume: 11, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cell Line; Combined Modality Therapy; Drug Resistanc

1984
[Prognostic value of the results of short-term polychemotherapy by the MOPP program of Hodgkin's disease stages III and IV].
    Polskie Archiwum Medycyny Wewnetrznej, 1984, Volume: 72, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans;

1984
An evaluation of long-term survival and treatment complications in children with Hodgkin's disease.
    Cancer, 1983, Mar-01, Volume: 51, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy, Combination; Evalua

1983
[Chemotherapy of Hodgkin disease with modified MOPP].
    Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis, 1983, Feb-08, Volume: 72, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Dose-Res

1983
[Acute leukemias and solid tumors in the course of Hodgkin disease].
    Bulletin du cancer, 1983, Volume: 70, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protoco

1983
Diagnosis and management of Hodgkin's disease in the adult.
    Cancer, 1983, Jun-15, Volume: 51, Issue:12 Suppl

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho

1983
Simultaneous occurrence of mycosis fungoides and Hodgkin disease: clinical and histologic correlations in three cases with ultrastructural studies in two.
    American journal of hematology, 1983, Volume: 14, Issue:4

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph

1983
Stage I-II Hodgkin's disease: current therapeutic options and recommendations.
    Blood, 1983, Volume: 62, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine

1983
Menstrual cycle, pregnancies and offspring before and after MOPP therapy for Hodgkin's disease.
    Cancer, 1983, Aug-01, Volume: 52, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Thera

1983
Early response to chemotherapy as a prognostic factor in Hodgkin's disease.
    Cancer, 1983, Sep-01, Volume: 52, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho

1983
Second malignancy complicating Hodgkin's disease.
    Journal of the Canadian Association of Radiologists, 1983, Volume: 34, Issue:2

    Topics: Acute Disease; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cycloph

1983
[Recurrence in Hodgkin's disease: incidence, therapy and prognosis. (Experience with 134 patients)].
    Wiener klinische Wochenschrift, 1983, May-13, Volume: 95, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina

1983
[Peculiarities of the recurrence of lymphogranulomatosis in children following combined chemotherapy].
    Voprosy onkologii, 1983, Volume: 29, Issue:8

    Topics: Age Factors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophos

1983
Acute nonlymphocytic leukemia after treatment for Hodgkin's disease.
    The American journal of medicine, 1983, Volume: 75, Issue:3

    Topics: Acute Disease; Adult; Age Factors; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy

1983
Primary Hodgkin's disease of the lung. Case report and review of the literature.
    Blut, 1983, Volume: 47, Issue:4

    Topics: Adult; Alcohol Drinking; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lu

1983
Sequential non-cross-resistant chemotherapy regimens (MOPP and CAVmP) in Hodgkin's disease stage IIIB and IV.
    Cancer, 1983, Nov-01, Volume: 52, Issue:9

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1983
Osteonecrosis of the femoral head following treatment for Hodgkin's disease.
    Irish journal of medical science, 1983, Volume: 152, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Femur Head

1983
Prognostic significance of large mediastinal involvement in Hodgkin's disease.
    Scandinavian journal of haematology, 1983, Volume: 31, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1983
Hodgkin disease clinical stages I, II, and III (A, B): results of radiotherapy with or without chemotherapy.
    Journal of surgical oncology, 1983, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cesi

1983
Results of treatment of 18 children with Hodgkin disease with MOPP chemotherapy as the only treatment modality.
    Medical and pediatric oncology, 1983, Volume: 11, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Growth

1983
[Recurrences in lymphogranulomatosis].
    Terapevticheskii arkhiv, 1983, Volume: 55, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Fe

1983
[Myocardial infarct in a patient with Hodgkin's disease treated with cyclic polychemotherapy].
    Kardiologia polska, 1983, Volume: 26, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamin

1983
Treatment of early stage Hodgkin's disease with radiation therapy plus short-cycle (3 MOPP) adjuvant chemotherapy.
    Tumori, 1983, Oct-31, Volume: 69, Issue:5

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Evaluation S

1983
A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Dose-Response Relationship, Drug

1983
Chemotherapy-radiotherapy versus chemotherapy in Hodgkin's disease with bone marrow involvement. Retrospective analysis of 32 cases.
    Acta haematologica, 1981, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Child

1981
[Hodgkin's disease in children: long-term therapeutic results (author's transl)].
    Bulletin du cancer, 1981, Volume: 68, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin

1981
Acute erythroblastic leukemia terminating a very long-lasting (27 years) Hodgkin's disease.
    Acta haematologica, 1982, Volume: 67, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukemia, Er

1982
[Radiotherapy of lymphogranulomatosis].
    MMW, Munchener medizinische Wochenschrift, 1982, Sep-17, Volume: 124, Issue:37

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans;

1982
[Chemotherapy of Hodgkin disease].
    MMW, Munchener medizinische Wochenschrift, 1982, Sep-17, Volume: 124, Issue:37

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho

1982
Gonadal function in Hodgkin's disease: long-term follow-up of chemotherapy.
    British medical journal (Clinical research ed.), 1982, Dec-04, Volume: 285, Issue:6355

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Combined Chemotherapy Protocols; Child; Drug Therapy,

1982
[Clinical and hematological characteristics and MOPP tolerance of patients with Hodgkin's lymphoma in the bone marrow].
    Haematologica, 1982, Volume: 67, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Drug

1982
The effective use of combined modality therapy for the treatment of patients with Hodgkin's disease who relapsed following radiotherapy.
    American journal of clinical oncology, 1983, Volume: 6, Issue:3

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Recur

1983
Radiation as salvage therapy for patients with Hodgkin's disease relapsing after MOPP (mechlorethamine, vincristine, prednisone, and procarbazine) chemotherapy.
    Cancer treatment reports, 1983, Volume: 67, Issue:9

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr

1983
Pretreatment nausea in cancer chemotherapy: a conditioned response?
    Psychosomatic medicine, 1980, Volume: 42, Issue:1

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Conditioning, Psycholo

1980
Measurement of drug dosage intensity in MVPP therapy in Hodgkin's disease.
    British journal of clinical pharmacology, 1980, Volume: 9, Issue:5

    Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Body Surface Area; Bon

1980
Irradiation in the treatment of Hodgkin disease: a follow-up report.
    Radiology, 1981, Volume: 139, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co

1981
[Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
    Wiener klinische Wochenschrift, 1981, Feb-20, Volume: 93, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise

1981
[Combined therapy of lymphogranulomatosis].
    Problemy gematologii i perelivaniia krovi, 1981, Volume: 26, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Cyclophosphamide; Drug The

1981
Survival in Hodgkin's disease: the role of immunocompetence and other major risk factors.
    Blood, 1982, Volume: 59, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Female; Hodgkin Di

1982
Reasons for failure of MOPP to cure Hodgkin's disease: The importance of dose and schedule.
    American journal of clinical oncology, 1982, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relati

1982
[10 years of DeVita protocol].
    Deutsche medizinische Wochenschrift (1946), 1982, Jul-09, Volume: 107, Issue:27

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans;

1982
Microbicidal activity of peripheral blood monocytes from patients with Hodgkin's disease for Toxoplasma gondii.
    The Journal of infectious diseases, 1982, Volume: 146, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Chlorambucil; Hodgkin Disease; Huma

1982
[Hodgkin's disease in childhood: long term results].
    Archives francaises de pediatrie, 1982, Volume: 39, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Drug Therapy, C

1982
[Treatment of lymphogranulomatosis].
    Meditsinskaia radiologiia, 1982, Volume: 27, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Hodgkin Disease; Humans;

1982
[Pregnancies and offspring after MOPP therapy].
    La Nouvelle presse medicale, 1982, Dec-04, Volume: 11, Issue:49

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Fertility; Fetus; Hodgkin

1982
Hodgkin's disease and acute promyelocytic leukaemia. A case report.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1980, Sep-13, Volume: 58, Issue:11

    Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia, Myeloid, Acute; Male; Mechloret

1980
Hodgkin's disease; tracheoesophageal fistula during MOPP chemotherapy.
    New York state journal of medicine, 1981, Volume: 81, Issue:10

    Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mechloreth

1981
Erythroleukaemia following treatment of Hodgkin's disease.
    Clinical and laboratory haematology, 1982, Volume: 4, Issue:4

    Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combinati

1982
[Chemotherapy of malignant lymphoma].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1982, Volume: 9, Issue:11

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine;

1982
Persistent immunologic abnormalities in long-term survivors of advanced Hodgkin's disease.
    Annals of internal medicine, 1980, Volume: 92, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Erythrocytes; Hodgkin Disease; Humans

1980
[Drug therapy of Hodgkin's disease].
    Der Internist, 1981, Volume: 22, Issue:5

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Therapy, Combination; Ho

1981
The management of stage I--II Hodgkin's disease with irradiation alone or combined modality therapy: the Stanford experience.
    Blood, 1982, Volume: 59, Issue:3

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lymph No

1982
Long-term complications of MOPP chemotherapy in patients with Hodgkin's disease.
    Cancer treatment reports, 1982, Volume: 66, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female

1982
Gonadal function after combination chemotherapy for Hodgkin's disease in childhood.
    Archives of disease in childhood, 1982, Volume: 57, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgk

1982
Supradiaphragmatic Hodgkin's disease: is there a role for MOPP chemotherapy in patients with bulky mediastinal disease?
    International journal of radiation oncology, biology, physics, 1980, Volume: 6, Issue:7

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Mediastinal Neoplasms; Predniso

1980
[Possibilities of treatment of reduction in Hodgkin's disease. III. Can polychemotherapy when combined with radiotherapy of localised stages be reduced? (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1981, May-01, Volume: 106, Issue:18

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age

1981
Avascular necrosis of bone in Hodgkin's disease patients treated with combined modality therapy.
    Cancer, 1981, Jun-15, Volume: 47, Issue:12

    Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Diseas

1981
Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease.
    Blood, 1981, Volume: 58, Issue:4

    Topics: Adolescent; Adult; Contraceptives, Oral; Female; Hodgkin Disease; Humans; Mechlorethamine; Menstruat

1981
Long-term follow up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease.
    The American journal of medicine, 1981, Volume: 71, Issue:4

    Topics: Adolescent; Adult; Amenorrhea; Antineoplastic Agents; Female; Follow-Up Studies; Hodgkin Disease; Ho

1981
[The current state of curability of Hodgkin's disease].
    Schweizerische medizinische Wochenschrift, 1981, Sep-05, Volume: 111, Issue:36

    Topics: Chromosome Aberrations; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemia; Mechlorethamin

1981
Evaluation of the significance of prognostic factors in stage III Hodgkin's disease treated with MOPP and radiotherapy.
    Cancer, 1980, Mar-15, Volume: 45, Issue:6

    Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Hepati

1980
Lactic acidosis associated with Hodgkin's disease: response to chemotherapy.
    The New England journal of medicine, 1980, Jul-03, Volume: 303, Issue:1

    Topics: Acidosis; Adult; Dexamethasone; Hodgkin Disease; Humans; Lactates; Male; Mechlorethamine; Vincristin

1980
The cure of disseminated Hodgkin's disease: prospects and problems.
    Annals of internal medicine, 1980, Volume: 92, Issue:5

    Topics: Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combination; Hodgkin Disease; Hum

1980
Skin infiltration in Hodgkin's disease.
    Archives of dermatology, 1980, Volume: 116, Issue:9

    Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Procar

1980
Osteonecrosis in patients with Hodgkin disease following combination chemotherapy.
    Medical and pediatric oncology, 1980, Volume: 8, Issue:2

    Topics: Adult; Drug Therapy, Combination; Female; Femur Head Necrosis; Hodgkin Disease; Humans; Mechloretham

1980
[Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
    Annales de medecine interne, 1980, Volume: 131, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans

1980
Hodgkin's disease in South African children.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1981, Jan-31, Volume: 59, Issue:5

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Follo

1981
Diagnosis, staging, and treatment of the malignant lymphomas.
    Comprehensive therapy, 1980, Volume: 6, Issue:7

    Topics: Biopsy; Cyclophosphamide; Drug Combinations; Hodgkin Disease; Humans; Lymph Nodes; Lymphoma; Mechlor

1980
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
    Polskie Archiwum Medycyny Wewnetrznej, 1995, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Ep

1995
Lymphocytosis of large granular lymphocytes in patients with Hodgkin's disease.
    American journal of hematology, 1995, Volume: 50, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; CD3 Complex; Dacarbazine; Doxorubicin; Et

1995
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:10

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Tr

1993
Early-stage Hodgkin's disease: long-term results with radiotherapy alone or combined radiotherapy and chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Combin

1994
Analysis of long-term results and prognostic factors among 138 patients with advanced Hodgkin's disease treated with the alternating MOPP/ABVD chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Sedimentation; B

1994
Hodgkin's disease with a mediastinal mass greater than 10 cm: results of four different treatment approaches.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5 Suppl 2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1994
Results of CAV regimen (CCNU, melphalan, and VP-16) as third-line salvage therapy for Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1994, Volume: 5, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox

1994
Lymphocyte predominant Hodgkin's disease: a clinicopathologic comparative study of histologic and immunophenotypic subtypes.
    International journal of radiation oncology, biology, physics, 1995, Jan-15, Volume: 31, Issue:2

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; B-L

1995
Primary Hodgkin's disease of the bone.
    Medical and pediatric oncology, 1995, Volume: 24, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Neoplasms; Doxorubicin; Femal

1995
[Lung fibrosis after bleomycin therapy].
    Pneumonologia i alergologia polska, 1994, Volume: 62, Issue:9-10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Hodgkin Disease; Humans

1994
Spontaneous fracture of the outlet catheter of a totally implanted catheter system (Port-A-Cath).
    The International journal of artificial organs, 1994, Volume: 17, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Catheterization, Central Veno

1994
Autologous stem cell transplantation as adjuvant treatment vs no further therapy for poor-risk Hodgkin's disease in first complete remission after MOPP/ABVD.
    Leukemia & lymphoma, 1995, Volume: 15 Suppl 1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic

1995
Hybrid MOPP/ABVD and radiotherapy in advanced Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:2

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc

1995
Factor VIII inhibitor prior to and during secondary acute nonlymphocytic leukemia in a patient with cured Hodgkin's disease.
    Leukemia & lymphoma, 1995, Volume: 16, Issue:5-6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Autoantibodies; Blood Transfusion; Combined Modality

1995
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequ

1995
[Hodgkin disease and amyloidosis].
    Duodecim; laaketieteellinen aikakauskirja, 1994, Volume: 110, Issue:6

    Topics: Adult; Amyloidosis; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubi

1994
Body wars: effect of friendly fire (cancer therapy)
    Journal of the National Cancer Institute, 1995, May-17, Volume: 87, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Hodgkin

1995
[Analysis of prognostic factors of Hodgkin's disease with Cox model].
    Zhonghua nei ke za zhi, 1994, Volume: 33, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Co

1994
MOPP, ABVD, or both to treat Hodgkin's disease.
    The New England journal of medicine, 1993, Apr-08, Volume: 328, Issue:14

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1993
MOPP, ABVD, or both to treat Hodgkin's disease.
    The New England journal of medicine, 1993, Apr-08, Volume: 328, Issue:14

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxor

1993
C-MOPP/ABV yields good results in a public hospital population with Hodgkin disease in Brazil.
    Cancer, 1993, May-01, Volume: 71, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brazil; Cyclophosphami

1993
Hodgkin's disease associated with central pontine myelinolysis.
    Medical and pediatric oncology, 1993, Volume: 21, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Demyelinating Disease

1993
Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy.
    International journal of radiation oncology, biology, physics, 1993, Apr-02, Volume: 25, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1993
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1993
Wide-field radiation therapy with or without chemotherapy for patients with Hodgkin disease in relapse after initial combination chemotherapy.
    Cancer, 1993, Jul-01, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child, Preschool

1993
Pediatric stage IV Hodgkin disease. Long-term survival.
    Cancer, 1993, Jul-01, Volume: 72, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Ther

1993
Hodgkin's disease and non-Hodgkin's lymphoma in an HIV positive patient.
    Leukemia & lymphoma, 1993, Volume: 9, Issue:4-5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Dexametha

1993
Thymic hyperplasia in adults following chemotherapy for malignancy.
    Australian and New Zealand journal of medicine, 1993, Volume: 23, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin

1993
[Effectiveness of chemotherapy and radiotherapy in 60 cases of Hodgkin's lymphoma].
    Zhonghua nei ke za zhi, 1993, Volume: 32, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Ra

1993
Late relapses in Hodgkin's disease: outcome of patients relapsing more than twelve months after primary chemotherapy.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1993, Volume: 4, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female;

1993
[Breast cancer after treatment of Hodgkin's disease].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1995, Volume: 24, Issue:1

    Topics: Adenocarcinoma; Adult; Aftercare; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms;

1995
Peripheral T-cell non-Hodgkin's lymphoma following treatment of nodular lymphocyte predominance Hodgkin's disease.
    Archives of pathology & laboratory medicine, 1995, Volume: 119, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Lymphocytes; Lymphoma, B-Ce

1995
Pregnancy after autologous bone marrow transplantation for malignant lymphomas.
    Nouvelle revue francaise d'hematologie, 1994, Volume: 36, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cyclophosphamide; Cyt

1994
Meningioma-like cerebral relapse of Hodgkin's disease.
    Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fatal Outcome; Female; Ho

1994
Myelodysplastic syndrome after autologous transplant for lymphoma.
    Blood, 1994, Dec-01, Volume: 84, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hematopoietic Stem Cell Transplantation; Hodgkin Dis

1994
Curative radiotherapy is the best single treatment modality for the favorable early stage Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1994, Nov-15, Volume: 30, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease;

1994
Second malignant neoplasms in patients with Hodgkin's disease.
    Australian and New Zealand journal of medicine, 1994, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Combined Moda

1994
Second primary cancers in patients continuously disease-free from Hodgkin's disease: a protective role for the spleen?
    Blood, 1994, Aug-15, Volume: 84, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modal

1994
Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
    British journal of cancer, 1994, Volume: 70, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Density; Etoposide; Follicle Stimulating

1994
Comparative dosimetry of O6-methylguanine in humans and rodents treated with procarbazine.
    Carcinogenesis, 1994, Volume: 15, Issue:8

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; DNA; Guanine; Hodgkin Disease; Humans; Leuk

1994
Treatment of early stages of Hodgkin's disease with novantrone, vincristine, vinblastine, prednisone, and radiotherapy.
    Seminars in hematology, 1994, Volume: 31, Issue:2 Suppl 3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1994
Malignant schwannoma following treatment for Hodgkin's disease.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1994, Volume: 6, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Female

1994
Chromosomal damage in sperm of patients surviving Hodgkin's disease following MOPP (nitrogen mustard, vincristine, procarbazine, and prednisone) therapy with and without radiotherapy.
    Human genetics, 1994, Volume: 93, Issue:3

    Topics: Adolescent; Adult; Aneuploidy; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome A

1994
Leukemia risk following Hodgkin's disease: relation to cumulative dose of alkylating agents, treatment with teniposide combinations, number of episodes of chemotherapy, and bone marrow damage.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:5

    Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Case-Co

1994
Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
    Annals of hematology, 1994, Volume: 68, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclop

1994
The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's disease.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 1994, Volume: 23, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd

1994
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
    Leukemia & lymphoma, 1993, Volume: 11, Issue:3-4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up St

1993
A technique using parallel-opposed high energy electron beams for reirradiation of tumors near the spinal cord.
    International journal of radiation oncology, biology, physics, 1993, Dec-01, Volume: 27, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham

1993
Ethical decision-making processes used by health care providers.
    Journal of advanced nursing, 1993, Volume: 18, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Decision Making; Decision Theory; Ethical Ana

1993
Gonadal function in prepubertal boys following treatment for Hodgkin's disease.
    The American journal of pediatric hematology/oncology, 1993, Volume: 15, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamid

1993
Breast cancer developing after therapy for Hodgkin's disease.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1993, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Intr

1993
Splenectomy and the increasing risk of secondary acute leukemia in Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1993
[Non-Hodgkin's lymphoma in a patient after many years of remission of Hodgkin's disease].
    Acta haematologica Polonica, 1995, Volume: 26, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymphoma, No

1995
Second malignant tumours in childhood Hodgkin's disease.
    Medical and pediatric oncology, 1996, Volume: 26, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Clinical Protocols; Cohort

1996
Is ABVD the standard regimen for Hodgkin's disease based on randomized CALGB comparison of MOPP, ABVD and MOPP alternating with ABVD?
    Leukemia, 1996, Volume: 10 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1996
Genetic instability in patients with Hodgkin's disease undergoing chemotherapy.
    The Journal of clinical investigation, 1995, Volume: 96, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox

1995
[Semen preservation and gonadal toxicity in the treatment of non Hodgkin lymphoma. Experience at the Gustave-Roussy Institute from 1980 to 1993].
    Bulletin du cancer, 1996, Volume: 83, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Ther

1996
Hodgkin's disease presenting as a cholestatic febrile illness: incidence and main characteristics in a series of 421 patients.
    Annals of hematology, 1996, Volume: 72, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cholestas

1996
Infradiaphragmatic Hodgkin's disease: long term results of combined modality therapy.
    Leukemia & lymphoma, 1996, Volume: 21, Issue:1-2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Top

1996
Irreversible gonadal damage in male survivors of pediatric Hodgkin's disease.
    Cancer, 1996, Nov-01, Volume: 78, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Follicle Stimulating Hormone; Fol

1996
Second malignancy in patients with Hodgkin's disease treated at the Royal Marsden Hospital.
    British journal of cancer, 1997, Volume: 75, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protoc

1997
[Hodgkin's disease in the very young child. Apropos of 11 cases].
    Bulletin du cancer, 1996, Volume: 83, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1996
Detection of a dormant 20q- leukemia clone in bone marrow cultures with hematopoietic growth factors: implications for secondary leukemia post-transplant.
    Bone marrow transplantation, 1997, Volume: 19, Issue:5

    Topics: Acute Disease; Adult; Anemia, Refractory, with Excess of Blasts; Antimetabolites, Antineoplastic; An

1997
Outcome of patients with Hodgkin's disease failing after primary MOPP-ABVD.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female;

1997
Five-year follow-up of saliva in patients treated for lymphomas.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1997, Volume: 83, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Ch

1997
A blood stem cell transplant in a person with concomitant Hodgkin disease and testicular carcinoma.
    Bone marrow transplantation, 1997, Volume: 19, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Germinoma; Hematopoietic

1997
Treatment of Hodgkin's disease in children with alternating mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) and adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) courses without radiotherapy.
    Medical and pediatric oncology, 1997, Volume: 29, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

1997
[A case of Hodgkin's disease with an uncommon clinical course. Predominant localization in the liver].
    Przeglad lekarski, 1996, Volume: 53, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Female; Hodgkin Disease; Huma

1996
Long-term pulmonary sequelae after treatment of childhood Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1997, Volume: 8 Suppl 1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1997
[Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Annales Academiae Medicae Stetinensis, 1996, Volume: 42

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bleomycin; Child; Child, P

1996
Resolution of paraneoplastic bile duct paucity following successful treatment of Hodgkin's disease.
    Hepatology (Baltimore, Md.), 1997, Volume: 26, Issue:1

    Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; Bile Duct Diseases; Bil

1997
Gonadal function following ABVD therapy for Hodgkin's disease.
    American journal of clinical oncology, 1997, Volume: 20, Issue:4

    Topics: Adolescent; Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkyla

1997
G-CSF (filgrastim) as an adjunct to MOPP/ABVD therapy in Hodgkin's disease.
    Acta oncologica (Stockholm, Sweden), 1997, Volume: 36, Issue:5

    Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antine

1997
Salvage radiotherapy for Hodgkin's disease following chemotherapy failure.
    International journal of radiation oncology, biology, physics, 1997, Oct-01, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Di

1997
A cure model with time-changing risk factor: an application to the analysis of secondary leukaemia. A report from the International Database on Hodgkin's Disease.
    Statistics in medicine, 1998, Jan-15, Volume: 17, Issue:1

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Disease-Fr

1998
Should MOPP-ABVD alone be standard for childhood Hodgkin's?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Dacarbazine; Doxorubicin; Hodgkin

1998
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
    British journal of cancer, 1998, Volume: 77, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci

1998
Hodgkin's disease in children in southern Africa: epidemiological characteristics, morbidity and long-term outcome.
    Annals of tropical paediatrics, 1997, Volume: 17, Issue:4

    Topics: Adolescent; Age Distribution; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Chil

1997
Levels of proteins C and S do not decline subsequent to first line chemotherapy in lymphoma patients.
    Hematological oncology, 1997, Volume: 15, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; alpha-2-Antiplasmin; Antineoplastic Combined Chemotherap

1997
Plasma levels of tumour necrosis factor and its soluble receptors correlate with clinical features and outcome of Hodgkin's disease patients.
    British journal of cancer, 1998, Volume: 77, Issue:12

    Topics: Adolescent; Adult; Aged; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Co

1998
Treatment-related deaths and second cancer risk after autologous stem-cell transplantation for Hodgkin's disease.
    Blood, 1998, Sep-15, Volume: 92, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hematopoietic Stem

1998
Second cancer among long-term survivors from Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1998, Sep-01, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleom

1998
Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1998
The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-con
    Haematologica, 1998, Volume: 83, Issue:9

    Topics: Abdomen; Actuarial Analysis; Acute Disease; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over;

1998
[Hodgkin's disease in two children of mother treated with nitrogranulogen].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 1998, Volume: 4, Issue:23

    Topics: Alkylating Agents; Child; Female; Hodgkin Disease; Humans; Male; Maternal Welfare; Mechlorethamine;

1998
[Clinical case of the month. The association of Hodgkin's disease and nephrotic syndrome].
    Revue medicale de Liege, 1998, Volume: 53, Issue:11

    Topics: Adult; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineop

1998
Unilateral proptosis in an immunocompetent man as the initial clinical manifestation of systemic Hodgkin disease.
    Ophthalmology, 1999, Volume: 106, Issue:2

    Topics: Acute Disease; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Exophthalmos;

1999
Advanced stage and unfavorable Hodgkin's disease in the Chinese-a 20-year experience.
    American journal of hematology, 1999, Volume: 61, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Daca

1999
High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
    British journal of cancer, 1999, Volume: 81, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine;

1999
Gemcitabine is active in relapsed Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1999, Volume: 17, Issue:8

    Topics: Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; D

1999
In vivo expansion of reinfused autologous peripheral blood stem cells after a myeloablative regimen, as an alternative to ex vivo expansion pretransplantation: an intriguing observation in apatient autografted twice.
    Bone marrow transplantation, 1999, Volume: 24, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Busulfan; Cyclophosphamide; Doxoru

1999
Association between alopecia and response to aggressive chemotherapy in patients with Hodgkin's disease.
    Medical hypotheses, 1999, Volume: 53, Issue:5

    Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin

1999
Treatment of pediatric Hodgkin's disease with chemotherapy alone or combined modality therapy.
    Radiation oncology investigations, 1999, Volume: 7, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cycl

1999
Circulating immune complexes in advanced Hodgkin's disease: qualitative analysis and prognostic significance.
    Archivum immunologiae et therapiae experimentalis, 2000, Volume: 48, Issue:3

    Topics: Adult; Antigen-Antibody Complex; Antineoplastic Combined Chemotherapy Protocols; C-Reactive Protein;

2000
Follow-up of sperm concentration and motility in patients with lymphoma.
    Human reproduction (Oxford, England), 2000, Volume: 15, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cryopreservation; Daca

2000
[Diagnostic problems due to alternative medicine].
    Schweizerische medizinische Wochenschrift, 2000, Jul-25, Volume: 130, Issue:29-30

    Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast N

2000
Radiotherapy of early stages Hodgkin's disease. 10 years experience of the Masaryk Memorial Cancer Institute.
    Neoplasma, 2000, Volume: 47, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined

2000
Efficacy of standard treatment in patients with Hodgkin's disease--a single center experience.
    Wiener klinische Wochenschrift, 2000, Jul-28, Volume: 112, Issue:14

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2000
[Thyroid lymphoma. A case report].
    Revista medica de Chile, 2000, Volume: 128, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Follow-Up Studies;

2000
[High-dose chemotherapy and autologous stem cell transplantation for refractory and relapsing Hodgkin's disease as first-line therapy-- studies at Sheba Medical Center--Tel Hashomer].
    Harefuah, 2000, Volume: 139, Issue:5-6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Combined Modality Ther

2000
Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy.
    International journal of radiation oncology, biology, physics, 2000, Nov-01, Volume: 48, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2000
[Changes in gonadal function in post-pubertal male survivors of acute lymphoblastic leukemia and Hodgkin's disease].
    Anales espanoles de pediatria, 2000, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Child; Cycl

2000
[Hodgkin's disease with systemic vasculitis and Lambert-Eaton myasthenic syndrome--case report].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 2000, Volume: 53, Issue:9-10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Hodgkin Disease; Humans; Lam

2000
Persistent paraneoplastic neurologic syndrome after successful therapy of Hodgkin's disease.
    European journal of haematology, 2001, Volume: 66, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Ataxia; Bleomycin; Combined Modality Therapy;

2001
Gingival overgrowth as the initial paraneoplastic manifestation of Hodgkin's lymphoma in a child. A case report.
    Journal of periodontology, 2001, Volume: 72, Issue:1

    Topics: Alveolar Bone Loss; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Dacarb

2001
Lung cancer after Hodgkin's disease: a nested case-control study of the relation to treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2001, Mar-15, Volume: 19, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Female; Hodgkin D

2001
The risk of second malignant tumors and its consequences for the overall survival of Hodgkin's disease patients and for the choice of their treatment at presentation: analysis of a series of 1524 cases consecutively treated at the Florence University Hosp
    International journal of radiation oncology, biology, physics, 2001, Apr-01, Volume: 49, Issue:5

    Topics: Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Confidence Intervals; F

2001
[The chemotherapeutic treatment of advanced Hodgkin's disease].
    Harefuah, 2001, Volume: 140, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomyci

2001
ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:9

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modali

2001
The serum levels of eosinophil cationic protein (ECP) are related to the infiltration of eosinophils in the tumours of patients with Hodgkin's disease.
    Leukemia & lymphoma, 2001, Volume: 42, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomyci

2001
Subdiaphragmatic Hodgkin's disease: the University of Florida experience.
    International journal of radiation oncology, biology, physics, 2002, Jan-01, Volume: 52, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Di

2002
[Treatment of advanced Hodgkin's disease: an analysis of 128 cases].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 2000, Volume: 22, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; CCAAT-Enhancer-Binding Prot

2000
Hematological malignancies and pregnancy: a final report of 84 children who received chemotherapy in utero.
    Clinical lymphoma, 2001, Volume: 2, Issue:3

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci

2001
Pulmonary toxicity secondary to procarbazine.
    American journal of clinical oncology, 2002, Volume: 25, Issue:2

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male

2002
Fifteen-year secondary leukaemia risk observed in 761 patients with Hodgkin's disease prospectively treated by MOPP or ABVD chemotherapy plus high-dose irradiation.
    British journal of haematology, 2002, Volume: 118, Issue:1

    Topics: Actuarial Analysis; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbaz

2002
[Criteria for choice of therapeutic procedures in lymphomas].
    Minerva medica, 1975, Apr-25, Volume: 66, Issue:31

    Topics: Antineoplastic Agents; Bleomycin; Cobalt Radioisotopes; Doxorubicin; Drug Therapy, Combination; Hodg

1975
[Current problems in therapy of evolutive malignant granuloma. Our experience with a new scheme of polychemotherapy].
    Minerva medica, 1975, Apr-25, Volume: 66, Issue:31

    Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Hodgkin

1975
Progress in the chemotherapy of hematologic diseases.
    Bibliotheca haematologica, 1975, Issue:40

    Topics: Antineoplastic Agents; Bleomycin; Daunorubicin; DNA Replication; Doxorubicin; Drug Therapy, Combinat

1975
Palliation in malignant pleural effusion.
    The American surgeon, 1975, Volume: 41, Issue:9

    Topics: Adenocarcinoma; Adult; Aged; Breast Neoplasms; Drainage; Female; Hodgkin Disease; Humans; Lung Neopl

1975
Pituitary function in patients receiving intermittent cytotoxic and corticosteroid therapy for malignant lymphoma.
    Lancet (London, England), 1976, Apr-03, Volume: 1, Issue:7962

    Topics: Adult; Antineoplastic Agents; Circadian Rhythm; Doxorubicin; Drug Therapy, Combination; Female; Hodg

1976
[Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1976, Aug-06, Volume: 101, Issue:32

    Topics: Adult; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hod

1976
New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
    Cancer, 1976, Volume: 38, Issue:2

    Topics: Adult; Aged; Bleomycin; Dacarbazine; Doxorubicin; Drug Administration Schedule; Drug Therapy, Combin

1976
Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
    Cancer, 1977, Volume: 39, Issue:4

    Topics: Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Therapy, Combination; Female; Hodgkin Disease; Huma

1977
[Effect of combined chemotherapy on the prognosis of Hodgkin's disease: retrospective study of 74 cases from 1959-1973].
    Schweizerische medizinische Wochenschrift, 1977, Apr-23, Volume: 107, Issue:16

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Cyclophosphamide; Dacarbazine; Dac

1977
Long term experience with combination chemotherapy in advanced Hodgkin's disease.
    Clinical oncology, 1977, Volume: 3, Issue:2

    Topics: Adult; Antineoplastic Agents; Bleomycin; Drug Therapy, Combination; Female; Hodgkin Disease; Humans;

1977
[Cytostatic chemotherapy of lymphogranulomatosis].
    Deutsche medizinische Wochenschrift (1946), 1978, Feb-10, Volume: 103, Issue:6

    Topics: Antineoplastic Agents; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Drug Therapy, Combinat

1978
Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
    Cancer, 1978, Volume: 41, Issue:5

    Topics: Adolescent; Adult; Bleomycin; Doxorubicin; Drug Resistance; Drug Therapy, Combination; Female; Hodgk

1978
Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
    Cancer, 1978, Volume: 41, Issue:6

    Topics: Adolescent; Adult; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance; Drug Therapy, Combination;

1978
Pregnancy after chemotherapy for Hodgkin's disease.
    Lancet (London, England), 1979, Jul-14, Volume: 2, Issue:8133

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Administration Schedule; Drug Therapy, Combina

1979
Adriamycin, bleomycin, vinblastine and imidazole carboxamide (ABVD) therapy for advanced Hodgkin's disease resistant to mustine, vinblastine, procarbazine and prednisolone (MVPP).
    Cancer chemotherapy and pharmacology, 1979, Volume: 2, Issue:3

    Topics: Adolescent; Adult; Alopecia; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Administrati

1979
Combination chemotherapy in stages I or II Hodgkin's disease.
    Lancet (London, England), 1979, Nov-17, Volume: 2, Issue:8151

    Topics: Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Di

1979
[Hodgkin's disease: classification, staging, therapy].
    Schweizerische medizinische Wochenschrift, 1978, Aug-12, Volume: 108, Issue:32

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparoscopy; Life Expectancy; Mechlorethamine; N

1978
Antibodies to Epstein-Barr-virus antigens before and after the development of Burkitt's lymphoma in a patient treated for Hodgkin's disease.
    The New England journal of medicine, 1975, Mar-20, Volume: 292, Issue:12

    Topics: Antibodies, Viral; Antigens, Viral; Burkitt Lymphoma; Child; Herpesvirus 4, Human; Hodgkin Disease;

1975
People with Hodgkin disease: the nursing challenge.
    The Nursing clinics of North America, 1978, Volume: 13, Issue:2

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Male; Mechlorethamine;

1978
Acute myelogenous leukemia as a late complication of the multimodality therapy for Hodgkin's disease.
    The Johns Hopkins medical journal, 1977, Volume: 141, Issue:5

    Topics: Adult; Biopsy; Bone Marrow; Cytarabine; Daunorubicin; Hodgkin Disease; Humans; Leukemia, Myeloid, Ac

1977
Fulminant sepsis after the successful treatment of Hodgkin's disease.
    The American journal of medicine, 1977, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Agents; Female; Haemophilus Infections; Hodgkin Disease; Humans; M

1977
Stages I--III Hodgkin's disease in children: results of staging and treatment.
    Cancer, 1977, Volume: 39, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Lym

1977
Stages IIB and IIIB Hodgkin's disease. Results of combined modality treatment.
    Cancer, 1977, Volume: 40, Issue:1

    Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore

1977
Management of Hodgkin's disease.
    Comprehensive therapy, 1979, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lympha

1979
Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
    Annals of internal medicine, 1979, Volume: 90, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans

1979
Malignant myelosclerosis (acute myelofibrosis): report of two cases following cytotoxic chemotherapy.
    Cancer, 1979, Volume: 43, Issue:4

    Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Glom

1979
An evaluation of total nodal irradiation as treatment for stage III A Hodgkin's disease.
    Cancer, 1979, Volume: 43, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Therapy, Combinat

1979
Extrapyramidal tract syndrome following intensive MOPP therapy for stage IV-B Hodgkin's disease in childhood.
    Cancer, 1979, Volume: 43, Issue:5

    Topics: Antineoplastic Agents; Basal Ganglia Diseases; Child; Drug Therapy, Combination; Hodgkin Disease; Hu

1979
Hodgkin's disease in children: treatment with low dose radiation and MOPP without staging laparotomy: a preliminary report.
    Cancer, 1979, Volume: 44, Issue:1

    Topics: Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech

1979
Hodgkin's disease: combination chemotherapy for relapse following radical radiotherapy.
    International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Disease;

1979
The role of combined modality therapy in the treatment of stage IIIA Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1979, Volume: 5, Issue:6

    Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Predniso

1979
[Results of the combined chemotherapy of stage III and IV lymphogranulomatosis].
    Voprosy onkologii, 1979, Volume: 25, Issue:11

    Topics: Drug Evaluation; Drug Therapy, Combination; Female; Hematopoiesis; Hodgkin Disease; Humans; Male; Me

1979
Feasibility of different combinations of chemotherapy (6 MOPP) plus radiotherapy in Hodgkin's disease.
    Tumori, 1979, Dec-31, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease;

1979
Hodgkin's disease: results of treatment with combination chemotherapy.
    The Medical journal of Australia, 1977, Dec-17, Volume: 2, Issue:25

    Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me

1977
Rapid development of keratoacanthoma and accelerated transformation into squamous cell carcinoma of the skin: a mutagenic effect of polychemotherapy in a patient with Hodgkin's disease?
    Cancer, 1978, Volume: 41, Issue:1

    Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Therapy, Combination; Hodgkin Disease; Humans;

1978
MVPP chemotherapy regimen for advanced Hodgkin's disease.
    British medical journal, 1978, Mar-18, Volume: 1, Issue:6114

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Femal

1978
Impact of salvage treatment on initial relapses in patients with Hodgkin disease, stages I-III.
    Blood, 1978, Volume: 51, Issue:5

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr

1978
Hemorrhagic cystitis with MOPP therapy.
    Cancer, 1978, Volume: 41, Issue:4

    Topics: Child; Cyclophosphamide; Cystitis; Drug Therapy, Combination; Hematuria; Hodgkin Disease; Humans; Ma

1978
Relapse of Hodgkin disease after extended-field radiotherapy.
    Medical and pediatric oncology, 1978, Volume: 4, Issue:2

    Topics: Adolescent; Adult; Aged; Bone Marrow; Child; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lym

1978
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease.
    The New England journal of medicine, 1978, Jul-06, Volume: 299, Issue:1

    Topics: Adolescent; Age Factors; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination;

1978
[MVPP multiple drug therapy combined with conventional radiotherapy in children with Hodgkin's disease].
    Pediatria polska, 1978, Volume: 53, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Mal

1978
[Relapses in Hodgkin's disease and their radiochemotherapy (author's transl)].
    La Radiologia medica, 1978, Volume: 64, Issue:2

    Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mech

1978
Childhood Hodgkin's disease in Uganda: a ten year experience.
    Cancer, 1978, Volume: 42, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gynec

1978
Patterns of relapse in advanced Hodgkin's disease treated with combination chemotherapy.
    Cancer, 1978, Volume: 42, Issue:2 Suppl

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Therapy, Combination; Female; Hodgkin Di

1978
The place of radiation therapy in the treatment of Hodgkin's disease.
    Cancer, 1978, Volume: 42, Issue:2 Suppl

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Myocardial

1978
[Polychemotherapy of lymphomas. Results of a selection of 32 cases diagnosed in stage III and stage IV and not previously treated].
    Minerva medica, 1978, Oct-17, Volume: 69, Issue:49

    Topics: Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine

1978
[MOPP chemotherapy of generalized Hodgkin's disease].
    Nowotwory, 1978, Volume: 28, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Therapy, Combination; Female; Hodgkin Disease;

1978
Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
    Israel journal of medical sciences, 1978, Volume: 14, Issue:12

    Topics: Adolescent; Adult; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neopl

1978
[Combination chemotherapy and synchronization therapy in lymphogranulomatosis and non-Hodgkin's lymphomas].
    Hamatologie und Bluttransfusion, 1976, Volume: 18

    Topics: Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphom

1976
Recent advances and controversies in the management of Hodgkin's disease.
    Surgery, gynecology & obstetrics, 1975, Volume: 140, Issue:3

    Topics: Adult; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Lymphography; Mechlorethamine

1975
[Combination chemotherapy (MOPP) in 60 patients with Hodgkin's disease (five years results) (author's transl)].
    Haematologica, 1975, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine

1975
The therapy of Hodgkin's disease in Nigeria: a five year study.
    African journal of medicine and medical sciences, 1976, Volume: 5, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Ther

1976
Diffuse pulmonary disease after therapy with nitrogen mustard, vincristine, procarbazine, and prednisone.
    The American review of respiratory disease, 1977, Volume: 115, Issue:1

    Topics: Adult; Biopsy; Drug Hypersensitivity; Female; Hodgkin Disease; Humans; Lung Diseases; Mechlorethamin

1977
[Combined cyclic treatment of generalized Hodgkin's disease by the MOPP program. Preliminary results and observed complications].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1977, Apr-04, Volume: 32, Issue:14

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd

1977
[Initial treatment of Hodgkin's disease with polychemotherapy. Long-term results in 226 cases (1- to 10-year follow-up)].
    Semaine des hopitaux. Therapeutique, 1977, Volume: 53, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Drug Evaluation; Drug Therapy, Combination; F

1977
Comparative Bayesian and traditional inference for gamma-modeled survival data.
    Biometrics, 1977, Volume: 33, Issue:2

    Topics: Bayes Theorem; Hodgkin Disease; Humans; Mechlorethamine; Statistics as Topic; Therapeutics

1977
[The results of radiotherapy managements in Hodgkin's disease (author's transl)].
    Journal de radiologie, d'electrologie, et de medecine nucleaire, 1977, Volume: 58, Issue:5

    Topics: Adolescent; Adult; Aged; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Me

1977
[81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
    Journal de radiologie, d'electrologie, et de medecine nucleaire, 1977, Volume: 58, Issue:5

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Retro

1977
The effect of quadruple chemotherapy on the peripheral blood lymphocyte populations in Hodgkin's disease.
    British journal of clinical pharmacology, 1977, Volume: 4, Issue:4

    Topics: Adult; Depression, Chemical; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukocyte Count; Ly

1977
[Recent progress in the treatment of Hodgkin's disease].
    Acquisitions medicales recentes, 1977

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinbl

1977
Hematologic neoplasia in patients treated for Hodgkin's disease.
    The New England journal of medicine, 1977, Dec-08, Volume: 297, Issue:23

    Topics: Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Leukemia; Male; Mechloreth

1977
[Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Nouvelle revue francaise d'hematologie; blood cells, 1977, Volume: 18, Issue:2

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mechlorethamine; Prednisone; Procarb

1977
[Polychemotherapy of Hodgkin's disease. Long-term results in 226 cases].
    Nouvelle revue francaise d'hematologie; blood cells, 1977, Volume: 18, Issue:2

    Topics: Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone;

1977
[Laparotomy in the therapy of Hodgkin's disease].
    Nouvelle revue francaise d'hematologie; blood cells, 1977, Volume: 18, Issue:2

    Topics: Cobalt Radioisotopes; Diaphragm; Drug Therapy, Combination; Hodgkin Disease; Humans; Laparotomy; Mec

1977
Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP.
    Cancer, 1976, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Alopecia; Antineoplastic Agents; Cyclophosphamide; Drug Therap

1976
Long term remissions with combined modality therapy for advanced Hodgkin's disease.
    Cancer, 1976, Volume: 37, Issue:6

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Age

1976
Initial relapses in previously treated Hodgkin's disease. I. Results of second treatment.
    Cancer, 1976, Volume: 37, Issue:6

    Topics: Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Neoplasm Metastasis; Neoplasm Recurrence, Lo

1976
Effects of nitrogen mustard and splenectomy on mouse bone marrow colony formation in vitro.
    Cancer, 1976, Volume: 38, Issue:3

    Topics: Animals; Bone Marrow; Bone Marrow Cells; Cell Division; Clone Cells; Hodgkin Disease; Male; Mechlore

1976
[Long-term remission in advanced stages of lymphogranulomatosis following combined chemotherapy using a modified de Vita system].
    Hamatologie und Bluttransfusion, 1976, Volume: 18

    Topics: Cyclophosphamide; Drug Therapy, Combination; Follow-Up Studies; Hodgkin Disease; Humans; Mechloretha

1976
Combination chemotherapy of Hodgkin's disease in children.
    Cancer, 1976, Volume: 38, Issue:4

    Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combinat

1976
Hypertrophic pulmonary osteoarthropathy in Hodgkin's disease: reversal with chemotherapy.
    Cancer, 1976, Volume: 38, Issue:4

    Topics: Adult; Antineoplastic Agents; Drug Therapy, Combination; Hodgkin Disease; Humans; Lung Diseases; Mal

1976
[Curative aspects of modern combination chemotherapy in generalized malignant lymphomas].
    Schweizerische medizinische Wochenschrift, 1976, May-29, Volume: 106, Issue:22

    Topics: Agranulocytosis; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Life

1976
Patterns of changes in peripheral blood composition in the course of combination chemotherapy of cancer.
    Strahlentherapie, 1976, Volume: 152, Issue:5

    Topics: Adult; Aged; Antineoplastic Agents; Cyclophosphamide; Drug Therapy, Combination; Female; Hematopoies

1976
The effect of nitrogen mustard on human mononuclear blood cells.
    Acta pathologica et microbiologica Scandinavica. Section C, Immunology, 1976, Volume: 84C, Issue:5

    Topics: Adult; Cell Survival; Cells, Cultured; Hodgkin Disease; Humans; Lymphocytes; Male; Mechlorethamine;

1976
Prednisone in MOPP chemotherapy for Hodgkin's disease.
    British medical journal, 1976, Dec-18, Volume: 2, Issue:6050

    Topics: Adult; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone

1976
Staging laparotomy and splenectomy: treatment and complications of Hodgkin's disease in children.
    American journal of hematology, 1976, Volume: 1, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Therapy, Combination; Female; Hodgkin Di

1976
Hodgkin disease with acute lymphoblastic leukemia.
    JAMA, 1975, Feb-10, Volume: 231, Issue:6

    Topics: Acute Disease; Adolescent; Daunorubicin; Drug Therapy, Combination; Hodgkin Disease; Humans; Leukemi

1975
Management of Hodgkin's and non-Hodgkin's lymphomas.
    The Medical clinics of North America, 1975, Volume: 59, Issue:2

    Topics: Administration, Oral; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Injectio

1975
Fetal renal malformation following treatment of Hodgkin's disease during pregnancy.
    Obstetrics and gynecology, 1975, Volume: 46, Issue:2

    Topics: Abnormalities, Drug-Induced; Abortion, Induced; Adult; Autopsy; Female; Fetus; Hodgkin Disease; Huma

1975
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Michigan medicine, 1975, Volume: 74, Issue:27

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret

1975
Combination chemotherapy in Hodgkin's disease: relation to radiotherapy.
    Bibliotheca haematologica, 1975, Issue:40

    Topics: Drug Therapy, Combination; Evaluation Studies as Topic; Hodgkin Disease; Humans; Mechlorethamine; Pr

1975
Towards curative treatment of advanced Hodgkin's disease.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1975, Sep-06, Volume: 49, Issue:38

    Topics: Chlorambucil; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proca

1975
[Experiences with combined cyclic chemotherapy (COPP type) in advanced lymphogranulomatosis].
    Orvosi hetilap, 1975, Dec-14, Volume: 116, Issue:50

    Topics: Adult; Aged; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, Combination; Female; Hodg

1975
Chemotherapy as a primary treatment of Hodgkin's disease (204 new cases, 1 to 8 years of follow-up).
    European journal of cancer, 1975, Volume: 11, Issue:10

    Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlore

1975
[Polychemotherapy without prednisone in Hodgkin's disease].
    Acta clinica Belgica, 1975, Volume: 30, Issue:4

    Topics: Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Midd

1975
Combination chemotherapy in Hodgkin's disease at advanced stages.
    Acta clinica Belgica, 1975, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechloret

1975
[Chemotherapy of advanced stages (IIIB and IV) of Hodgkin's disease].
    Acta clinica Belgica, 1975, Volume: 30, Issue:4

    Topics: Adolescent; Adult; Child; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Male; Mechlore

1975
Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.
    Blood, 1976, Volume: 47, Issue:2

    Topics: Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Humans; Lymphoma; Mechlorethamine; Pos

1976
Testicular function after combination chemotherapy for Hodgkin's disease.
    Scandinavian journal of haematology, 1976, Volume: 16, Issue:1

    Topics: Adult; Antineoplastic Agents; Cell Count; Cyclophosphamide; Drug Therapy, Combination; Follicle Stim

1976
Unusual cardiac reaction to chemotherapy following mediastinal irradiation in a patient with Hodgkin's disease.
    The American journal of medicine, 1976, Volume: 60, Issue:1

    Topics: Adult; Drug Therapy, Combination; Heart; Hodgkin Disease; Humans; Male; Mechlorethamine; Mediastinal

1976
Spinal cord compression in malignant lymphoma. Treatment and results.
    Cancer, 1976, Volume: 37, Issue:3

    Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Hodgkin Disease; Humans; Infant; Mechlorethamine;

1976
[Combined chemotherapy in Hodgkin's disease].
    Nederlands tijdschrift voor geneeskunde, 1976, Jun-12, Volume: 120, Issue:24

    Topics: Antineoplastic Agents; Blood Cell Count; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlor

1976
Non-Hodgkin's lymphoma in children.
    Pediatric clinics of North America, 1976, Volume: 23, Issue:2

    Topics: Adolescent; Central Nervous System; Child; Diagnosis, Differential; Hodgkin Disease; Humans; Lymphom

1976
The Second International Symposium on Hodgkin's Disease. Workshop III: Recommendations for future clinical trials.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modali

1992
[Four cases of Hodgkin's disease treated with MOPP/ABV hybrid regimen using nitrogen mustard-N-oxide hydrochloride].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1992, Volume: 19, Issue:14

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Drug Administra

1992
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
    Journal d'urologie, 1992, Volume: 98, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Dysgermi

1992
Salivary flow and composition in lymphoma patients before, during and after treatment with cytostatic drugs.
    European journal of cancer. Part B, Oral oncology, 1992, Volume: 28B, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols

1992
[Second neoplasms as a late complication of the treatment of Hodgkin's disease].
    Sangre, 1992, Volume: 37, Issue:6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinom

1992
Hodgkin's disease and acute leukemia. Is it a true association?
    Archives of medical research, 1992,Spring, Volume: 23, Issue:1

    Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil

1992
Bilateral aseptic necrosis of the humeral head following combined therapy for Hodgkin's lymphoma.
    Italian journal of orthopaedics and traumatology, 1992, Volume: 18, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1992
Avascular necrosis of the femoral head after treatment of Hodgkin's disease.
    Acta oncologica (Stockholm, Sweden), 1992, Volume: 31, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubic

1992
Simultaneously occurring alopecia areata and Hodgkin's lymphoma: complete remission of both diseases with MOPP/ABV chemotherapy.
    Medical and pediatric oncology, 1992, Volume: 20, Issue:4

    Topics: Adult; Alopecia Areata; Antineoplastic Combined Chemotherapy Protocols; Autoimmune Diseases; Bleomyc

1992
Management of stage II Hodgkin's disease: 15 years experience at St. Bartholomew's Hospital.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1992
ABEP as primary chemotherapy for Hodgkin's disease.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 28A, Issue:10

    Topics: Aclarubicin; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cytarabin

1992
[Radiotherapy vs. chemotherapy in early-stage Hodgkin's disease: a justified approach?].
    Bulletin du cancer, 1992, Volume: 79, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Decision Making; Hodgkin D

1992
Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation.
    BMJ (Clinical research ed.), 1992, May-02, Volume: 304, Issue:6835

    Topics: Adolescent; Adult; Alkylating Agents; Child; Chlorambucil; Cohort Studies; Female; Follow-Up Studies

1992
Remission of scleroderma during chemotherapy for lymphoma.
    Annals of the rheumatic diseases, 1992, Volume: 51, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham

1992
The frequency of translocations after treatment for Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1992, Volume: 24, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 4; Combined Modality Therap

1992
Selective metaphasic arrest of erythroblasts by vincristine in patients receiving high doses of recombinant human erythropoietin for myelosuppressive anemia.
    Leukemia, 1992, Volume: 6 Suppl 4

    Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Erythroblasts; Erythropoietin; Hodgkin Disea

1992
Early stage Hodgkin's disease: ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP.
    European journal of cancer (Oxford, England : 1990), 1992, Volume: 29A, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1992
Residual mediastinal mass after treatment of Hodgkin's disease: a decision analysis.
    Medical hypotheses, 1992, Volume: 38, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Decision Trees; Hodgkin D

1992
Patterns of survival in patients with advanced Hodgkin's disease (HD) treated in a single centre over 20 years.
    British journal of cancer, 1992, Volume: 65, Issue:3

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; beta 2-Microgl

1992
[Hodgkin's disease. Our 9-year experience with the 1980 protocol].
    Sangre, 1992, Volume: 37, Issue:1

    Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy

1992
Late cardiopulmonary toxicity after treatment for Hodgkin's disease.
    British journal of cancer, 1992, Volume: 65, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Exerci

1992
Radiation therapy is better than chemotherapy in early-stage Hodgkin's disease? Not so fast.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1992, Volume: 10, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1992
Chromosome aberrations following cytotoxic therapy in patients in complete remission from lymphoma.
    Carcinogenesis, 1992, Volume: 13, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cells, Cultured; Chromosome Aberrations

1992
Induction of chromosome breaks and sister chromatid exchanges in patients with Hodgkin's disease by two combination chemotherapy regimens of different leukemogenic potential.
    Cancer research, 1990, Feb-01, Volume: 50, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Chromosomes; Dacarbazi

1990
Treatment of Hodgkin's disease with MOPP chemotherapy: effect of dose and schedule modification on treatment outcome.
    Oncology, 1990, Volume: 47, Issue:1

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dose-Response R

1990
Secondary uncommon solid neoplasms in cured Hodgkin's disease and follow-up of the original B-DOPA chemotherapy patient group.
    American journal of clinical oncology, 1990, Volume: 13, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Squamous Cell; Dacarbaz

1990
Development of pulmonary histiocytosis X after chemotherapy for Hodgkin disease.
    AJR. American journal of roentgenology, 1990, Volume: 155, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Fem

1990
The impact of breakthrough clinical trials on survival in population based tumor registries.
    Journal of clinical epidemiology, 1991, Volume: 44, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Hodg

1991
Salvage chemotherapy in Hodgkin's disease. Results in patients relapsing more than twelve months after first complete remission.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1990, Volume: 1, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Et

1990
Hodgkin's disease in adults in Saudi Arabia. Clinical features, prognostic factors and an analysis of therapy. Outcome of combination chemotherapy only, for both localized and advanced disease.
    International journal of cancer, 1991, Apr-01, Volume: 47, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Dacarbazine; Doxorubi

1991
Growth and development of children of mothers treated with chemotherapy during pregnancy: current status of 43 children.
    American journal of hematology, 1991, Volume: 36, Issue:4

    Topics: Acute Disease; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Behavior; Bleomyci

1991
Development of effective salvage treatment programs for Hodgkin's disease: an ongoing clinical challenge.
    Blood, 1991, May-15, Volume: 77, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1991
Outcome of treatment of first relapse of Hodgkin's disease after primary chemotherapy: identification of risk factors from the British Columbia experience 1970 to 1988.
    Blood, 1991, May-15, Volume: 77, Issue:10

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1991
MACOP-B and VACOP-B in diffuse large cell lymphomas and MOPP/ABV in Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc

1991
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2 Suppl 2

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin

1991
Haematological toxicity compromises MOPP/ABVD chemotherapy in Hodgkin's disease.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1991
Serum antithrombin III and alpha-2-antiplasmin concentrations in patients with Hodgkin's disease in the course of chemotherapy.
    Neoplasma, 1991, Volume: 38, Issue:3

    Topics: Adult; Aged; alpha-Macroglobulins; Antineoplastic Combined Chemotherapy Protocols; Antithrombin III;

1991
In vivo somatic mutation in the lymphocytes of Hodgkin's disease patients.
    Environmental and molecular mutagenesis, 1991, Volume: 18, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols

1991
Intensive chemotherapy and low-dose radiotherapy for the treatment of advanced-stage Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:9

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschoo

1991
[Hodgkin's disease during pregnancy. Study of late effects in the newborn infants].
    Boletin medico del Hospital Infantil de Mexico, 1991, Volume: 48, Issue:9

    Topics: Abnormalities, Drug-Induced; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chrom

1991
Chemotherapy combined with involved-field radiotherapy for 177 children with Hodgkin's disease treated in 1983-1987.
    Acta paediatrica Japonica : Overseas edition, 1991, Volume: 33, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chemotherapy, Adjuvant; Child

1991
[Treatment of Hodgkin's disease. National Protocol of Antineoplastic Drugs: preliminary report].
    Revista medica de Chile, 1991, Volume: 119, Issue:1

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc

1991
Maternal and foetal outcome following Hodgkin's disease in pregnancy.
    British journal of cancer, 1992, Volume: 65, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Birth Weight; Case-Control Studies; Cesarean

1992
An analysis of prognostic factors in stage III and IV Hodgkin's disease treated at a single centre with MVPP.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Discriminant Analy

1991
Mechlorethamine, vinblastine, procarbazine and prednisolone (MVPP) for advanced Hodgkin's disease.
    European journal of cancer (Oxford, England : 1990), 1991, Volume: 27, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu

1991
Transient reversal of bone marrow aplasia associated with lymphocyte depleted Hodgkin's disease after combination chemotherapy.
    American journal of hematology, 1991, Volume: 38, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Marrow; Female; Hodgkin Disease;

1991
Hodgkin's disease of the liver; prognosis and possible indications for radiotherapy.
    Clinical oncology (Royal College of Radiologists (Great Britain)), 1991, Volume: 3, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Clinical Protocols; Hodgkin Disease; H

1991
Sister chromatid exchange frequency in Hodgkin's disease patients with elevated in vivo hprt mutant frequencies.
    Carcinogenesis, 1991, Volume: 12, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemothera

1991
Treatment of advanced-stage massive mediastinal Hodgkin's disease: the case for combined modality treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

1991
In vitro fertilization techniques with frozen-thawed sperm: a method for preserving the progenitive potential of Hodgkin patients.
    Fertility and sterility, 1991, Volume: 55, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cryopreservation; Embryo Transfer; Female; Fe

1991
Treatment of childhood Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Hodgkin Disease; Humans; Me

1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1991, Volume: 2, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1991
Early-stage Hodgkin's disease: a choice of treatments or a treatment of choice?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1991, Volume: 9, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Combined Modality Therapy;

1991
Influence of age and duration of follow-up on lung function after combined chemotherapy for Hodgkin's disease.
    The European respiratory journal, 1990, Volume: 3, Issue:10

    Topics: Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Femal

1990
Thoracic irradiation in Hodgkin's disease: disease control and long-term complications.
    International journal of radiation oncology, biology, physics, 1990, Volume: 18, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined

1990
Active oxygen radicals produced by leukocytes of malignant lymphoma.
    Chinese medical journal, 1990, Volume: 103, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Electron Spin Resonan

1990
Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: the Stanford experience.
    International journal of radiation oncology, biology, physics, 1990, Volume: 19, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1990
Acute nonlymphocytic leukemia after radiation and MOPP chemotherapy for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1990
Prognostic factors for patients relapsing after radiotherapy for early-stage Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine

1990
MOPP dose intensity and survival: flawed analysis.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1990
Delayed life-threatening pneumonitis secondary to procarbazine.
    American journal of clinical oncology, 1990, Volume: 13, Issue:3

    Topics: Adult; Alveolitis, Extrinsic Allergic; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Di

1990
Treatment of lower torso stages I and II Hodgkin's disease with radiation with or without adjuvant mechlorethamine, vincristine, procarbazine, and prednisone.
    Cancer, 1990, Jul-01, Volume: 66, Issue:1

    Topics: Abdominal Neoplasms; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therap

1990
Hodgkin's disease in children: treatment with MOPP and low-dose, extended field irradiation without laparotomy. Late results and toxicity.
    Medical and pediatric oncology, 1990, Volume: 18, Issue:4

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1990
Luteinizing hormone pulsatility in men with damage to the germinal epithelium.
    International journal of andrology, 1990, Volume: 13, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Hodgkin Disease; Humans; Ley

1990
The long-term effects of MVPP chemotherapy for Hodgkin's disease on bone marrow function.
    British journal of cancer, 1990, Volume: 62, Issue:1

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cohort Studies; Colo

1990
Laparotomy and splenectomy in Hodgkin's disease: a reappraisal after twenty years.
    Scandinavian journal of haematology, 1985, Volume: 34, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1985
MOPP/ABV hybrid program: combination chemotherapy based on early introduction of seven effective drugs for advanced Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:9

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomyc

1985
Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi

1985
[Malignant lymphoma].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:9 Suppl

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cycloph

1985
CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
    Seminars in oncology, 1986, Volume: 13, Issue:1 Suppl 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Etoposide; Hodg

1986
Prognosis of bulky Hodgkin's disease treated with chemotherapy alone or combined with radiotherapy.
    Cancer surveys, 1985, Volume: 4, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1985
[Laparotomy with splenectomy in the evaluation of the results of cytostatic treatment of patients with advanced Hodgkin's disease].
    Polskie Archiwum Medycyny Wewnetrznej, 1986, Volume: 75, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dox

1986
ABVD versus MOPP: which is better?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1987
Prognostic value of response after three MOPP cycles in Hodgkin's disease--stage III and IV.
    Blut, 1987, Volume: 54, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Resistance

1987
Hodgkin's disease (HD): a historical perspective.
    European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:11

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarba

1986
Minimal long-term cardiopulmonary dysfunction following treatment for Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1987, Volume: 13, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Body Composition; Elec

1987
Treatment of Hodgkin's disease in children with or without radiotherapy.
    Cancer, 1987, Jun-01, Volume: 59, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

1987
[Controversial aspects in the current treatment of Hodgkin's disease].
    Revista clinica espanola, 1987, Volume: 180, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1987
MOPP/ABV hybrid chemotherapy for advanced Hodgkin's disease.
    Seminars in hematology, 1987, Volume: 24, Issue:2 Suppl 1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Dru

1987
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
    Bulletin du cancer, 1987, Volume: 74, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modalit

1987
Serum lysozyme activity in patients with Hodgkin's disease undergoing chemotherapy.
    Folia haematologica (Leipzig, Germany : 1928), 1987, Volume: 114, Issue:3

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu

1987
Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
    Journal of cancer research and clinical oncology, 1988, Volume: 114, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Follow-Up Stu

1988
[Hodgkin's disease in children. Current therapeutic strategies].
    Bulletin du cancer, 1988, Volume: 75, Issue:1

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1988
Low O6-alkylguanine DNA alkyltransferase activity in the peripheral blood lymphocytes of patients with therapy-related acute nonlymphocytic leukemia.
    Cancer research, 1988, Jun-01, Volume: 48, Issue:11

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease

1988
Is first salvage chemotherapy the last-line chemotherapy in children with Hodgkin's disease? A tentative answer based on long observation of two patients.
    Folia haematologica (Leipzig, Germany : 1928), 1987, Volume: 114, Issue:6

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bleomycin; Child; Combined Modal

1987
[Improved survival rates in Hodgkin's disease].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; D

1988
An update on the Vancouver experience in the management of advanced Hodgkin's disease treated with the MOPP/ABV Hybrid program.
    Seminars in hematology, 1988, Volume: 25, Issue:2 Suppl 2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; D

1988
[Hodgkin's disease and AIDS. Presentation of 5 cases].
    Revista clinica espanola, 1988, Volume: 182, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin

1988
High-dose chemotherapy with autologous bone marrow transplantation in 50 advanced resistant Hodgkin's disease patients: an Italian study group report.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi

1988
Procarbazine hypersensitivity manifested as a fixed drug eruption.
    Medical and pediatric oncology, 1988, Volume: 16, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Drug Eru

1988
Pediatric Hodgkin's disease: pulmonary, cardiac, and thyroid function following combined modality therapy.
    International journal of radiation oncology, biology, physics, 1989, Volume: 16, Issue:3

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Comb

1989
[Femoral osteonecrosis in patients treated with radiochemotherapy of Hodgkin's lymphoma].
    La Radiologia medica, 1989, Volume: 77, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cobalt Radioisotopes; Combined Mod

1989
[Function of the lungs in patients with Hodgkin's disease after chemotherapy and radiotherapy].
    Pediatria polska, 1988, Volume: 63, Issue:11

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cobalt Radioisotopes;

1988
Allogeneic marrow transplantation for refractory Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:8

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplant

1989
Total lymphoid irradiation, high-dose chemotherapy and autologous bone marrow transplantation for chemotherapy-resistant Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1989, Volume: 17, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combi

1989
Conventional salvage therapy for Hodgkin's lymphoma.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Mod

1989
Treatment of childhood Hodgkin's disease with chemotherapy alone. Experiences from the Royal Children's Hospital, Melbourne.
    Cancer treatment and research, 1989, Volume: 41

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Daca

1989
Free-from-failure survival in Hodgkin's disease. Long-term analysis of 148 cases treated with a MOPP-modified protocol.
    Acta haematologica, 1989, Volume: 82, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combine

1989
[Radiotherapy with neoadjuvant chemotherapy].
    Annales de medecine interne, 1989, Volume: 140, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Doxorub

1989
[A case of Hodgkin's disease exhibiting erythrodermia probably due to allergic reaction to vinca alkaloids].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1989, Volume: 16, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dermatitis, Exfoliative; Drug Eruptions; Hodgkin Dis

1989
[Recurrent paralysis induced by vincristine during the treatment of Hodgkin's disease].
    Presse medicale (Paris, France : 1983), 1989, Nov-25, Volume: 18, Issue:39

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mechlorethamine

1989
[Hodgkin's disease diagnosed from the numerous Reed-Sternberg cells in the bone marrow].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:5

    Topics: Antigens, Differentiation; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bone

1989
Pediatric Hodgkin's disease. Later results and toxicity--the Toronto experience.
    Cancer treatment and research, 1989, Volume: 41

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Follow

1989
Combined modality therapy for mediastinal Hodgkin's disease. Prognostic significance of constitutional symptoms and size of disease.
    Cancer, 1985, Jan-15, Volume: 55, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Comb

1985
Prognostic factors for Stage IV Hodgkin's disease treated with MOPP, with or without bleomycin.
    Cancer, 1985, Feb-15, Volume: 55, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Hodgkin Disease;

1985
Third-line salvage chemotherapy in Hodgkin's disease.
    Seminars in oncology, 1985, Volume: 12, Issue:1 Suppl 2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Dox

1985
[Advances in the chemotherapy of malignant lymphoma 1. Chemotherapy of Hodgkin's disease].
    Zhonghua nei ke za zhi, 1985, Volume: 24, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; D

1985
How much MOPP?
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Hodgkin Disease; H

1989
Dose intensity of MOPP chemotherapy and survival in Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1989, Volume: 7, Issue:12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Discriminant Analysis; Dose-Res

1989
[Hodgkin's disease].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1989, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th

1989
Two cycles of MOPP and definitive radiotherapy for stage IIIA and IIIB Hodgkin's disease.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117

    Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Fert

1989
Treatment of advanced Hodgkin's disease with modified MOPP regimens. A long-term observation.
    Neoplasma, 1989, Volume: 36, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Hu

1989
MOPP therapy in children with Hodgkin's disease.
    The American journal of pediatric hematology/oncology, 1989,Winter, Volume: 11, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin Disease; Hu

1989
Is androgen substitution necessary in hypogonadal patients when they are treated with chemotherapy for malignant diseases?
    Medical and pediatric oncology, 1989, Volume: 17, Issue:3

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Diseases; Hodgkin Dis

1989
Ten-year nodular sclerosis Hodgkin's disease and second malignancies.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1989
Hodgkin's disease presenting as myelofibrosis.
    Cancer, 1989, Oct-15, Volume: 64, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Diagnosis, Differential; Female;

1989
Cutaneous Hodgkin's disease in a patient with human immunodeficiency virus infection.
    Cancer, 1989, Dec-15, Volume: 64, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; H

1989
MOPP chemotherapy alone: a suitable treatment for early stages of Hodgkin's disease?
    Lancet (London, England), 1985, May-25, Volume: 1, Issue:8439

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Dise

1985
Advanced Hodgkin disease (clinical stages IIIB and IV): low relapse rate after brief chemotherapy followed by high-dose total lymphoid irradiation.
    American journal of hematology, 1989, Volume: 30, Issue:3

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

1989
Chlorambucil, vinblastine, procarbazine, and prednisone. An effective but less toxic regimen than MOPP for advanced-stage Hodgkin's disease.
    Cancer, 1989, Mar-15, Volume: 63, Issue:6

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Chlorambucil; Female; Hodg

1989
[Treatment of Hodgkin's disease by chemotherapy with MOPP alone. Long-term results].
    Presse medicale (Paris, France : 1983), 1986, Mar-29, Volume: 15, Issue:13

    Topics: Adolescent; Adult; Algeria; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Follow-Up

1986
A method for analysing case-control studies with ordinal exposure variables.
    Biometrics, 1985, Volume: 41, Issue:3

    Topics: Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Biometry; Burkitt Lymphoma; Cl

1985
Hodgkin's disease following Wilms' tumor: a case report.
    Medical and pediatric oncology, 1987, Volume: 15, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgk

1987
Second malignant neoplasm in treated Hodgkin's disease. Report of a patient and scope of the problem.
    American journal of diseases of children (1960), 1986, Volume: 140, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Combined Modality Therapy; G

1986
Retroperitoneal fibrosis following treatment for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H

1987
Regression of mediastinal Hodgkin disease after therapy: evaluation of time interval.
    Radiology, 1987, Volume: 164, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Follow-Up Studies

1987
Case report: multiagent chemotherapy of Hodgkin's disease associated with red cell aplasia, acquired ichthyosis and anhidrosis.
    East African medical journal, 1987, Volume: 64, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Hypohidrosis; Ichthyosis; M

1987
The pituitary-Leydig cell axis in men with severe damage to the germinal epithelium.
    Clinical endocrinology, 1987, Volume: 27, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Follicle Stimulating Hormone; Hod

1987
Plasma inhibin levels in men with chemotherapy-induced severe damage to the seminiferous epithelium.
    Clinical endocrinology, 1988, Volume: 29, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Follicle Stimulating Hormone; Hod

1988
Glomerulonephritis preceding late relapse of Hodgkin's disease.
    Postgraduate medical journal, 1988, Volume: 64, Issue:751

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Glomerulonephritis; Glomerulosclerosis, Foca

1988
The effects of four drug regimens on sister chromatid exchange frequency in patients with lymphomas.
    Cancer genetics and cytogenetics, 1988, Volume: 36, Issue:1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; DNA Damage; Doxorubicin; Hodgkin D

1988
The karyotype in secondary hematologic disorders after treatment for Hodgkin's disease. A study of 19 patients.
    Cancer genetics and cytogenetics, 1988, Volume: 36, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Female; Hodgkin Disea

1988
Prognostic factors for survival in stage IIIB and IV Hodgkin's disease: a multivariate analysis comparing two specialist treatment centres.
    British journal of cancer, 1988, Volume: 58, Issue:4

    Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Leukoc

1988
Dibromdulcitol containing chemotherapeutic regimen in the treatment of childhood Hodgkin's disease.
    Neoplasma, 1988, Volume: 35, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Female; Hodgkin

1988
Treatment of patients with "minimal" stage IIIA Hodgkin's disease.
    International journal of radiation oncology, biology, physics, 1987, Volume: 13, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1987
[10 years' therapy of Hodgkin's disease in the Oncology Department of the Basel Canton Hospital: a retrospective study].
    Onkologie, 1987, Volume: 10, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1987
Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease.
    Cancer, 1988, Jan-15, Volume: 61, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Female; Hodgkin

1988
Tumor burden as the most important prognostic factor in early stage Hodgkin's disease. Relations to other prognostic factors and implications for choice of treatment.
    Cancer, 1988, Apr-15, Volume: 61, Issue:8

    Topics: Antineoplastic Combined Chemotherapy Protocols; Blood Sedimentation; Combined Modality Therapy; Fema

1988
Severe delayed neurotoxicity after accidental high-dose nitrogen mustard.
    American journal of hematology, 1988, Volume: 27, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechlorethamine; Me

1988
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Dose-Response Relationship

1988
[Acute leukemia in patients treated for Hodgkin's disease].
    Recenti progressi in medicina, 1988, Volume: 79, Issue:1

    Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Human

1988
[Comparative evaluation of the efficacy of chemotherapy and chemoradiotherapy of stage IIIB Hodgkin's disease].
    Voprosy onkologii, 1988, Volume: 34, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1988
Nitrogen mustard, vincristine, procarbazine, and prednisolone for relapse after radiation in Hodgkin's disease. An analysis of long-term follow-up.
    Cancer, 1988, Jul-15, Volume: 62, Issue:2

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Child; Fema

1988
[Prognostic factors in the chemoradiation treatment of III-stage lymphogranulomatosis].
    Meditsinskaia radiologiia, 1988, Volume: 33, Issue:7

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Th

1988
[Second tumors in patients treated for Hodgkin's disease].
    Revista clinica espanola, 1988, Volume: 182, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modali

1988
ChlVPP--an effective and well-tolerated alternative to MOPP therapy for Hodgkin's disease.
    American journal of clinical oncology, 1988, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Hodgk

1988
Two cycles of MOPP and radiotherapy for stage III1A and stage III1B Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1988, Volume: 6, Issue:8

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedul

1988
Chemotherapy responsive collagenous colitis in a patient with Hodgkin's disease: a possible paraneoplastic phenomenon.
    The Netherlands journal of medicine, 1987, Volume: 31, Issue:5-6

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Basement Membrane; Colitis; Collagen Diseases;

1987
Gallium citrate Ga 67 accumulation in pulmonary lesions after chemotherapy (MOPP).
    Southern medical journal, 1986, Volume: 79, Issue:10

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Gallium Radioisotopes; Hodgkin Diseas

1986
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
    Cancer, 1987, Jan-15, Volume: 59, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Erythrocyte Indices; Hodgkin Disease; Humans; Leukem

1987
Plasma and leukocytic bactericidal activity in the course of chemotherapy of Hodgkin's disease.
    Acta medica Polona, 1987, Volume: 28, Issue:1-4

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Bactericidal Activity

1987
Wide-field radiation therapy alone or with chemotherapy for Hodgkin's disease in relapse from combination chemotherapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:4

    Topics: Actuarial Analysis; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child, Presch

1987
[Hodgkin's disease. Study of 100 cases].
    Medicina clinica, 1987, Feb-07, Volume: 88, Issue:5

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th

1987
Nitroblue tetrazolium test in patients with Hodgkin's disease in the course of chemotherapy.
    Neoplasma, 1987, Volume: 34, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Granulocytes; Hodgk

1987
Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1987
[Evaluation of the effectiveness of chemoradiotherapy of stage IIIA Hodgkin's disease].
    Meditsinskaia radiologiia, 1987, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female

1987
[Role of radiotherapy in the treatment of stage IIIB Hodgkin's disease in children].
    Meditsinskaia radiologiia, 1987, Volume: 32, Issue:5

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1987
Observations on the treatment of mediastinal masses in Hodgkin's disease emphasizing site of failure.
    American journal of clinical oncology, 1987, Volume: 10, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Child; C

1987
Recurrent "syncytial variant" of Hodgkin's disease: an immunohistologic diagnosis.
    Human pathology, 1987, Volume: 18, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Hodgkin Disease; Hu

1987
Stage I to IIB Hodgkin's disease: the combined experience at Stanford University and the Joint Center for Radiation Therapy.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:7

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1987
Pregnancy following nonsurgical donor ovum transfer to a functionally agonadal woman.
    Fertility and sterility, 1987, Volume: 48, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Embryo Transfer; Estradiol; Female; Hodgkin D

1987
Predictive value of the early response to chemotherapy in high-risk stages II and III Hodgkin's disease.
    Cancer, 1987, Oct-15, Volume: 60, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1987
Intramedullary spinal cord metastasis in Hodgkin's disease. Rapid diagnosis and treatment resulting in neurologic recovery.
    Cancer, 1987, Oct-15, Volume: 60, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Di

1987
[Twin pregnancy after iatrogenic menopause].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1987, Volume: 16, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Estrogens; Female; Hodgkin Disease; Humans; I

1987
Hodgkins disease: a personal account.
    Nursing, 1987, Volume: 3, Issue:20

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham

1987
[Photochemotherapy of eyelid lesions].
    Annales de dermatologie et de venereologie, 1987, Volume: 114, Issue:6-7

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Eyelid Diseases; Female; Hodgkin Disease; Huma

1987
Hodgkin's disease presenting with central nervous system involvement.
    Australian and New Zealand journal of medicine, 1987, Volume: 17, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal

1987
Improved survival in the treatment of advanced Hodgkin's disease at a nonuniversity institution (1970-1979).
    Cancer, 1986, Jan-01, Volume: 57, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu

1986
Mallory-Weiss tear and cytotoxic-induced emesis.
    The Medical journal of Australia, 1986, Jan-20, Volume: 144, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Male; Mallory-Weiss

1986
Reversible mechlorethamine-associated hearing loss in a patient with Hodgkin's disease.
    Cancer, 1986, Mar-15, Volume: 57, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Audiometry; Auditory Threshold; Cyclophospham

1986
Variation of SCE frequency in lymphocyte cultures from patients with Hodgkin's disease before, during, and after treatment.
    Cancer genetics and cytogenetics, 1986, Feb-01, Volume: 20, Issue:1-2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Hodgkin Disease; Human

1986
Pancytopenia with myelofibrosis. An unusual presentation of childhood Hodgkin's disease.
    Clinical pediatrics, 1986, Volume: 25, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Child; Female; Hodgkin Disease; Humans;

1986
Gastric non-Hodgkin's lymphoma after successful treatment of Hodgkin's disease.
    Oncology, 1986, Volume: 43, Issue:2

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Celiac Disease; Hodgkin Disease; Humans; Immun

1986
[Clinical features and treatment of Hodgkin's disease].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1986, Volume: 13, Issue:3 Pt 1

    Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Immunity, Cellular;

1986
Purpura fulminans in pneumococcal sepsis.
    Archives of internal medicine, 1986, Volume: 146, Issue:3

    Topics: Acute Kidney Injury; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Fema

1986
Unusual thoracic radiographic findings in children treated for Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:6

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

1986
A rare opportunity to observe aspects of the natural history of untreated Hodgkin's disease.
    The Medical journal of Australia, 1986, Jun-09, Volume: 144, Issue:12

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Lymph Nodes;

1986
[Hodgkin's disease in children; treatment results with or without radiotherapy].
    Nederlands tijdschrift voor geneeskunde, 1986, May-10, Volume: 130, Issue:19

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1986
Prognostic significance of tumour burden in Hodgkin's disease PS I and II.
    Scandinavian journal of haematology, 1986, Volume: 36, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Mediastina

1986
[Hodgkin's disease in children; treatment results with or without radiotherapy].
    Nederlands tijdschrift voor geneeskunde, 1986, May-17, Volume: 130, Issue:20

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Hodgkin Disease; Humans; Mechlorethamine; Pre

1986
Lymphomatoid papulosis: remission following intravenously administered acyclovir.
    Dermatologica, 1986, Volume: 172, Issue:6

    Topics: Acyclovir; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Injections, Intr

1986
[The role of radiotherapy in the treatment of stage I-II Hodgkin's disease in children].
    Meditsinskaia radiologiia, 1986, Volume: 31, Issue:7

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1986
MOPP after two decades.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1986, Volume: 4, Issue:9

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1986
Treatment of Hodgkin's disease stages I and II with chemotherapy alone.
    Medical and pediatric oncology, 1986, Volume: 14, Issue:4

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Female; Hodgkin Disease; H

1986
Hodgkin's disease presenting with isolated craniospinal involvement.
    Cancer, 1986, Oct-15, Volume: 58, Issue:8

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Combined Modality Therapy; D

1986
Thymic hyperplasia masquerading as recurrent Hodgkin's disease: case report and review of the literature.
    Journal of surgical oncology, 1986, Volume: 33, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Hodgkin Disease

1986
[The role of radiotherapy in the treatment of Stage IIIA Hodgkin's disease in children].
    Voprosy onkologii, 1986, Volume: 32, Issue:9

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modali

1986
Chemotherapy treated Hodgkins disease--a fifteen year review.
    Irish journal of medical science, 1986, Volume: 155, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Female; Follow-Up Studies; Hodg

1986
Treatment of pathologically staged IIIA Hodgkin's disease.
    American journal of clinical oncology, 1986, Volume: 9, Issue:5

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female; Hodgkin Disease;

1986
MOPP after two decades.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1987
Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    The New England journal of medicine, 1987, Mar-19, Volume: 316, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Combined Modality Therapy;

1987
Radiotherapy of stage I and II Hodgkin disease with inguinal presentation.
    Radiology, 1985, Volume: 154, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy;

1985
Cystic degeneration of thymic Hodgkin's disease following radiation therapy.
    Cancer, 1985, Jan-15, Volume: 55, Issue:2

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cysts; Diagnosis, Differential; Hodgkin Disea

1985
Clinical significance of heat labile Regan isoenzyme variant in Hodgkin's disease.
    Cancer, 1985, Feb-01, Volume: 55, Issue:3

    Topics: Adult; Alkaline Phosphatase; Antineoplastic Combined Chemotherapy Protocols; GPI-Linked Proteins; Ho

1985
The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Tolerance; Female; Hod

1985
Hodgkin's disease in adults: the challenge.
    Postgraduate medical journal, 1985, Volume: 61, Issue:712

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Laparotomy; Mechlore

1985
[Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
    Deutsche medizinische Wochenschrift (1946), 1985, Apr-19, Volume: 110, Issue:16

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Hodgkin Disease; Hu

1985
Simultaneous presentation of relapsing Hodgkin's disease and treatment-related non-Hodgkin's lymphoma.
    Medical and pediatric oncology, 1985, Volume: 13, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; Humans;

1985
Hodgkin's disease, intracranial involvement. Report of a case and review of the literature.
    American journal of clinical oncology, 1985, Volume: 8, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Hodgkin Disease; Humans; Mal

1985
Stage III Hodgkin's disease: improved survival with combined modality therapy as compared with radiation therapy alone.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:9

    Topics: Actuarial Analysis; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child;

1985
[MOPP therapy of Hodgkin's disease previously treated with MOPP].
    Medicina clinica, 1985, May-18, Volume: 84, Issue:19

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Mechlorethamine; Prednisone

1985
[Pregnancy and fetal development after therapy of Hodgkin's disease].
    Strahlentherapie, 1985, Volume: 161, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Embryonic and Fetal Develop

1985
Therapeutic implications of mediastinal involvement in advanced Hodgkin's disease.
    Scandinavian journal of haematology, 1985, Volume: 35, Issue:2

    Topics: Antineoplastic Combined Chemotherapy Protocols; Follow-Up Studies; Hodgkin Disease; Humans; Mechlore

1985
Osteonecrosis of sternum and rib in a patient treated for Hodgkin's disease.
    Cancer, 1985, Nov-01, Volume: 56, Issue:9

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H

1985
Pediatric Hodgkin's disease in India.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:12

    Topics: Actuarial Analysis; Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child;

1985
[Primary gastric Hodgkin's disease].
    Zhonghua zhong liu za zhi [Chinese journal of oncology], 1985, Volume: 7, Issue:5

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Hodgkin Disease; H

1985
[The role of radiotherapy in the treatment of Hodgkin's disease].
    Gan no rinsho. Japan journal of cancer clinics, 1985, Volume: 31, Issue:15

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Th

1985
[Acute lymphoblastic leukemia L3 in Hodgkin's disease in remission: primary or secondary leukosis?].
    Recenti progressi in medicina, 1985, Volume: 76, Issue:4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Hodgkin Disease; Humans; Karyotyping; Leukemia, Lymp

1985
Varicella in immunodepressed children.
    Postgraduate medical journal, 1985, Volume: 61 Suppl 4

    Topics: Antineoplastic Combined Chemotherapy Protocols; Chickenpox; Child; Female; Hodgkin Disease; Humans;

1985
Reduction of fatal complications from combined modality therapy in Hodgkin's disease.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1985, Volume: 3, Issue:4

    Topics: Actuarial Analysis; Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Pro

1985
Current status and new vistas in combination chemotherapy.
    The Mount Sinai journal of medicine, New York, 1985, Volume: 52, Issue:6

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Hodgkin Disease; H

1985
Pregnancy after chemotherapy induced ovarian failure.
    British medical journal (Clinical research ed.), 1985, Mar-23, Volume: 290, Issue:6472

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Hodgkin Disease; Humans; Mechloretham

1985
Stage IA to IIB supradiaphragmatic Hodgkin's disease. Long-term survival and relapse frequency.
    Cancer, 1985, May-01, Volume: 55, Issue:9 Suppl

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Presch

1985
The management of stage II Hodgkin's disease with a large mediastinal mass: a prospective program emphasizing irradiation.
    International journal of radiation oncology, biology, physics, 1985, Volume: 11, Issue:2

    Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy;

1985
Risk of acute nonlymphocytic leukemia and preleukemia in patients treated with cyclophosphamide for non-Hodgkin's lymphomas. Comparison with results obtained in patients treated for Hodgkin's disease and ovarian carcinoma with other alkylating agents.
    Annals of internal medicine, 1985, Volume: 103, Issue:2

    Topics: Acute Disease; Adolescent; Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Prot

1985
Management of malignant lymphomas: a practical and philosophical approach.
    Southern medical journal, 1973, Volume: 66, Issue:1

    Topics: Bleomycin; Cyclophosphamide; Hodgkin Disease; Hospitals, Special; Humans; Laparotomy; Lymphoma; Mech

1973
Clinical trials with intensive chemotherapy and radiotherapy in Hodgkin's disease.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bleomycin; Child; Doxorubicin; Drug Therapy, Combina

1973
International Symposium on Hodgkin's Disease. Session 4. Small group workshops. Report on workshop: Chemotherapy.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Antineoplastic Agents; Bleomycin; Carmustine; Doxorubicin; Drug Therapy, Combination; Hodgkin Diseas

1973
Acute leukemia in Hodgkin's disease.
    Cancer, 1974, Volume: 33, Issue:5

    Topics: Adult; Bleomycin; Carmustine; Chlorambucil; Drug Therapy, Combination; Female; Hodgkin Disease; Huma

1974
Prognosis and survival with extranodal Hodgkin's disease.
    Journal of chronic diseases, 1974, Volume: 27, Issue:9-10

    Topics: Adult; Carmustine; Chlorambucil; Cyclophosphamide; Drug Therapy, Combination; Hodgkin Disease; Human

1974
[Chemotherapy of Hodgkin's disease].
    La Revue du praticien, 1974, Oct-11, Volume: 24, Issue:45

    Topics: Antineoplastic Agents; Bleomycin; Drug Hypersensitivity; Drug Therapy, Combination; Hodgkin Disease;

1974
Letter: Chemotherapy of Hodgkin's disease.
    Lancet (London, England), 1974, Dec-07, Volume: 2, Issue:7893

    Topics: Adolescent; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Hodgkin D

1974
[Cytostatic effects on nucleic acid- and protein synthesis of benign and malignant lymphomas].
    Chemotherapy, 1967, Volume: 12, Issue:3

    Topics: Amides; Antineoplastic Agents; Dactinomycin; DNA, Neoplasm; Hodgkin Disease; Humans; Hydralazine; In

1967
[Hodgkin's disease in the practice of general medicine. Problems posed by the diagnosis, surveillance of treatments and social rehabilitation of patients].
    La Revue du praticien, 1974, Oct-11, Volume: 24, Issue:45

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Biopsy; Chlorambucil; Cyclophosphamide; Hodgkin

1974
Amyloidosis: origin from fixed periodic acid-Schiff positive reticuloendothelial cells in loco and basic factors in pathogenesis.
    American journal of pharmacy and the sciences supporting public health, 1966, Volume: 15, Issue:1 Pt 1

    Topics: Adrenocorticotropic Hormone; Agammaglobulinemia; Amyloidosis; Animals; Arthritis, Rheumatoid; Cortis

1966
The treatment of malignant pleural effusions.
    Cancer, 1974, Volume: 33, Issue:4

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Small Cell; Carcinoma, Squamou

1974
[Confusion of uncertain etiology in Hodgkin's disease].
    Lakartidningen, 1974, Sep-18, Volume: 71, Issue:38

    Topics: Aged; Cognition Disorders; Female; Herpes Zoster; Hodgkin Disease; Humans; Mechlorethamine; Predniso

1974
Association of Hodgkin disease and Gaucher disease.
    Archives of pathology, 1974, Volume: 98, Issue:6

    Topics: Adult; Autopsy; Biopsy; Gaucher Disease; Hodgkin Disease; Humans; Liver; Lymph Nodes; Lymphocytes; M

1974
Letter: Chemotherapy of Hodgkin's disease.
    The New England journal of medicine, 1974, Dec-12, Volume: 291, Issue:24

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Remis

1974
[Treatment of Hodgkin's disease. Experience of the Hôpital Saint-Louis].
    La Revue du praticien, 1974, Oct-11, Volume: 24, Issue:45

    Topics: Antineoplastic Agents; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlore

1974
Hodgkin's disease of the spleen: some clinical aspects and problems.
    Haematologia, 1974, Volume: 8, Issue:1-4

    Topics: Adrenal Cortex Hormones; Adult; Cyclophosphamide; Endoscopy; Female; Hodgkin Disease; Humans; Kerato

1974
Chemotherapy of Hodgkin's disease.
    Australasian radiology, 1974, Volume: 18, Issue:4

    Topics: Adrenal Cortex Hormones; Aged; Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine;

1974
[Hodgkin's disease complicated by myeloblastic leukosis].
    Revue medicale de Liege, 1973, Jun-15, Volume: 28, Issue:12

    Topics: Adult; Biopsy; Hodgkin Disease; Humans; Hydrazines; Leukemia, Myeloid, Acute; Lymph Nodes; Male; Mec

1973
Comparative chemotherapy of AKR lymphoma and human hematological neoplasia.
    Cancer research, 1974, Volume: 34, Issue:1

    Topics: Animals; Antineoplastic Agents; Biological Assay; Carmustine; Cyclohexanes; Cyclophosphamide; Cytara

1974
Evidence for a specific seminiferous tubular factor affecting follicle-stimulating hormone secretion in man.
    The Journal of clinical investigation, 1972, Volume: 51, Issue:4

    Topics: Adult; Biopsy; Cell Count; Clomiphene; Cyclophosphamide; Follicle Stimulating Hormone; Hodgkin Disea

1972
The place of chemotherapy in Hodgkin's disease and allied disorders.
    Proceedings of the Royal Society of Medicine, 1972, Volume: 65, Issue:12

    Topics: Blood Cell Count; Hodgkin Disease; Humans; Laparotomy; Liver Function Tests; Lymphoma, Large B-Cell,

1972
Management of patients with non-Hodgkin's lymphoma.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Lymphography; Ly

1973
Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
    JAMA, 1973, Jan-08, Volume: 223, Issue:2

    Topics: Burkitt Lymphoma; Cyclophosphamide; Hodgkin Disease; Humans; Leukemia; Lymphoma; Lymphoma, Large B-C

1973
Nephrosis of Hodgkin disease. An immune complex-induced lesion.
    Archives of internal medicine, 1973, Volume: 132, Issue:4

    Topics: Antigen-Antibody Complex; Basement Membrane; Biopsy; Blood Urea Nitrogen; Body Weight; Capillaries;

1973
Updated Hodgkin's disease: B. Curability of localized disease. Comment: The mantle failure: The transdiaphragmatic extension.
    JAMA, 1973, Jan-01, Volume: 223, Issue:1

    Topics: Diaphragm; Hodgkin Disease; Humans; Lymph Nodes; Lymphography; Mechlorethamine; Methods; Procarbazin

1973
Treatment of Hodgkin's disease. Results obtained by individualized treatment using radiotherapy and cytostatics.
    Scandinavian journal of haematology, 1972, Volume: 9, Issue:6

    Topics: Adolescent; Adult; Aged; Child; Cyclophosphamide; Female; Hodgkin Disease; Humans; Male; Mechloretha

1972
The MOPP controversy.
    Eye, ear, nose & throat monthly, 1972, Volume: 51, Issue:12

    Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincristine

1972
Multiple-drug therapy in Hodgkin's disease.
    European journal of cancer, 1972, Volume: 8, Issue:5

    Topics: Antiemetics; Drug Synergism; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Prednisone; Pro

1972
The treatment of Hodgkin's disease.
    Transactions of the Medical Society of London, 1972, Volume: 88

    Topics: Agranulocytosis; Antineoplastic Agents; Bone Marrow Diseases; Chlorambucil; Drug Combinations; Hodgk

1972
Treatment of Hodgkin's disease.
    JAMA, 1972, Volume: 222, Issue:4

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Procarbazine; Referral and Consultat

1972
Combination chemotherapy of acute leukemia and Hodgkin's disease.
    JAMA, 1972, Nov-27, Volume: 222, Issue:9

    Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Leukemia; Mechlorethamine; Predni

1972
Hodgkin's disease therapeutic program.
    JAMA, 1972, Nov-27, Volume: 222, Issue:9

    Topics: Antineoplastic Agents; Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Proc

1972
Splenectomy effects on chemotherapy in Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Evaluation Studies as Topic; Ho

1973
Eastern cooperative oncology group studies.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Antineoplastic Agents; Blood Cell Count; Carmustine; Cyclophosphamide; Hodgkin Disease; Humans; Mech

1973
Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Adult; Antineoplastic Agents; Benzoates; Blood Cell Count; Blood Platelets; Cyclophosphamide; Evalua

1973
Low dose radiation therapy and combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Radiology, 1973, Volume: 107, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Female; Hodgkin Disease; Humans; Male; Mechlorethami

1973
Antidiuretic response to cyclophosphamide in man.
    The Journal of pharmacology and experimental therapeutics, 1973, Volume: 185, Issue:2

    Topics: Adult; Aged; Cyclophosphamide; Diuresis; Female; Glomerular Filtration Rate; Hodgkin Disease; Humans

1973
MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients.
    Cancer, 1973, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Age Factors; Aged; Antineoplastic Agents; Benzoates; Evaluation Studies as Topic;

1973
Chemotherapy in Hodgkin's disease (lymphadenoma).
    Drug and therapeutics bulletin, 1973, Jul-20, Volume: 11, Issue:15

    Topics: Drug Combinations; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vinca Alkaloi

1973
[Non-leukemic hematosarcomas. Hodgkin's disease. Current therapeutic ideas. Personal experience with multiple drug therapy].
    Revue medicale de Liege, 1973, Jun-15, Volume: 28, Issue:12

    Topics: Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Methylprednisolone; Procarbazine; Vincrist

1973
Hodgkin's disease of the colon.
    Southern medical journal, 1973, Volume: 66, Issue:9

    Topics: Adult; Biopsy; Colonic Neoplasms; Female; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Pre

1973
Status and perspectives in chemotherapy of Hodgkin's disease.
    Archives of internal medicine, 1973, Volume: 131, Issue:3

    Topics: Animals; Antineoplastic Agents; Benzoates; Breast Neoplasms; Burkitt Lymphoma; Cyclophosphamide; Cyt

1973
Updated Hodgkin's disease. C. Advanced disease and special problems. Management with combination therapy.
    JAMA, 1973, Jan-08, Volume: 223, Issue:2

    Topics: Antineoplastic Agents; Benzoates; Carmustine; Hodgkin Disease; Humans; Mechlorethamine; Prednisone;

1973
Updated Hodgkins' disease. C. Advanced disease and special problems. Advances in chemotherapy.
    JAMA, 1973, Jan-08, Volume: 223, Issue:2

    Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu

1973
Updated Hodgkin's disease. C. Advanced disease and special problems. Combined chemotherapy-radiotherapy program.
    JAMA, 1973, Jan-08, Volume: 223, Issue:2

    Topics: Antineoplastic Agents; Benzoates; Cyclophosphamide; Evaluation Studies as Topic; Hodgkin Disease; Hu

1973
Combined drug treatment of Hodgkin's disease: remission induction, remission duration, and survival; an appraisal.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Adult; Age Factors; Antineoplastic Agents; Biopsy; Carmustine; Chlorambucil; Cyclophosphamide; Dacti

1973
Combination chemotherapy in advanced and recurrent Hodgkin's disease.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination;

1973
Intensive chemotherapy for Hodgkin's disease: long-term complications.
    National Cancer Institute monograph, 1973, Volume: 36

    Topics: Antineoplastic Agents; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; E

1973
The use of different drugs and combinations in the treatment of Hodgkin's disease.
    Series haematologica (1968), 1973, Volume: 6, Issue:2

    Topics: Administration, Oral; Anemia; Drug Evaluation; Drug Therapy, Combination; Hodgkin Disease; Humans; I

1973
Hodgkin's disease in childhood.
    Blood, 1973, Volume: 42, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Child; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Pr

1973
Uremia due to occult lymphomatous infiltration of the kidneys.
    Cancer, 1974, Volume: 33, Issue:1

    Topics: Biopsy; Drug Therapy, Combination; Female; Hodgkin Disease; Humans; Kidney Neoplasms; Mechlorethamin

1974
Letter: Therapy for Hodgkin's disease.
    Annals of internal medicine, 1974, Volume: 80, Issue:2

    Topics: Drug Therapy, Combination; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Vincr

1974
[Pathology of treated Hodgkin's disease. A retrospective study (author's transl)].
    Deutsche medizinische Wochenschrift (1946), 1974, Feb-15, Volume: 99, Issue:7

    Topics: Adolescent; Adult; Age Factors; Aged; Autopsy; Child; Child, Preschool; Drug Therapy, Combination; D

1974
Protection from chemotherapeutic epilation by prior irradiation.
    Radiology, 1974, Volume: 112, Issue:1

    Topics: Adolescent; Alopecia; Antineoplastic Agents; Child; Cyclophosphamide; Drug Therapy, Combination; Fem

1974
Combination chemotherapy of Hodgkin's disease.
    Cancer, 1974, Volume: 33, Issue:6

    Topics: Age Factors; Bone Marrow; Drug Therapy, Combination; Evaluation Studies as Topic; Follow-Up Studies;

1974
[Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease].
    Harefuah, 1974, Apr-01, Volume: 86, Issue:7

    Topics: Adolescent; Adult; Child; Child, Preschool; Disseminated Intravascular Coagulation; Drug Therapy, Co

1974
Combination chemotherapy.
    Proceedings of the Royal Society of Medicine, 1974, Volume: 67, Issue:6 Pt 1

    Topics: Antineoplastic Agents; Bone Marrow; Bone Marrow Cells; Chemical Phenomena; Chemistry; Daunorubicin;

1974
Combined chemotherapy and radiotherapy for advanced Hodgkin's disease and reticulum cell sarcoma: a preliminary report.
    Southern medical journal, 1971, Volume: 64, Issue:7

    Topics: Adolescent; Adult; Aged; Blood Cell Count; Cyclophosphamide; Female; Hodgkin Disease; Humans; Lympho

1971
Combination chemotherapy in malignant disease.
    Clinical radiology, 1971, Volume: 22, Issue:4

    Topics: Administration, Oral; Blood Cell Count; Breast Neoplasms; Bronchial Neoplasms; Child, Preschool; Fem

1971
Severe cerebral toxicity after intravenous nitrogen mustard therapy.
    Cancer, 1972, Volume: 29, Issue:2

    Topics: Adult; Brain Diseases; Coma; Dexamethasone; Diuresis; Fever; Hodgkin Disease; Humans; Hydrocephalus;

1972
Combination chemotherapy (MOPP) in the management of advanced Hodgkin's disease. A progress report on 55 patients.
    The Medical journal of Australia, 1972, Jan-08, Volume: 1, Issue:2

    Topics: Adolescent; Adrenal Cortex Hormones; Adult; Benzoates; Bone and Bones; Drug Combinations; Female; Ho

1972
Endobronchial Hodgkin's disease and bronchoesophageal fistula.
    Chest, 1972, Volume: 61, Issue:7

    Topics: Adult; Biopsy; Bronchial Fistula; Bronchial Neoplasms; Bronchopneumonia; Esophageal Fistula; Female;

1972
Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
    Blood, 1972, Volume: 39, Issue:5

    Topics: Agranulocytosis; Alkylating Agents; Bone Marrow Cells; Bone Marrow Examination; Cyclophosphamide; En

1972
Combination chemotherapy of Hodgkin's disease in private practice.
    JAMA, 1972, Jul-17, Volume: 221, Issue:3

    Topics: Adolescent; Adult; Aged; Anemia; Biopsy; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Mid

1972
Treatment of Hodgkin's disease in private practice.
    JAMA, 1972, Jul-17, Volume: 221, Issue:3

    Topics: Hodgkin Disease; Humans; Mechlorethamine; Medicine; Prednisone; Private Practice; Procarbazine; Refe

1972
[Hodgkin's disease].
    Naika. Internal medicine, 1971, Volume: 27, Issue:6

    Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Chlorambucil; Cyclophosphamide; Fema

1971
Hodgkin's disease of the bone marrow.
    Cancer research, 1971, Volume: 31, Issue:11

    Topics: Alkaline Phosphatase; Blood Platelets; Bone Marrow; Drug Combinations; Hematocrit; Hodgkin Disease;

1971
[Results of treatment of Hodgkin's disease with large doses of nitrogranulogen and glucocorticoids].
    Wiadomosci lekarskie (Warsaw, Poland : 1960), 1971, Nov-15, Volume: 24, Issue:22

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Drug Synergism; Female; Glucocorticoids; Hodgkin Dis

1971
Solitary intracranial metastasis by Hodgkin's disease.
    Archives of internal medicine, 1967, Volume: 120, Issue:6

    Topics: Adult; Brain Neoplasms; Cerebral Angiography; Cerebral Ventriculography; Dura Mater; Female; Hodgkin

1967
Lymphoma-like presentation of Kaposi's sarcoma. Three cases without characteristic skin lesions.
    Archives of dermatology, 1966, Volume: 93, Issue:5

    Topics: Aged; Blood; Blood Protein Electrophoresis; Diagnosis, Differential; Female; Hodgkin Disease; Humans

1966
Recent advances in chemotherapy of lymphoma.
    The Johns Hopkins medical journal, 1967, Volume: 121, Issue:2

    Topics: Alkylating Agents; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Lymphoma; Lymphoma, Larg

1967
A comparison of nitrogen mustard and vinblastine sulfate in the treatment of patients with Hodgkin's disease.
    Canadian Medical Association journal, 1970, Feb-14, Volume: 102, Issue:3

    Topics: Adolescent; Adult; Aged; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Vinbla

1970
Chemotherapy of the lymphomas.
    Proceedings of the Royal Society of Medicine, 1970, Volume: 63, Issue:1

    Topics: Antimetabolites; Cyclophosphamide; Female; Hodgkin Disease; Humans; Hydrazines; Lymphoma; Mechloreth

1970
Combination chemotherapy in generalized Hodgkin's disease.
    British medical journal, 1970, Jul-04, Volume: 3, Issue:5713

    Topics: Antimetabolites; Bone Marrow; Drug Synergism; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine;

1970
[Chemotherapy of malignant lymphomas].
    Duodecim; laaketieteellinen aikakauskirja, 1970, Volume: 86, Issue:16

    Topics: Adrenal Cortex Hormones; Amines; Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines

1970
Long-term remission in Hodgkin's disease after nitrogen mustard therapy.
    Cancer, 1970, Volume: 26, Issue:4

    Topics: Adolescent; Biopsy; Hodgkin Disease; Humans; Male; Mechlorethamine; Prognosis

1970
Procarbazine hydrochloride (Matulane) for Hodgkin's disease.
    The Medical letter on drugs and therapeutics, 1970, Aug-21, Volume: 12, Issue:17

    Topics: Antineoplastic Agents; Benzoates; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Vincristine

1970
Treatment of Hodgkin's disease: with what and by whom?
    Annals of internal medicine, 1970, Volume: 73, Issue:6

    Topics: Cyclophosphamide; Drug Synergism; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine

1970
Combination chemotherapy in the treatment of advanced Hodgkin's disease.
    Annals of internal medicine, 1970, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Bone Neoplasms; Child; Cyclophosphamide; Drug Synerg

1970
A combined clinical and histological assessment of survival of patients with Hodgkin's disease.
    Journal of clinical pathology, 1971, Volume: 24, Issue:5

    Topics: Biopsy; Follow-Up Studies; Hodgkin Disease; Humans; Lymph Nodes; Mechlorethamine; Prognosis

1971
Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
    Radiologic clinics of North America, 1968, Volume: 6, Issue:1

    Topics: Adult; Antineoplastic Agents; Busulfan; Chlorambucil; Hodgkin Disease; Humans; Leukemia; Lymphoma; M

1968
[Hodgkin's disease in children. Study of 72 personal cases].
    Archives francaises de pediatrie, 1968, Volume: 25, Issue:3

    Topics: Adolescent; Child; Child, Preschool; Female; Hodgkin Disease; Humans; Hydrazines; Male; Mechloretham

1968
[The phenomenon of nitrogen mustard aggravation].
    Turk Tip Cemiyeti mecmuasi, 1968, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Aged; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Paraplegia; Sp

1968
Endobronchial presentation of malignant lymphoma.
    The American review of respiratory disease, 1968, Volume: 98, Issue:5

    Topics: Bone Neoplasms; Bronchial Neoplasms; Bronchoscopy; Chlorambucil; Hodgkin Disease; Humans; Male; Mech

1968
Response of the fever of Hodgkin's disease to nitrogen mustard (NSC-762): an evaluation of its significance.
    Cancer chemotherapy reports, 1969, Volume: 53, Issue:2

    Topics: Adolescent; Adult; Aged; Female; Fever; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged

1969
Perforation of transverse colon in a patient with Hodgkin's disease.
    Canadian Medical Association journal, 1965, Oct-09, Volume: 93, Issue:15

    Topics: Adolescent; Colonic Neoplasms; Cyclophosphamide; Female; Hodgkin Disease; Humans; In Vitro Technique

1965
Control of fever in Hodgkin's disease by indomethacin.
    JAMA, 1965, Nov-08, Volume: 194, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antineoplastic Agents; Aspirin; Female; Fever

1965
Advanced Hodgkin's disease. Management with chemotherapeutic agents.
    JAMA, 1965, Jan-25, Volume: 191, Issue:4

    Topics: Chlorambucil; Cyclophosphamide; Hodgkin Disease; Humans; Hydrazines; Mechlorethamine; Prednisone; Vi

1965
Hypogammaglobulinemia in Hodgkin's disease treated with nitrogen mustard.
    Archives of internal medicine, 1966, Volume: 118, Issue:3

    Topics: Adult; Agammaglobulinemia; Hodgkin Disease; Humans; Liver Neoplasms; Male; Mechlorethamine

1966
[On the genesis of amyloidosis during Hodgkin's granuloma. (Considerations on therapeutic treatment].
    Giornale di clinica medica, 1966, Volume: 47, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Amyloidosis; Female; Hodgkin Disease; Humans; Male; Mechlorethamine;

1966